<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD004953.pub3" GROUP_ID="NEONATAL" ID="640903101615541084" MERGED_FROM="" MODIFIED="2017-07-21 18:59:48 +0100" MODIFIED_BY="Colleen Ovelman" REVIEW_NO="" REVMAN_SUB_VERSION="5.3.5 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="7.0">
<COVER_SHEET MODIFIED="2017-07-21 13:59:16 -0400" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2014-12-30 10:43:04 -0500" MODIFIED_BY="[Empty name]">Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes</TITLE>
<CONTACT>
<PERSON ID="74399549152662702367110526175045" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Matteo</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Bruschettini</LAST_NAME>
<SUFFIX/>
<POSITION>Senior Consultant Neonatologist</POSITION>
<EMAIL_1>matteo.bruschettini@med.lu.se</EMAIL_1>
<EMAIL_2>matbrus@gmail.com</EMAIL_2>
<URL>www.matteobruschettini.com</URL>
<MOBILE_PHONE>+46769307828</MOBILE_PHONE>
<ADDRESS>
<DEPARTMENT>Department of Paediatrics</DEPARTMENT>
<ORGANISATION>Lund University, Skåne University Hospital</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>Lund</CITY>
<ZIP/>
<REGION/>
<COUNTRY CODE="SE">Sweden</COUNTRY>
<PHONE_1>+46769307828</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CONTACT>
<CREATORS MODIFIED="2017-07-21 13:59:03 -0400" MODIFIED_BY="Colleen Ovelman">
<PERSON ID="74399549152662702367110526175045" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Matteo</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Bruschettini</LAST_NAME>
<SUFFIX/>
<POSITION>Senior Consultant Neonatologist</POSITION>
<EMAIL_1>matteo.bruschettini@med.lu.se</EMAIL_1>
<EMAIL_2>matbrus@gmail.com</EMAIL_2>
<URL>www.matteobruschettini.com</URL>
<MOBILE_PHONE>+46769307828</MOBILE_PHONE>
<ADDRESS>
<DEPARTMENT>Department of Paediatrics</DEPARTMENT>
<ORGANISATION>Lund University, Skåne University Hospital</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>Lund</CITY>
<ZIP/>
<REGION/>
<COUNTRY CODE="SE">Sweden</COUNTRY>
<PHONE_1>+46769307828</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="18339" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Colm</FIRST_NAME>
<MIDDLE_INITIALS>PF</MIDDLE_INITIALS>
<LAST_NAME>O'Donnell</LAST_NAME>
<SUFFIX/>
<POSITION>Consultant Neonatologist</POSITION>
<EMAIL_1>codonnell@nmh.ie</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Neonatology</DEPARTMENT>
<ORGANISATION>National Maternity Hospital</ORGANISATION>
<ADDRESS_1>Holles Street</ADDRESS_1>
<ADDRESS_2/>
<CITY>Dublin 2</CITY>
<ZIP/>
<REGION/>
<COUNTRY CODE="IE">Ireland</COUNTRY>
<PHONE_1>+353 1 6373100</PHONE_1>
<PHONE_2/>
<FAX_1>+353 1 6614623</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="17716" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Peter</FIRST_NAME>
<MIDDLE_INITIALS>G</MIDDLE_INITIALS>
<LAST_NAME>Davis</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>pgd@unimelb.edu.au</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT/>
<ORGANISATION>The University of Melbourne</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>Melbourne</CITY>
<ZIP/>
<REGION/>
<COUNTRY CODE="AU">Australia</COUNTRY>
<PHONE_1>+61 3 83453763</PHONE_1>
<PHONE_2/>
<FAX_1>+61 3 83453789</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="15287" ROLE="AUTHOR">
<PREFIX>Prof</PREFIX>
<FIRST_NAME>Colin</FIRST_NAME>
<MIDDLE_INITIALS>J</MIDDLE_INITIALS>
<LAST_NAME>Morley</LAST_NAME>
<SUFFIX>MA DCH MD FRCPCH</SUFFIX>
<POSITION/>
<EMAIL_1>colin@morleys.net</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Obstetrics and Gynecology</DEPARTMENT>
<ORGANISATION>University of Cambridge</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>Cambridge</CITY>
<ZIP/>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="19748" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Lorenzo</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Moja</LAST_NAME>
<SUFFIX>MD, MSc, Dr Pub Health, PhD</SUFFIX>
<POSITION/>
<EMAIL_1>lorenzo.moja@unimi.it</EMAIL_1>
<EMAIL_2/>
<URL>www.cochrane.it</URL>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Biomedical Sciences for Health</DEPARTMENT>
<ORGANISATION>University of Milan</ORGANISATION>
<ADDRESS_1>Via Pascal 36</ADDRESS_1>
<ADDRESS_2/>
<CITY>Milan</CITY>
<ZIP>20133</ZIP>
<REGION/>
<COUNTRY CODE="IT">Italy</COUNTRY>
<PHONE_1>+390239014517</PHONE_1>
<PHONE_2/>
<FAX_1>+39023559048</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="11859217973128491003110526175816" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Simona</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Zappettini</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>simona.zappettini@regione.liguria.it</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT/>
<ORGANISATION>Regional Health Agency of the Liguria Region</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>Genoa</CITY>
<ZIP/>
<REGION/>
<COUNTRY CODE="IT">Italy</COUNTRY>
<PHONE_1>+390105488217</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="06949243198815337251110526175424" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Maria Grazia</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Calevo</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>mariagraziacalevo@ospedale-gaslini.ge.it</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Epidemiology, Biostatistics and Committees Unit</DEPARTMENT>
<ORGANISATION>Istituto Giannina Gaslini</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>Genoa</CITY>
<ZIP>16147</ZIP>
<REGION/>
<COUNTRY CODE="IT">Italy</COUNTRY>
<PHONE_1>+390105636301/423</PHONE_1>
<PHONE_2/>
<FAX_1>+390108981116</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CREATORS>
<DATES MODIFIED="2017-02-17 11:29:01 -0500" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="17" MONTH="2" YEAR="2017"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="17" MONTH="2" YEAR="2017"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="17" MONTH="2" YEAR="2019"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="4" YEAR="2004"/>
<REVIEW_PUBLISHED ISSUE="7" YEAR="2015"/>
<LAST_CITATION_ISSUE ISSUE="7" YEAR="2017"/>
</DATES>
<WHATS_NEW MODIFIED="2017-07-21 13:59:16 -0400" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2017-07-21 13:57:47 -0400" MODIFIED_BY="[Empty name]">
<DATE DAY="21" MONTH="7" YEAR="2017"/>
<DESCRIPTION>
<P>Typo corrected: Schwaberger 2015 used near-infrared spectroscopy (NIRS) not a numerical rating scale (NRS).</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2017-07-21 13:59:16 -0400" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2017-07-21 13:59:16 -0400" MODIFIED_BY="[Empty name]">
<DATE DAY="13" MONTH="6" YEAR="2017"/>
<DESCRIPTION>
<P>We included six new studies but made no changes to the main conclusions </P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2017-07-21 13:59:12 -0400" MODIFIED_BY="[Empty name]">
<DATE DAY="13" MONTH="6" YEAR="2017"/>
<DESCRIPTION>
<P>We updated searches in 2017 and found six new eligible studies for inclusion</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2017-07-09 06:56:34 -0400" MODIFIED_BY="[Empty name]">
<DATE DAY="6" MONTH="7" YEAR="2015"/>
<DESCRIPTION>
<P>We updated review author affiliation</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2017-07-09 06:56:45 -0400" MODIFIED_BY="[Empty name]">
<DATE DAY="10" MONTH="7" YEAR="2008"/>
<DESCRIPTION>
<P>We converted the review to new review format</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2017-07-12 04:49:01 -0400" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES MODIFIED="2017-07-12 04:47:35 -0400" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2017-07-12 04:47:35 -0400" MODIFIED_BY="[Empty name]">
<NAME>Institute for Clinical Sciences, Lund University; Research &amp; Development, Section for HTA Analysis, Skåne University Hospital, Lund</NAME>
<COUNTRY CODE="SE">Sweden</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE MODIFIED="2015-04-06 12:20:30 -0400" MODIFIED_BY="[Empty name]">
<NAME>Royal Women's Hospital, Melbourne</NAME>
<COUNTRY CODE="AU">Australia</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE MODIFIED="2015-04-06 12:20:29 -0400" MODIFIED_BY="[Empty name]">
<NAME>University of Melbourne</NAME>
<COUNTRY CODE="AU">Australia</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE MODIFIED="2015-04-06 12:20:16 -0400" MODIFIED_BY="[Empty name]">
<NAME>Istituto Giannina Gaslini, Genoa</NAME>
<COUNTRY CODE="IT">Italy</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES MODIFIED="2017-07-12 04:49:01 -0400" MODIFIED_BY="[Empty name]">
<SOURCE>
<NAME>Murdoch Childrens Research Insitute</NAME>
<COUNTRY CODE="AU">Australia</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>National Health and Medical Research Council</NAME>
<COUNTRY CODE="AU">Australia</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE MODIFIED="2017-07-12 04:49:01 -0400" MODIFIED_BY="[Empty name]">
<NAME>Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services</NAME>
<COUNTRY CODE="US">USA</COUNTRY>
<DESCRIPTION>
<UL>
<LI>Editorial support of the Cochrane Neonatal Review Group has been funded with Federal funds from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services, USA, under Contract No. HHSN275201100016C</LI>
</UL>
</DESCRIPTION>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2017-07-19 17:34:00 -0400" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2017-07-12 05:20:32 -0400" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2013-06-07 12:56:56 -0400" MODIFIED_BY="[Empty name]">Prolonged lung inflation for neonatal resuscitation</TITLE>
<SUMMARY_BODY MODIFIED="2017-07-12 05:20:32 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>Review question</B>
</P>
<P>Does the use of prolonged (or sustained, &gt; 1 second duration) lung inflation rather than standard inflations (&#8804; 1 second) improve survival and other important outcomes among newly born babies receiving resuscitation at birth?</P>
<P>
<B>Background</B>
</P>
<P>At birth, the lungs are filled with fluid, which must be replaced by air for babies to breathe properly. Some babies have difficulty establishing effective breathing at birth, and 1 in every 20 to 30 babies receives help to do so. A variety of devices are used to help babies begin normal breathing. Some of these devices allow caregivers to give long (or sustained) inflations. These sustained inflations may help inflate the lungs and may keep the lungs inflated better than if they are not used.</P>
<P>
<B>Study characteristics</B>
</P>
<P>We collected and analysed all relevant studies to answer the review question and found eight studies enrolling 941 infants. In all studies, babies were born before the due date (from 23 to 36 weeks of gestational age). The sustained inflation lasted between 15 and 20 seconds at pressure between 20 and 30 cmH<SUB>2</SUB>O. Most studies provided one or more additional sustained inflations in cases of poor clinical response, for example, persistent low heart rate. We analysed one study (which included only nine babies) separately because researchers combined use of sustained or standard inflations with chest compressions.</P>
<P>
<B>Key results</B>
</P>
<P>The included studies showed no important differences among babies who received sustained versus standard inflations in terms of mortality, need for intubation during the first three days of life, or chronic lung disease. Babies receiving sustained inflation at birth may spend fewer days on mechanical ventilation. Several ongoing studies might help us to clarify whether differences between the two techniques may occur, as now we cannot exclude that small to moderate differences exist.</P>
<P>
<B>Quality of evidence</B>
</P>
<P>The quality of evidence is low to moderate because overall only a small number of studies have looked at this intervention; few babies were included in these studies; and some studies could have been better designed.</P>
<P>
<B>How up-to-date is this review?</B>
</P>
<P>We searched for studies that had been published up to February 2017.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2017-07-12 05:18:13 -0400" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2017-07-12 05:14:02 -0400" MODIFIED_BY="[Empty name]">
<P>At birth, infants' lungs are fluid-filled. For newborns to have a successful transition, this fluid must be replaced by air to enable effective breathing. Some infants are judged to have inadequate breathing at birth and are resuscitated with positive pressure ventilation (PPV). Giving prolonged (sustained) inflations at the start of PPV may help clear lung fluid and establish gas volume within the lungs.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2017-07-10 11:27:43 -0400" MODIFIED_BY="[Empty name]">
<P>To assess the efficacy of an initial sustained (&gt; 1 second duration) lung inflation versus standard inflations (&#8804; 1 second) in newly born infants receiving resuscitation with intermittent PPV.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2017-07-12 05:14:24 -0400" MODIFIED_BY="[Empty name]">
<P>We used the standard search strategy of the Cochrane Neonatal Review Group to search the Cochrane Central Register of Controlled Trials (CENTRAL; 2017, Issue 1), MEDLINE via PubMed (1966 to 17 February 2017), Embase (1980 to 17 February 2017), and the Cumulative Index to Nursing and Allied Health Literature (CINAHL) (1982 to 17 February 2017). We also searched clinical trials databases, conference proceedings, and the reference lists of retrieved articles to identify randomised controlled trials and quasi-randomised trials<B>.</B>
</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2017-07-10 11:30:35 -0400" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trials (RCTs) and quasi-RCTs comparing initial sustained lung inflation (SLI) versus standard inflations given to infants receiving resuscitation with PPV at birth.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2017-07-10 11:31:57 -0400" MODIFIED_BY="[Empty name]">
<P>We assessed the methodological quality of included trials using Cochrane Effective Practice and Organisation of Care Group (EPOC) criteria (assessing randomisation, blinding, loss to follow-up, and handling of outcome data). We evaluated treatment effects using a fixed-effect model with risk ratio (RR) for categorical data and mean, standard deviation (SD), and weighted mean difference (WMD) for continuous data. We assessed the quality of evidence using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2017-07-12 05:17:11 -0400" MODIFIED_BY="[Empty name]">
<P>Eight trials enrolling 941 infants met our inclusion criteria. Investigators in seven trials (932 infants) administered sustained inflation with no chest compressions. Use of sustained inflation had no impact on the primary outcomes of this review - mortality in the delivery room (typical RR 2.66, 95% confidence interval (CI) 0.11 to 63.40; participants = 479; studies = 5; I² not applicable) and mortality during hospitalisation (typical RR 1.01, 95% CI 0.67 to 1.51; participants = 932; studies = 7; I² = 19%); the quality of the evidence was low for death in the delivery room (limitations in study design and imprecision of estimates) and was moderate for death before discharge (limitations in study design of most included trials). Amongst secondary outcomes, duration of mechanical ventilation was shorter in the SLI group (mean difference (MD) -5.37 days, 95% CI -6.31 to -4.43; participants = 524; studies = 5; I² = 95%; low-quality evidence). Heterogeneity, statistical significance, and magnitude of effects of this outcome are largely influenced by a single study: When this study was removed from the analysis, the effect was largely reduced (MD -1.71 days, 95% CI -3.04 to -0.39, I² = 0%). Results revealed no differences in any of the other secondary outcomes (e.g. rate of endotracheal intubation outside the delivery room by 72 hours of age (typical RR 0.93, 95% CI 0.79 to 1.09; participants = 811; studies = 5; I² = 0%); need for surfactant administration during hospital admission (typical RR 0.97, 95% CI 0.86 to 1.10; participants = 932; studies = 7; I² = 0%); rate of chronic lung disease (typical RR 0.95, 95% CI 0.74 to 1.22; participants = 683; studies = 5; I² = 47%); pneumothorax (typical RR 1.44, 95% CI 0.76 to 2.72; studies = 6, 851 infants; I² = 26%); or rate of patent ductus arteriosus requiring pharmacological treatment (typical RR 1.08, 95% CI 0.90 to 1.30; studies = 6, 745 infants; I² = 36%). The quality of evidence for these secondary outcomes was moderate (limitations in study design of most included trials - GRADE) except for pneumothorax (low quality: limitations in study design and imprecision of estimates - GRADE).</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2017-07-12 05:18:13 -0400" MODIFIED_BY="[Empty name]">
<P>Sustained inflation was not better than intermittent ventilation for reducing mortality in the delivery room and during hospitalisation. The number of events across trials was limited, so differences cannot be excluded. When considering secondary outcomes, such as need for intubation, need for or duration of respiratory support, or bronchopulmonary dysplasia, we found no evidence of relevant benefit for sustained inflation over intermittent ventilation. The duration of mechanical ventilation was shortened in the SLI group. This result should be interpreted cautiously, as it can be influenced by study characteristics other than the intervention. Future RCTs should aim to enrol infants who are at higher risk of morbidity and mortality, should stratify participants by gestational age, and should provide more detailed monitoring of the procedure, including measurements of lung volume and presence of apnoea before or during the SLI.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2017-07-19 17:34:00 -0400" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2017-07-12 06:49:36 -0400" MODIFIED_BY="[Empty name]">
<CONDITION MODIFIED="2017-07-10 12:18:45 -0400" MODIFIED_BY="[Empty name]">
<P>At birth, infants' lungs are filled with fluid, which must be cleared for effective respiration to occur. Most newly born infants achieve this spontaneously and may use considerable negative pressure (up to -50 cmH<SUB>2</SUB>O) for initial inspirations (<LINK REF="REF-Karlberg-1962" TYPE="REFERENCE">Karlberg 1962</LINK>; <LINK REF="REF-Milner-1977" TYPE="REFERENCE">Milner 1977</LINK>). However, it is estimated that 3% to 5% of newly born infants receive some help to breathe at delivery (<LINK REF="REF-Saugstad-1998" TYPE="REFERENCE">Saugstad 1998</LINK>). Adequate ventilation is the key to successful neonatal resuscitation and stabilisation (<LINK REF="REF-Wyckoff-2015" TYPE="REFERENCE">Wyckoff 2015</LINK>). Positive pressure ventilation (PPV) is recommended for infants who have absent or inadequate respiratory efforts, bradycardia, or both, at birth (<LINK REF="REF-Wyckoff-2015" TYPE="REFERENCE">Wyckoff 2015</LINK>). Use of manual ventilation devices - self-inflating bags, flow-inflating (or anaesthetic) bags, and T-piece devices - with a face mask or endotracheal tube (ETT) is advised. Although it is not included in the International Liaison Committee on Resuscitation (ILCOR) guidelines, respiratory support of infants in the delivery room with a mechanical ventilator and a nasopharyngeal tube has been described (<LINK REF="REF-Lindner-1999" TYPE="REFERENCE">Lindner 1999</LINK>).</P>
</CONDITION>
<INTERVENTION MODIFIED="2017-07-12 05:49:49 -0400" MODIFIED_BY="[Empty name]">
<P>Devices recommended for PPV in the delivery room differ in terms of physical characteristics and ability to deliver sustained lung inflation (SLI). The most commonly used self-inflating bag (<LINK REF="REF-O_x0027_Donnell-2004a" TYPE="REFERENCE">O'Donnell 2004a</LINK>; <LINK REF="REF-O_x0027_Donnell-2004b" TYPE="REFERENCE">O'Donnell 2004b</LINK>) may be of insufficient size to support sustained inflation (&gt; 1 second). Both flow-inflating bags and T-pieces may be used to consistently deliver inflations &gt; 1 second. Although target inflation pressures and long inspiratory times are achieved more consistently in mechanical models when T-piece devices rather than bags are used, no recommendation can be made as to which device is preferable (<LINK REF="REF-Wyckoff-2015" TYPE="REFERENCE">Wyckoff 2015</LINK>; <LINK REF="REF-Wyllie-2015" TYPE="REFERENCE">Wyllie 2015</LINK>). Positive end-expiratory pressure (PEEP) is very important for aerating the lungs and improving oxygenation; SLI consists of prolonged high-level PEEP.</P>
</INTERVENTION>
<THEORY MODIFIED="2017-07-12 05:50:15 -0400" MODIFIED_BY="[Empty name]">
<P>When airways are liquid-filled, it might be unnecessary to interrupt inflation pressures to allow the lung to deflate and exhale CO<SUB>2</SUB> (<LINK REF="REF-Hooper-2016" TYPE="REFERENCE">Hooper 2016</LINK>). <LINK REF="REF-Boon-1979" TYPE="REFERENCE">Boon 1979</LINK> described a study of 20 term infants delivered by Caesarean section under general anaesthesia who were resuscitated with a T-piece via an ETT. Trial authors reported that gas continued to flow through the flow sensor placed between the T-piece and the ETT toward the infant at the end of a standard inflation of 1 second on respiratory traces obtained (<LINK REF="REF-Boon-1979" TYPE="REFERENCE">Boon 1979</LINK>). On the basis of this observation, this group performed a non-randomised trial of sustained inflations given via a T-piece and an ETT to nine term infants during delivery room resuscitation. Investigators reported that initial inflation with a T-piece lasting 5 seconds produced a two-fold increase in inflation volume compared with standard resuscitation techniques (<LINK REF="REF-Vyas-1981" TYPE="REFERENCE">Vyas 1981</LINK>). Citing these findings, a retrospective cohort study described the effects of a change in management strategy for extremely low birth weight infants in the delivery room (<LINK REF="REF-Lindner-1999" TYPE="REFERENCE">Lindner 1999</LINK>). The new management strategy included the introduction of an initial sustained inflation of 15 seconds obtained with a mechanical ventilator via a nasopharyngeal tube. This change in strategy was associated with a reduction in the proportion of infants intubated for ongoing respiratory support without an apparent increase in adverse outcomes. Pulmonary morbidity in very low birth weight infants was reported to be related directly to mortality in 50% of cases of death (<LINK REF="REF-Drew-1982" TYPE="REFERENCE">Drew 1982</LINK>). Moreover, multiple SLIs in very preterm infants improved both heart rate and cerebral tissue oxygen saturation, in the absence of any detrimental effects (<LINK REF="REF-Fuchs-2011" TYPE="REFERENCE">Fuchs 2011</LINK>). An observational study showed that sustained inflation of 10 seconds at 25 cmH<SUB>2</SUB>O in 70 very preterm infants at birth was not effective for infants who were not breathing, possibly owing to active glottic adduction (<LINK REF="REF-van-Vonderen-2014" TYPE="REFERENCE">van Vonderen 2014</LINK>). Newly born infants frequently take a breath and then prolong expiration via glottic closure and diaphragmatic braking, giving themselves prolonged end-expiratory pressure.</P>
</THEORY>
<IMPORTANCE MODIFIED="2017-07-12 06:49:36 -0400" MODIFIED_BY="[Empty name]">
<P>Recommendations regarding use of sustained inflation at birth have varied between international bodies. Although European Resuscitation Council guidelines suggest giving five inflation breaths if the newborn is gasping or is not breathing (<LINK REF="REF-Wyllie-2015" TYPE="REFERENCE">Wyllie 2015</LINK>), the American Heart Association states that evidence is insufficient to recommend an optimum inflation time (<LINK REF="REF-Wyckoff-2015" TYPE="REFERENCE">Wyckoff 2015</LINK>). Differences between these guidelines and their algorithms are intriguing (<LINK REF="REF-Klingenberg-2016" TYPE="REFERENCE">Klingenberg 2016</LINK>). A narrative review reported that sustained inflation may reduce the need for mechanical ventilation among preterm infants at risk for respiratory distress syndrome (RDS) (<LINK REF="REF-Lista-2010" TYPE="REFERENCE">Lista 2010</LINK>). The same review showed that respiratory outcomes among infants receiving sustained inflation (25 cmH<SUB>2</SUB>O for 15 seconds) were improved over those reported for an historical group (<LINK REF="REF-Lista-2011" TYPE="REFERENCE">Lista 2011</LINK>).</P>
<P>This review updates the existing review "Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes", which was published in the <I>Cochrane Database of Systematic Reviews</I> in 2015 (<LINK REF="REF-O_x0027_Donnell-2015" TYPE="REFERENCE">O'Donnell 2015</LINK>).</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2017-07-12 05:50:44 -0400" MODIFIED_BY="[Empty name]">
<P>To assess the efficacy of an initial sustained (&gt; 1 second duration) lung inflation (SLI) versus standard inflations (&#8804; 1 second) in newborn infants receiving resuscitation with intermittent PPV.</P>
</OBJECTIVES>
<METHODS MODIFIED="2017-07-12 14:19:41 -0400" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2017-07-12 05:30:16 -0400" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2017-07-10 13:57:47 -0400" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trials (RCTs) and quasi-RCTs. We excluded observational studies (case-control studies, case series) and cluster-RCTs.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2017-07-10 13:57:57 -0400" MODIFIED_BY="[Empty name]">
<P>Term and preterm infants resuscitated via PPV at birth.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2017-07-12 05:29:09 -0400" MODIFIED_BY="[Empty name]">
<P>Interventions included resuscitation with initial sustained (&gt; 1 second) inflation versus resuscitation with regular (&#8804; 1 second) inflations:</P>
<UL>
<LI>with no chest compressions as part of the initial resuscitation (primary comparison); or</LI>
<LI>with chest compressions as part of the initial resuscitation (secondary comparison).</LI>
</UL>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2017-07-12 05:30:16 -0400" MODIFIED_BY="[Empty name]">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2017-07-10 13:58:54 -0400" MODIFIED_BY="[Empty name]">
<UL>
<LI>Death in the delivery room</LI>
<LI>Death during hospitalisation</LI>
<LI>Death to latest follow-up</LI>
</UL>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2017-07-12 05:30:16 -0400" MODIFIED_BY="[Empty name]">
<UL>
<LI>Apgar scores at 1 and 5 minutes</LI>
<LI>Heart rate at 5 minutes</LI>
<LI>Endotracheal intubation in the delivery room</LI>
<LI>Endotracheal intubation outside the delivery room during hospitalisation</LI>
<LI>Surfactant administration in the delivery room or during hospital admission</LI>
<LI>Need for mechanical ventilation</LI>
<LI>Duration in hours of respiratory support (i.e. nasal continuous airway pressure and ventilation via an ETT considered separately and in total)</LI>
<LI>Duration in days of supplemental oxygen requirement</LI>
<LI>Chronic lung disease: need for supplemental oxygen at 28 days of life; need for supplemental oxygen at 36 weeks of gestational age for infants born at or before 32 weeks of gestation</LI>
<LI>Air leaks (pneumothorax, pneumomediastinum, pneumopericardium, pulmonary interstitial emphysema) reported individually or as a composite outcome</LI>
<LI>Cranial ultrasound abnormalities: any intraventricular haemorrhage (IVH), grade 3 or 4 according to the Papile classification (<LINK REF="REF-Papile-1978" TYPE="REFERENCE">Papile 1978</LINK>), and cystic periventricular leukomalacia</LI>
<LI>Seizures including clinical and electroencephalographic</LI>
<LI>Hypoxic ischaemic encephalopathy for term and late preterm infants (grade 1 to 3 (<LINK REF="REF-Sarnat-1976" TYPE="REFERENCE">Sarnat 1976</LINK>))</LI>
<LI>Long-term neurodevelopmental outcomes (rates of cerebral palsy on physician assessment, developmental delay (i.e. intelligence quotient (IQ) 2 standard deviations (SDs) &lt; mean on validated assessment tool (e.g. Bayley's Mental Developmental Index))</LI>
<LI>Retinopathy of prematurity (ROP) (all stages and &#8805; stage 3)</LI>
<LI>Patent ductus arteriosus (PDA) (pharmacological treatment and surgical ligation)</LI>
</UL>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2017-07-10 14:07:09 -0400" MODIFIED_BY="[Empty name]">
<P>See <A HREF="http://onlinelibrary.wiley.com/o/cochrane/clabout/articles/NEONATAL/sect0-meta.html">Cochrane Neonatal Review Group</A> (CNRG) search strategy.</P>
<ELECTRONIC_SEARCHES MODIFIED="2017-07-10 14:07:09 -0400" MODIFIED_BY="[Empty name]">
<P>We used the criteria and standard methods of Cochrane and the Cochrane Neonatal Review Group (see <A HREF="http://neonatal.cochrane.org/resources-review-authors">the Cochrane Neonatal search strategy for specialized register</A>).</P>
<P>We conducted a comprehensive search that included the Cochrane Central Register of Controlled Trials (CENTRAL; 2017, Issue 1) in the Cochrane Library; MEDLINE via PubMed (1966 to 17 February 2017); Embase (1980 to 17 February 2017); and the Cumulative Index to Nursing and Allied Health Literature (CINAHL) (1982 to 17 February 2017), using the following search terms: (sustained inflation) OR (sustained AND inflation) OR (sustained AND (inflat* AND (lung OR pulmonary))), plus database-specific limiters for RCTs and neonates (see <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK> for full search strategy for each database). We did not apply language restrictions.<BR/>
<BR/>We searched clinical trials registries for ongoing and recently completed trials (<A HREF="https://www.clinicaltrials.gov/">clinicaltrials.gov</A>; the World Health Organization International Trials Registry and Platform - <A HREF="http://www.whoint/ictrp/search/en/">www.whoint/ictrp/search/en/</A>; and <A HREF="http://www.isrctn.com/">the ISRCTN Registry</A>).</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2017-07-10 14:06:32 -0400" MODIFIED_BY="[Empty name]">
<P>We also searched abstracts of the Pediatric Academic Society (PAS) from 2000 to 2017, electronically through the PAS website (<A HREF="http://www.abstracts2view.com/pasall/">abstractsonline</A>), using the following key words: "sustained inflation" AND "clinical trial".</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2017-07-12 14:19:41 -0400" MODIFIED_BY="[Empty name]">
<STUDY_SELECTION MODIFIED="2017-07-12 05:32:45 -0400" MODIFIED_BY="[Empty name]">
<P>For this update, two review authors (MB, MGC) independently screened all titles and abstracts to determine which trials met the inclusion criteria. We retrieved full-text copies of all papers that were potentially relevant. We resolved disagreements by discussion between review authors.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2017-07-12 05:51:22 -0400" MODIFIED_BY="[Empty name]">
<P>Two review authors (MB, MGC) independently undertook data abstraction using a data extraction form developed <I>ad hoc</I> and integrated with a modified version of the Cochrane Effective Practice and Organisation of Care Group (EPOC) data collection checklist (<LINK REF="REF-EPOC-2015" TYPE="REFERENCE">EPOC 2015</LINK>).</P>
<P>We extracted the following characteristics from each included trial.</P>
<UL>
<LI>Administrative details: study author(s); published or unpublished; year of publication; year in which trial was conducted; details of other relevant papers cited.</LI>
<LI>Trial details: study design; type, duration, and completeness of follow-up; country and location of study; informed consent; ethics approval.</LI>
<LI>Details of participants: birth weight; gestational age; number of participants.</LI>
<LI>Details of intervention: type of ventilation device used; type of interface; duration and level of pressure of sustained lung inflation (SLI).</LI>
<LI>Details of outcomes: death during hospitalisation or to latest follow-up; heart rate at 5 minutes; duration in hours of respiratory support; duration in days of supplemental oxygen requirement; long-term neurodevelopmental outcomes; any adverse events.</LI>
</UL>
<P>We resolved disagreements by discussion between review authors. When available, we described ongoing trials identified by detailing primary trial author, research question(s) posed, and methods and outcome measures applied, together with an estimate of the reporting date.</P>
<P>When queries arose or additional data were required, we contacted trial authors.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2017-07-12 14:19:41 -0400" MODIFIED_BY="[Empty name]">
<P>Two review authors (MB, SZ) independently assessed risk of bias (low, high, or unclear) of all included trials using the Cochrane &#8216;Risk of bias&#8217; tool (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>) for the following domains.</P>
<UL>
<LI>Sequence generation (selection bias).</LI>
<LI>Allocation concealment (selection bias).</LI>
<LI>Blinding of participants and personnel (performance bias).</LI>
<LI>Blinding of outcome assessment (detection bias).</LI>
<LI>Incomplete outcome data (attrition bias).</LI>
<LI>Selective reporting (reporting bias).</LI>
<LI>Any other bias.</LI>
</UL>
<P>We resolved disagreements by discussion or via consultation with a third assessor. See <LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK> for a detailed description of risk of bias for each domain.&#8195;</P>
<SUBSECTION>
<HEADING LEVEL="4">Selection bias (random sequence generation and allocation concealment)</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Random sequence generation</HEADING>
<P>For each included trial, we categorised risk of bias regarding random sequence generation as follows.</P>
<UL>
<LI>Low risk - adequate (any truly random process, e.g. random number table; computer random number generator).</LI>
<LI>High risk - inadequate (any non-random process, e.g. odd or even date of birth; hospital or clinic record number).</LI>
<LI>Unclear risk - no or unclear information provided.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Allocation concealment</HEADING>
<P>For each included trial, we categorised risk of bias regarding allocation concealment as follows.</P>
<UL>
<LI>Low risk - adequate (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes).</LI>
<LI>High risk - inadequate (open random allocation; unsealed or non-opaque envelopes, alternation; date of birth).</LI>
<LI>Unclear risk - no or unclear information provided.</LI>
</UL>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Performance bias</HEADING>
<P>Owing to the nature of the intervention, all trials were unblinded, leading to high risk of performance bias.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Detection bias</HEADING>
<P>For each included trial, we categorised the methods used to blind outcome assessors from knowledge of which intervention a participant received. We assessed blinding separately for different outcomes or different classes of outcomes.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Attrition bias</HEADING>
<P>For each included trial and for each outcome, we described completeness of data including attrition and exclusions from analysis. We noted whether attrition and exclusions were reported, numbers included in the analysis at each stage (compared with the total number of randomised participants), reasons for attrition or exclusion when reported, and whether missing data were balanced across groups or were related to outcomes.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Reporting bias</HEADING>
<P>For each included trial, we described how we investigated the risk of selective outcome reporting bias and what we found. We assessed methods as follows.</P>
<UL>
<LI>Low risk - adequate (when it is clear that all of a trial's prespecified outcomes and all expected outcomes of interest to the review have been reported).</LI>
<LI>High risk - inadequate (when not all of a trial's prespecified outcomes have been reported; one or more reported primary outcomes were not prespecified; outcomes of interest were reported incompletely and so cannot be used; or the trial failed to include results of a key outcome that would have been expected to be reported).</LI>
<LI>Unclear risk - no or unclear information provided (study protocol was not available).</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Other bias</HEADING>
<P>For each included trial, we described any important concerns that we had about other possible sources of bias (e.g. whether a potential source of bias was related to the specific trial design, whether the trial was stopped early owing to some data-dependent process). We assessed whether each trial was free of other problems that could put it at risk of bias as follows.</P>
<UL>
<LI>Low risk - no concerns of other bias raised.</LI>
<LI>High risk - concerns raised about multiple looks at data with results made known to investigators, differences in numbers of participants enrolled in abstract, and final publications of the paper.</LI>
<LI>Unclear - concerns raised about potential sources of bias that could not be verified by contacting trial authors.</LI>
</UL>
<P>We did not score blinding of the intervention because this was not applicable.</P>
<P>One review author entered data into <LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>, and a second review author checked entered data for accuracy.</P>
</SUBSECTION>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2017-07-12 05:41:30 -0400" MODIFIED_BY="[Empty name]">
<P>We conducted measures of treatment effect data analysis using <LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>. We determined outcome measures for dichotomous data (e.g. death, endotracheal intubation in the delivery room, frequency of retinopathy) as risk ratios (RRs) with 95% confidence intervals (CIs). We calculated continuous data (e.g. duration of respiratory support, Apgar score) using mean differences (MDs) and SDs.</P>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2017-06-13 13:37:30 -0400" MODIFIED_BY="[Empty name]">
<P>The unit of randomisation was the intended unit of analysis (individual neonate).</P>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2017-07-10 19:02:45 -0400" MODIFIED_BY="[Empty name]">
<P>We contacted trial authors to request missing data when needed.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2017-07-10 19:04:00 -0400" MODIFIED_BY="[Empty name]">
<P>As a measure of consistency, we used the I² statistic and the Q (Chi²) test (<LINK REF="REF-Deeks-2011" TYPE="REFERENCE">Deeks 2011</LINK>). We judged statistical significance of the Q (Chi²) statistic by P &lt; 0.10 because of the low statistical power of the test. We used the following cut-offs for heterogeneity: &lt; 25% no (none) heterogeneity; 25% to 49% low heterogeneity; 50% to 74% moderate heterogeneity; and &#8805; 75% high heterogeneity (<LINK REF="REF-Higgins-2003" TYPE="REFERENCE">Higgins 2003</LINK>). We combined trial results using the fixed-effect model, regardless of statistical evidence of heterogeneity effect sizes<I>.</I>
</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2017-03-28 03:52:18 -0400" MODIFIED_BY="[Empty name]">
<P>See <LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>.</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2017-07-12 06:49:58 -0400" MODIFIED_BY="[Empty name]">
<P>We performed statistical analyses using <LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>. We used the standard methods of the Cochrane Neonatal Review Group. For categorical data, we used RRs, relative risk reductions, and absolute risk difference (RDs). We obtained means and SDs for continuous data and performed analyses using MDs and WMDs when appropriate. We calculated 95% CIs. We presented the number needed to treat for an additional beneficial outcome (NNTB) and the number needed to treat for an additional harmful outcome (NNTH), as appropriate. For each comparison reviewed, meta-analysis could be feasible if we identified more than one eligible trial, and if homogeneity among trials was sufficient with respect to participants and interventions. We combined trials using the fixed-effect model, regardless of statistical evidence of heterogeneity effect sizes<I>. </I>For estimates of RR and RD, we used the Mantel-Haenszel method.</P>
<SUBSECTION>
<HEADING LEVEL="3">Quality of evidence</HEADING>
<P>We used the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach, as outlined in the <I>GRADE Handbook</I> (<LINK REF="REF-Sch_x00fc_nemann-2013" TYPE="REFERENCE">Schünemann 2013</LINK>), to assess the quality of evidence for the following (clinically relevant) outcomes: death in the delivery room or during hospitalisation; endotracheal intubation in the delivery room or outside the delivery room during hospitalisation; surfactant administration in the delivery room or during hospital admission; need for mechanical ventilation; chronic lung disease; air leaks; and cranial ultrasound abnormalities.</P>
<P>Two review authors independently assessed the quality of evidence for each of the outcomes above. We considered evidence from RCTs as high quality but downgraded evidence one level for serious (or two levels for very serious) limitations on the basis of the following: design (risk of bias), consistency across studies, directness of evidence, precision of estimates, and presence of publication bias. We used the <LINK REF="REF-GRADEpro-GDT" TYPE="REFERENCE">GRADEpro GDT</LINK> Guideline Development Tool to create a &#8216;Summary of findings&#8217; table to report the quality of evidence.</P>
<P>The GRADE approach yields an assessment of the quality of a body of evidence according to one of four grades.</P>
<UL>
<LI>High: We are very confident that the true effect lies close to that of the estimate of the effect.</LI>
<LI>Moderate: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.</LI>
<LI>Low: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect.</LI>
<LI>Very low: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect.</LI>
</UL>
</SUBSECTION>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2017-07-12 05:51:42 -0400" MODIFIED_BY="[Empty name]">
<P>We planned to perform the following subgroup analyses of the safety and efficacy of sustained inflation during resuscitation in subgroups.<BR/>
</P>
<UL>
<LI>Term (&#8805; 37 weeks of gestation) and preterm (&lt; 37 weeks of gestation) infants.</LI>
<LI>Type of ventilation device used (self-inflating bag, flow-inflating bag, T-piece, mechanical ventilator).</LI>
<LI>Interface used (i.e. face mask, ETT, nasopharyngeal tube). </LI>
<LI>Duration of sustained lung inflation (i.e. &gt; 1 second to 5 seconds, &gt; 5 seconds).</LI>
</UL>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2017-07-12 05:45:25 -0400" MODIFIED_BY="[Empty name]">
<P>We planned to conduct sensitivity analyses to explore effects of the methodological quality of trials and checked to ascertain whether studies with high risk of bias overestimated treatment effects.</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2017-07-19 17:34:00 -0400" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2017-07-19 17:34:00 -0400" MODIFIED_BY="[Empty name]">
<P>We have provided results of the search for this review update in the study flow diagram (<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>).</P>
<P>See <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies,</LINK> <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies,</LINK> and <LINK TAG="CHARACTERISTICS_OF_ONGOING_STUDIES" TYPE="SECTION">Characteristics of ongoing studies</LINK> sections for details.</P>
<INCLUDED_STUDIES_DESCR MODIFIED="2017-07-19 17:34:00 -0400" MODIFIED_BY="[Empty name]">
<P>Eight trials recruiting 941 infants (473 in SLI groups, 468 in control groups) met the inclusion criteria (<LINK REF="STD-El_x002d_Chimi-2017" TYPE="STUDY">El-Chimi 2017</LINK>; <LINK REF="STD-Jiravisitkul-2017" TYPE="STUDY">Jiravisitkul 2017</LINK>; <LINK REF="STD-Lindner-2005" TYPE="STUDY">Lindner 2005</LINK>; <LINK REF="STD-Lista-2015" TYPE="STUDY">Lista 2015</LINK>; <LINK REF="STD-Mercadante-2016" TYPE="STUDY">Mercadante 2016</LINK>; <LINK REF="STD-Ngan-2017" TYPE="STUDY">Ngan 2017</LINK>; <LINK REF="STD-Schm_x00f6_lzer-2015" TYPE="STUDY">Schmölzer 2015</LINK>; <LINK REF="STD-Schwaberger-2015" TYPE="STUDY">Schwaberger 2015</LINK>). We pooled seven trials (with 932 infants) in the primary comparison (i.e. use of sustained inflation with no chest compressions) (<LINK REF="STD-El_x002d_Chimi-2017" TYPE="STUDY">El-Chimi 2017</LINK>; <LINK REF="STD-Jiravisitkul-2017" TYPE="STUDY">Jiravisitkul 2017</LINK>; <LINK REF="STD-Lindner-2005" TYPE="STUDY">Lindner 2005</LINK>; <LINK REF="STD-Lista-2015" TYPE="STUDY">Lista 2015</LINK>; <LINK REF="STD-Mercadante-2016" TYPE="STUDY">Mercadante 2016</LINK>; <LINK REF="STD-Ngan-2017" TYPE="STUDY">Ngan 2017</LINK>; <LINK REF="STD-Schwaberger-2015" TYPE="STUDY">Schwaberger 2015</LINK>). In contrast to other trials, <LINK REF="STD-Schwaberger-2015" TYPE="STUDY">Schwaberger 2015</LINK> sought to use near-infrared spectroscopy (NIRS) to investigate whether SLI affected physiological changes in cerebral blood volume and oxygenation. We could not perform any meta-analysis in the secondary comparison (intervention superimposed on uninterrupted chest compressions) because we included only one trial (a pilot study of nine preterm infants) (<LINK REF="STD-Schm_x00f6_lzer-2015" TYPE="STUDY">Schmölzer 2015</LINK>).</P>
<P>We have listed characteristics of populations and interventions and comparisons of the eight trials under <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> and in <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>.</P>
<SUBSECTION>
<HEADING LEVEL="4">Settings and populations</HEADING>
<P>Researchers conducted the included studies on four different continents: two in Italy (<LINK REF="STD-Lista-2015" TYPE="STUDY">Lista 2015</LINK>; <LINK REF="STD-Mercadante-2016" TYPE="STUDY">Mercadante 2016</LINK>), two in Canada by the same contact author (<LINK REF="STD-Ngan-2017" TYPE="STUDY">Ngan 2017</LINK>; <LINK REF="STD-Schm_x00f6_lzer-2015" TYPE="STUDY">Schmölzer 2015</LINK>), one in Germany (<LINK REF="STD-Lindner-2005" TYPE="STUDY">Lindner 2005</LINK>), one in Austria (<LINK REF="STD-Schwaberger-2015" TYPE="STUDY">Schwaberger 2015</LINK>), one in Egypt (<LINK REF="STD-El_x002d_Chimi-2017" TYPE="STUDY">El-Chimi 2017</LINK>), and one in Thailand (<LINK REF="STD-Jiravisitkul-2017" TYPE="STUDY">Jiravisitkul 2017</LINK>). Only one study was conducted at multiple centres (<LINK REF="STD-Lista-2015" TYPE="STUDY">Lista 2015</LINK>). Five of the six trials identified for this update included infants with mean birth weight &gt; 1 kg (<LINK REF="STD-El_x002d_Chimi-2017" TYPE="STUDY">El-Chimi 2017</LINK>; <LINK REF="STD-Jiravisitkul-2017" TYPE="STUDY">Jiravisitkul 2017</LINK>; <LINK REF="STD-Mercadante-2016" TYPE="STUDY">Mercadante 2016</LINK>; <LINK REF="STD-Ngan-2017" TYPE="STUDY">Ngan 2017</LINK>; <LINK REF="STD-Schwaberger-2015" TYPE="STUDY">Schwaberger 2015</LINK>), whereas the two previously included studies (<LINK REF="STD-Lindner-2005" TYPE="STUDY">Lindner 2005</LINK>; <LINK REF="STD-Lista-2015" TYPE="STUDY">Lista 2015</LINK>) and the pilot trial (<LINK REF="STD-Schm_x00f6_lzer-2015" TYPE="STUDY">Schmölzer 2015</LINK>) enrolled extremely low birth weight infants. <LINK REF="STD-Mercadante-2016" TYPE="STUDY">Mercadante 2016</LINK> was the only trial conducted in late preterm infants. No trials enrolled full-term infants. <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK> shows additional information on populations.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Interventions</HEADING>
<P>Trials pooled in the primary comparison (i.e. without chest compressions) reported that peak inspiratory pressure (PIP) was sustained for 15 seconds in six trials (<LINK REF="STD-El_x002d_Chimi-2017" TYPE="STUDY">El-Chimi 2017</LINK>; <LINK REF="STD-Jiravisitkul-2017" TYPE="STUDY">Jiravisitkul 2017</LINK>; <LINK REF="STD-Lindner-2005" TYPE="STUDY">Lindner 2005</LINK>; <LINK REF="STD-Lista-2015" TYPE="STUDY">Lista 2015</LINK>; <LINK REF="STD-Mercadante-2016" TYPE="STUDY">Mercadante 2016</LINK>; <LINK REF="STD-Schwaberger-2015" TYPE="STUDY">Schwaberger 2015</LINK>) and for 20 seconds in <LINK REF="STD-Ngan-2017" TYPE="STUDY">Ngan 2017</LINK>. However, levels of PIP ranged from 20 cmH<SUB>2</SUB>O (<LINK REF="STD-El_x002d_Chimi-2017" TYPE="STUDY">El-Chimi 2017</LINK>; <LINK REF="STD-Lindner-2005" TYPE="STUDY">Lindner 2005</LINK>) to 24 (<LINK REF="STD-Ngan-2017" TYPE="STUDY">Ngan 2017</LINK>), 25 (<LINK REF="STD-Jiravisitkul-2017" TYPE="STUDY">Jiravisitkul 2017</LINK>; <LINK REF="STD-Lista-2015" TYPE="STUDY">Lista 2015</LINK>; <LINK REF="STD-Mercadante-2016" TYPE="STUDY">Mercadante 2016</LINK>), and 30 cmH<SUB>2</SUB>O (<LINK REF="STD-Schwaberger-2015" TYPE="STUDY">Schwaberger 2015</LINK>). Investigators provided additional SLIs in cases of poor response, with the same (<LINK REF="STD-Jiravisitkul-2017" TYPE="STUDY">Jiravisitkul 2017</LINK>; <LINK REF="STD-Mercadante-2016" TYPE="STUDY">Mercadante 2016</LINK>; <LINK REF="STD-Schwaberger-2015" TYPE="STUDY">Schwaberger 2015</LINK>) or higher PIP (<LINK REF="STD-El_x002d_Chimi-2017" TYPE="STUDY">El-Chimi 2017</LINK>; <LINK REF="STD-Lindner-2005" TYPE="STUDY">Lindner 2005</LINK>); researchers in <LINK REF="STD-Ngan-2017" TYPE="STUDY">Ngan 2017</LINK> based the duration of the second SLI on exhaled CO<SUB>2 </SUB>values. As regards interface and ventilation devices, most included trials used mask and T-piece. However, <LINK REF="STD-Lindner-2005" TYPE="STUDY">Lindner 2005</LINK> used nasopharyngeal tube and ventilator, and <LINK REF="STD-El_x002d_Chimi-2017" TYPE="STUDY">El-Chimi 2017</LINK> introduced a relevant bias into the study design by using a T-piece ventilator in the SLI group and a self-inflating bag in the control group (mask in both SLI and control groups). No trials reported whether prespecified levels of pressure for the SLI were actually delivered according to the protocol. Study authors did not monitor leaks at the mask and lung volumes during the manoeuvre. Whether the infant breathed before or during the SLI was not recorded: Apnoeic newborns at birth are known to show less gain in lung volume during an SLI than actively breathing infants (<LINK REF="REF-Lista-2017" TYPE="REFERENCE">Lista 2017</LINK>).</P>
<P>For the secondary comparison, in which infants in both SLI and control groups were resuscitated with chest compressions, duration of SLI was 20 + 20 seconds (<LINK REF="STD-Schm_x00f6_lzer-2015" TYPE="STUDY">Schmölzer 2015</LINK>).</P>
<P>
<LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK> shows additional information on interventions.</P>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2017-07-12 05:57:52 -0400" MODIFIED_BY="[Empty name]">
<P>We have summarised the reasons for exclusion of potentially eligible trials (<LINK REF="STD-Bouziri-2011" TYPE="STUDY">Bouziri 2011</LINK>; <LINK REF="STD-Harling-2005" TYPE="STUDY">Harling 2005</LINK>; <LINK REF="STD-te-Pas-2007" TYPE="STUDY">te Pas 2007</LINK>) in the <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK> table.</P>
<P>In particular, we excluded <LINK REF="STD-te-Pas-2007" TYPE="STUDY">te Pas 2007</LINK> because sustained inflation was only one element of the intervention, and because it is not possible to determine the relative contributions of various elements of this intervention to differences observed between groups. We excluded <LINK REF="STD-Harling-2005" TYPE="STUDY">Harling 2005</LINK>, as investigators randomised infants in this trial to receive inflation for 2 seconds or 5 seconds at initiation of PPV. All infants thus received sustained (&gt; 1 second) inflations as defined in our protocol (<LINK REF="REF-O_x0027_Donnell-2004" TYPE="REFERENCE">O'Donnell 2004</LINK>).</P>
<P>For the 2017 update, we excluded no eligible studies.</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2017-07-12 06:01:12 -0400" MODIFIED_BY="[Empty name]">
<P>We have presented a summary of the 'Risk of bias' assessment in <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK> and <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>. We have provided details of the methodological quality of included trials in the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> section.</P>
<ALLOCATION MODIFIED="2017-07-12 05:59:57 -0400" MODIFIED_BY="[Empty name]">
<P>One trial had high risk of selection bias: This quasi-randomised trial (odd-numbered sheets indicated allocation to the SLI group, and even-numbered sheets to the control group) did not use opaque envelopes (information provided by study authors) (<LINK REF="STD-El_x002d_Chimi-2017" TYPE="STUDY">El-Chimi 2017</LINK>). In <LINK REF="STD-Jiravisitkul-2017" TYPE="STUDY">Jiravisitkul 2017</LINK> and <LINK REF="STD-Schwaberger-2015" TYPE="STUDY">Schwaberger 2015</LINK>, risk of selection bias was low as regards random sequence generation and allocation concealment (opaque, numbered envelopes). In <LINK REF="STD-Ngan-2017" TYPE="STUDY">Ngan 2017</LINK>, risk of selection bias was low as regards random sequence generation and was unclear for allocation concealment: Timing of randomisation resulted in many post-randomisation exclusions, as results showed more post-randomisation exclusions in the SLI group than in the control group. In the other four trials, risk of selection bias was unclear as regards random sequence generation and was low as regards allocation concealment (opaque, numbered envelopes) (<LINK REF="STD-Lindner-2005" TYPE="STUDY">Lindner 2005</LINK>; <LINK REF="STD-Lista-2015" TYPE="STUDY">Lista 2015</LINK>; <LINK REF="STD-Mercadante-2016" TYPE="STUDY">Mercadante 2016</LINK>; <LINK REF="STD-Schm_x00f6_lzer-2015" TYPE="STUDY">Schmölzer 2015</LINK>).</P>
</ALLOCATION>
<BLINDING MODIFIED="2017-07-12 05:38:58 -0400" MODIFIED_BY="[Empty name]">
<P>Owing to the nature of the intervention, all trials were unblinded, leading to high risk of performance bias. However, four trials blinded researchers assessing trial endpoints to the nature of study treatments (<LINK REF="STD-Lista-2015" TYPE="STUDY">Lista 2015</LINK>; <LINK REF="STD-Mercadante-2016" TYPE="STUDY">Mercadante 2016</LINK>; <LINK REF="STD-Ngan-2017" TYPE="STUDY">Ngan 2017</LINK>; <LINK REF="STD-Schm_x00f6_lzer-2015" TYPE="STUDY">Schmölzer 2015</LINK>).</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2017-07-12 06:00:56 -0400" MODIFIED_BY="[Empty name]">
<P>
<LINK REF="STD-El_x002d_Chimi-2017" TYPE="STUDY">El-Chimi 2017</LINK> referred almost half of enrolled infants to other NICUs; we excluded these studies from analysis owing to failure of follow-up, although the primary outcome of the study (treatment failure/success within 72 hours) could have been determined and reported for these infants. In <LINK REF="STD-Ngan-2017" TYPE="STUDY">Ngan 2017</LINK>, post-randomisation exclusion (27%) resulted in fewer included infants in the SLI group. Most trials accounted for all outcomes (<LINK REF="STD-Lindner-2005" TYPE="STUDY">Lindner 2005</LINK>; <LINK REF="STD-Lista-2015" TYPE="STUDY">Lista 2015</LINK>; <LINK REF="STD-Mercadante-2016" TYPE="STUDY">Mercadante 2016</LINK>; <LINK REF="STD-Schwaberger-2015" TYPE="STUDY">Schwaberger 2015</LINK>).</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2017-07-10 19:53:46 -0400" MODIFIED_BY="[Empty name]">
<P>Four trials provided complete results for all reported outcomes (<LINK REF="STD-Lindner-2005" TYPE="STUDY">Lindner 2005</LINK>; <LINK REF="STD-Lista-2015" TYPE="STUDY">Lista 2015</LINK>; <LINK REF="STD-Ngan-2017" TYPE="STUDY">Ngan 2017</LINK>; <LINK REF="STD-Schwaberger-2015" TYPE="STUDY">Schwaberger 2015</LINK>).</P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2017-07-12 06:01:12 -0400" MODIFIED_BY="[Empty name]">
<P>
<LINK REF="STD-El_x002d_Chimi-2017" TYPE="STUDY">El-Chimi 2017</LINK> and <LINK REF="STD-Schwaberger-2015" TYPE="STUDY">Schwaberger 2015</LINK> did not report sample size calculations. For <LINK REF="STD-Schwaberger-2015" TYPE="STUDY">Schwaberger 2015</LINK>, investigators registered the protocol after study initiation. <LINK REF="STD-Jiravisitkul-2017" TYPE="STUDY">Jiravisitkul 2017</LINK> planned sample sizes of 40 infants for each group but allocated only 38 to the control group. <LINK REF="STD-Lindner-2005" TYPE="STUDY">Lindner 2005</LINK> was stopped after the interim analysis. It was unclear why study authors made this decision. <LINK REF="STD-Ngan-2017" TYPE="STUDY">Ngan 2017</LINK> did not achieve the planned sample size; in addition, the incidence of the primary outcome in the control group was less than that assumed for the sample size calculation, leading to lack of power to detect the chosen effect size. The other trials appear free of other bias.</P>
<P>We were unable to explore possible bias through generation of funnel plots because fewer than ten trials met the inclusion criteria of this Cochrane review.</P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2017-07-12 14:23:50 -0400" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Primary comparison: use of initial sustained inflation versus standard inflations in newborns receiving resuscitation with no chest compressions</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Death (Outcome 1.1) </HEADING>
<SUBSECTION>
<HEADING LEVEL="6">Death in the delivery room (Outcome 1.1.1)</HEADING>
<P>Five trials (N = 479) reported this outcome (<LINK REF="STD-El_x002d_Chimi-2017" TYPE="STUDY">El-Chimi 2017</LINK>; <LINK REF="STD-Jiravisitkul-2017" TYPE="STUDY">Jiravisitkul 2017</LINK>; <LINK REF="STD-Lindner-2005" TYPE="STUDY">Lindner 2005</LINK>; <LINK REF="STD-Mercadante-2016" TYPE="STUDY">Mercadante 2016</LINK>; <LINK REF="STD-Schwaberger-2015" TYPE="STUDY">Schwaberger 2015</LINK>); one event occurred in the SLI group in <LINK REF="STD-Jiravisitkul-2017" TYPE="STUDY">Jiravisitkul 2017</LINK> (death in delivery room at 15 to 20 minutes of life, severe birth asphyxia as the result of a prolapsed cord), and none in the other four trials (typical RR 2.66, 95% CI 0.11 to 63.40; typical RD 0.00, 95% CI -0.02 to 0.02; participants = 479; studies = 5; I² not applicable for RR and I² = 0% for RD; <LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK> and <LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK>). We obtained data for this outcome directly from trial authors (<LINK REF="STD-Jiravisitkul-2017" TYPE="STUDY">Jiravisitkul 2017</LINK>; <LINK REF="STD-Lindner-2005" TYPE="STUDY">Lindner 2005</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Death during hospitalisation (Outcome 1.2.1)</HEADING>
<P>All trials included in the primary comparison (<LINK REF="STD-El_x002d_Chimi-2017" TYPE="STUDY">El-Chimi 2017</LINK>; <LINK REF="STD-Jiravisitkul-2017" TYPE="STUDY">Jiravisitkul 2017</LINK>; <LINK REF="STD-Lindner-2005" TYPE="STUDY">Lindner 2005</LINK>; <LINK REF="STD-Lista-2015" TYPE="STUDY">Lista 2015</LINK>; <LINK REF="STD-Mercadante-2016" TYPE="STUDY">Mercadante 2016</LINK>; <LINK REF="STD-Ngan-2017" TYPE="STUDY">Ngan 2017</LINK>; <LINK REF="STD-Schwaberger-2015" TYPE="STUDY">Schwaberger 2015</LINK>) reported mortality during hospitalisation (typical RR 1.01, 95% CI 0.67 to 1.51; typical RD 0.00, 95% CI -0.03 to 0.03; participants = 932; studies = 7; I² = 19% for RR and I² = 0% for RD; <LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK> and <LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK>).</P>
<P>We obtained data for this outcome directly from trial authors (<LINK REF="STD-El_x002d_Chimi-2017" TYPE="STUDY">El-Chimi 2017</LINK>; <LINK REF="STD-Jiravisitkul-2017" TYPE="STUDY">Jiravisitkul 2017</LINK>; <LINK REF="STD-Lindner-2005" TYPE="STUDY">Lindner 2005</LINK>).</P>
<P>In <LINK REF="STD-El_x002d_Chimi-2017" TYPE="STUDY">El-Chimi 2017</LINK>, 12 and 19 infants in SLI and control groups, respectively, died. In <LINK REF="STD-Jiravisitkul-2017" TYPE="STUDY">Jiravisitkul 2017</LINK>, two infants in each group died: In the SLI group, one died of severe birth asphyxia as the result of a prolapsed cord, and the other died at 3 hours of life of suspected umbilical catheter migration with haemothorax; in the control group, one died of severe respiratory distress syndrome at 2 hours of life, and the other of septic shock at 168 days of life. In <LINK REF="STD-Lindner-2005" TYPE="STUDY">Lindner 2005</LINK>, three deaths occurred in the sustained inflation group: at day 1 (respiratory failure), at day 36 (necrotising enterocolitis), and at day 107 (liver fibrosis of unknown origin). In <LINK REF="STD-Lista-2015" TYPE="STUDY">Lista 2015</LINK>, 12 infants in the control group and 17 in the sustained inflations group died during the trial. <LINK REF="STD-Mercadante-2016" TYPE="STUDY">Mercadante 2016</LINK> and <LINK REF="STD-Schwaberger-2015" TYPE="STUDY">Schwaberger 2015</LINK> reported no events.</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Apgar score at one minute (Outcome 1.2) </HEADING>
<P>Five trials (N = 529) (<LINK REF="STD-Jiravisitkul-2017" TYPE="STUDY">Jiravisitkul 2017</LINK>; <LINK REF="STD-Lindner-2005" TYPE="STUDY">Lindner 2005</LINK>; <LINK REF="STD-Mercadante-2016" TYPE="STUDY">Mercadante 2016</LINK>; <LINK REF="STD-Ngan-2017" TYPE="STUDY">Ngan 2017</LINK>; <LINK REF="STD-Schwaberger-2015" TYPE="STUDY">Schwaberger 2015</LINK>) reported this outcome (MD -0.08, 95% CI -0.26 to 0.09; participants = 529; studies = 5; I² = 0%; <LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>). We obtained data for this outcome directly from trial authors (<LINK REF="STD-Jiravisitkul-2017" TYPE="STUDY">Jiravisitkul 2017</LINK>; <LINK REF="STD-Lindner-2005" TYPE="STUDY">Lindner 2005</LINK>; <LINK REF="STD-Mercadante-2016" TYPE="STUDY">Mercadante 2016</LINK>; <LINK REF="STD-Ngan-2017" TYPE="STUDY">Ngan 2017</LINK>; <LINK REF="STD-Schwaberger-2015" TYPE="STUDY">Schwaberger 2015</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Apgar score at five minutes (Outcome 1.3) </HEADING>
<P>Six trials (N = 641) (<LINK REF="STD-El_x002d_Chimi-2017" TYPE="STUDY">El-Chimi 2017</LINK>; <LINK REF="STD-Jiravisitkul-2017" TYPE="STUDY">Jiravisitkul 2017</LINK>; <LINK REF="STD-Lindner-2005" TYPE="STUDY">Lindner 2005</LINK>; <LINK REF="STD-Mercadante-2016" TYPE="STUDY">Mercadante 2016</LINK>; <LINK REF="STD-Ngan-2017" TYPE="STUDY">Ngan 2017</LINK>; <LINK REF="STD-Schwaberger-2015" TYPE="STUDY">Schwaberger 2015</LINK>) reported this outcome (MD -0.02, 95% CI -0.13 to 0.08; participants = 641; studies = 6; I² = 46%; <LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>). We obtained data for this outcome directly from trial authors (<LINK REF="STD-El_x002d_Chimi-2017" TYPE="STUDY">El-Chimi 2017</LINK>; <LINK REF="STD-Jiravisitkul-2017" TYPE="STUDY">Jiravisitkul 2017</LINK>; <LINK REF="STD-Lindner-2005" TYPE="STUDY">Lindner 2005</LINK>; <LINK REF="STD-Mercadante-2016" TYPE="STUDY">Mercadante 2016</LINK>; <LINK REF="STD-Ngan-2017" TYPE="STUDY">Ngan 2017</LINK>; <LINK REF="STD-Schwaberger-2015" TYPE="STUDY">Schwaberger 2015</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Endotracheal intubation (Outcome 1.4)</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">Endotracheal intubation in the delivery room (Outcome 1.4.1)</HEADING>
<P>Five trials (N = 601) (<LINK REF="STD-El_x002d_Chimi-2017" TYPE="STUDY">El-Chimi 2017</LINK>; <LINK REF="STD-Jiravisitkul-2017" TYPE="STUDY">Jiravisitkul 2017</LINK>; <LINK REF="STD-Lindner-2005" TYPE="STUDY">Lindner 2005</LINK>; <LINK REF="STD-Mercadante-2016" TYPE="STUDY">Mercadante 2016</LINK>; <LINK REF="STD-Ngan-2017" TYPE="STUDY">Ngan 2017</LINK>) reported this outcome (typical RR 0.86, 95% CI 0.62 to 1.19; typical RD -0.03, 95% CI -0.08 to 0.03; participants = 601; studies = 5; I² = 64% for RR and I² = 74% for RD; <LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>; <LINK REF="FIG-05" TYPE="FIGURE">Figure 5</LINK>). We obtained data for this outcome directly from trial authors (<LINK REF="STD-Mercadante-2016" TYPE="STUDY">Mercadante 2016</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Endotracheal intubation outside the delivery room within 24 hours (Outcome 1.4.2)</HEADING>
<P>Two trials (N = 225) (<LINK REF="STD-Mercadante-2016" TYPE="STUDY">Mercadante 2016</LINK>; <LINK REF="STD-Schwaberger-2015" TYPE="STUDY">Schwaberger 2015</LINK>) reported this outcome (RR 1.40, 95% CI 0.53 to 3.68; RD 0.02, 95% CI -0.04 to 0.07; participants = 225; studies = 2). The test for heterogeneity was not applicable because only one trial (<LINK REF="STD-Lindner-2005" TYPE="STUDY">Lindner 2005</LINK>) reported events (<LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>; <LINK REF="FIG-05" TYPE="FIGURE">Figure 5</LINK>). We obtained data for this outcome directly from trial authors (<LINK REF="STD-Mercadante-2016" TYPE="STUDY">Mercadante 2016</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Endotracheal intubation outside the delivery room by 72 hours (Outcome 1.4.3)</HEADING>
<P>Five included trials (N = 811) (<LINK REF="STD-El_x002d_Chimi-2017" TYPE="STUDY">El-Chimi 2017</LINK>; <LINK REF="STD-Lindner-2005" TYPE="STUDY">Lindner 2005</LINK>; <LINK REF="STD-Lista-2015" TYPE="STUDY">Lista 2015</LINK>; <LINK REF="STD-Mercadante-2016" TYPE="STUDY">Mercadante 2016</LINK>; <LINK REF="STD-Ngan-2017" TYPE="STUDY">Ngan 2017</LINK>) reported this outcome (typical RR 0.93, 95% CI 0.79 to 1.09; typical RD -0.03, 95% CI -0.09 to 0.03; participants = 811; studies = 5; I² = 0% for RR and I² = 53% for RD) (<LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4;</LINK> <LINK REF="FIG-05" TYPE="FIGURE">Figure 5</LINK>). We obtained data for this outcome directly from trial authors (<LINK REF="STD-Mercadante-2016" TYPE="STUDY">Mercadante 2016</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Surfactant administration (Outcome 1.5)</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">Surfactant administration in the delivery room (Outcome 1.5.1)</HEADING>
<P>Three trials (N = 335) (<LINK REF="STD-El_x002d_Chimi-2017" TYPE="STUDY">El-Chimi 2017</LINK>; <LINK REF="STD-Lindner-2005" TYPE="STUDY">Lindner 2005</LINK>; <LINK REF="STD-Ngan-2017" TYPE="STUDY">Ngan 2017</LINK>) reported this outcome (typical RR 1.43, 95% CI 0.82 to 2.49; typical RD 0.04, 95% CI -0.02 to 0.11; participants = 335; studies = 3; I² = 0% for RR and I² = 72% for RD; <LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5;</LINK> <LINK REF="FIG-06" TYPE="FIGURE">Figure 6</LINK>). We obtained data for this outcome directly from trial authors (<LINK REF="STD-El_x002d_Chimi-2017" TYPE="STUDY">El-Chimi 2017</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Surfactant administration during hospital admission (Outcome 1.5.2)</HEADING>
<P>All trials included in the primary comparison (<LINK REF="STD-El_x002d_Chimi-2017" TYPE="STUDY">El-Chimi 2017</LINK>; <LINK REF="STD-Jiravisitkul-2017" TYPE="STUDY">Jiravisitkul 2017</LINK>; <LINK REF="STD-Lindner-2005" TYPE="STUDY">Lindner 2005</LINK>; <LINK REF="STD-Lista-2015" TYPE="STUDY">Lista 2015</LINK>; <LINK REF="STD-Mercadante-2016" TYPE="STUDY">Mercadante 2016</LINK>; <LINK REF="STD-Ngan-2017" TYPE="STUDY">Ngan 2017</LINK>; <LINK REF="STD-Schwaberger-2015" TYPE="STUDY">Schwaberger 2015</LINK>) (N = 932) reported this outcome (typical RR 0.97, 95% CI 0.86 to 1.10; typical RD -0.01, 95% CI -0.06 to 0.04; participants = 932; studies = 7; I² = 0% for RR and I² = 0% for RD; <LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5;</LINK> <LINK REF="FIG-06" TYPE="FIGURE">Figure 6</LINK>). We obtained data for this outcome directly from trial authors (<LINK REF="STD-El_x002d_Chimi-2017" TYPE="STUDY">El-Chimi 2017</LINK>; <LINK REF="STD-Lindner-2005" TYPE="STUDY">Lindner 2005;</LINK> <LINK REF="STD-Mercadante-2016" TYPE="STUDY">Mercadante 2016</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Need for mechanical ventilation (Outcome 1.6)</HEADING>
<P>Three trials (N = 484) reported this outcome (<LINK REF="STD-El_x002d_Chimi-2017" TYPE="STUDY">El-Chimi 2017</LINK>; <LINK REF="STD-Jiravisitkul-2017" TYPE="STUDY">Jiravisitkul 2017</LINK>; <LINK REF="STD-Lista-2015" TYPE="STUDY">Lista 2015</LINK>) (typical RR 0.87, 95% CI 0.74 to 1.03; typical RD -0.06, 95% CI -0.14 to 0.01; participants = 484; studies = 3; I² = 0% for RR and I² = 85% for RD) (<LINK REF="CMP-001.06" TYPE="ANALYSIS">Analysis 1.6</LINK>). We obtained data for this outcome directly from trial authors (<LINK REF="STD-El_x002d_Chimi-2017" TYPE="STUDY">El-Chimi 2017</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Duration of nasal continuous airway pressure (Outcome 1.7)</HEADING>
<P>Three trials (N = 355) reported this outcome (<LINK REF="STD-El_x002d_Chimi-2017" TYPE="STUDY">El-Chimi 2017</LINK>; <LINK REF="STD-Lindner-2005" TYPE="STUDY">Lindner 2005</LINK>; <LINK REF="STD-Mercadante-2016" TYPE="STUDY">Mercadante 2016</LINK>) (MD 0.26 days, 95% CI -0.19 to 0.72; participants = 355; studies = 3; I² = 59%) (<LINK REF="CMP-001.07" TYPE="ANALYSIS">Analysis 1.7</LINK>). We obtained data for this outcome directly from trial authors; data for this outcome refer to survivors at time of assessment (<LINK REF="STD-El_x002d_Chimi-2017" TYPE="STUDY">El-Chimi 2017</LINK>; <LINK REF="STD-Lindner-2005" TYPE="STUDY">Lindner 2005</LINK>; <LINK REF="STD-Mercadante-2016" TYPE="STUDY">Mercadante 2016</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Duration of ventilation via an ETT (Outcome 1.8)</HEADING>
<P>Five trials (N = 524) reported this outcome (<LINK REF="STD-Jiravisitkul-2017" TYPE="STUDY">Jiravisitkul 2017</LINK>; <LINK REF="STD-Lindner-2005" TYPE="STUDY">Lindner 2005</LINK>; <LINK REF="STD-Mercadante-2016" TYPE="STUDY">Mercadante 2016</LINK>; <LINK REF="STD-Ngan-2017" TYPE="STUDY">Ngan 2017</LINK>; <LINK REF="STD-Schwaberger-2015" TYPE="STUDY">Schwaberger 2015</LINK>) (MD -5.37 days, 95% CI -6.31 to -4.43; participants = 524; studies = 5; I² = 95%; <LINK REF="CMP-001.08" TYPE="ANALYSIS">Analysis 1.8</LINK>). Data for this outcome refer to survivors at time of assessment (<LINK REF="STD-Jiravisitkul-2017" TYPE="STUDY">Jiravisitkul 2017</LINK>; <LINK REF="STD-Lindner-2005" TYPE="STUDY">Lindner 2005</LINK>; <LINK REF="STD-Mercadante-2016" TYPE="STUDY">Mercadante 2016</LINK>). We obtained data for this outcome directly from trial authors (<LINK REF="STD-Jiravisitkul-2017" TYPE="STUDY">Jiravisitkul 2017</LINK>; <LINK REF="STD-Mercadante-2016" TYPE="STUDY">Mercadante 2016</LINK>; <LINK REF="STD-Ngan-2017" TYPE="STUDY">Ngan 2017</LINK>; <LINK REF="STD-Schwaberger-2015" TYPE="STUDY">Schwaberger 2015</LINK>). Heterogeneity, statistical significance, and magnitude of effects of this outcome are largely influenced by a single study (<LINK REF="STD-Ngan-2017" TYPE="STUDY">Ngan 2017</LINK>): when this study was removed from the analysis, the effect was largely reduced (MD -1.71 days, 95% CI -3.04 to -0.39, I² = 0%).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Duration of respiratory support (nasal continuous airway pressure and ventilation via an ETT, considered in total) (Outcome 1.9)</HEADING>
<P>Two trials (N = 243) reported this outcome (<LINK REF="STD-Lindner-2005" TYPE="STUDY">Lindner 2005</LINK>; <LINK REF="STD-Mercadante-2016" TYPE="STUDY">Mercadante 2016</LINK>) (MD 0.69 days, 95% CI 0.23 to 1.16; participants = 243; studies = 2; I² = 0%; <LINK REF="CMP-001.09" TYPE="ANALYSIS">Analysis 1.9</LINK>). We obtained data for this outcome directly from trial authors; data refer to survivors at time of assessment (<LINK REF="STD-Lindner-2005" TYPE="STUDY">Lindner 2005</LINK>; <LINK REF="STD-Mercadante-2016" TYPE="STUDY">Mercadante 2016</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Duration of supplemental oxygen requirement (days) (Outcome 1.10)</HEADING>
<P>One trial (N = 81) reported this outcome (<LINK REF="STD-Jiravisitkul-2017" TYPE="STUDY">Jiravisitkul 2017</LINK>) (MD -9.73, 95% CI -25.06 to 5.60; participants = 81; studies = 1; <LINK REF="CMP-001.10" TYPE="ANALYSIS">Analysis 1.10</LINK>). The test for heterogeneity was not applicable. We obtained data for this outcome directly from trial authors (<LINK REF="STD-Jiravisitkul-2017" TYPE="STUDY">Jiravisitkul 2017</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Chronic lung disease (i.e. need for supplemental oxygen at 36 weeks of gestational age for infants born at or before 32 weeks of gestation) (Outcome 1.11)</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">Bronchopulmonary dysplasia (BPD) any grade (Outcome 1.11.1)</HEADING>
<P>Two trials (N = 220) reported this outcome (<LINK REF="STD-Lindner-2005" TYPE="STUDY">Lindner 2005</LINK>; <LINK REF="STD-Ngan-2017" TYPE="STUDY">Ngan 2017</LINK>) (typical RR 0.90, 95% CI 0.69 to 1.19; typical RD -0.05, 95% CI -0.17 to 0.08; participants = 220; studies = 2; I² = 0% for RR and I² = 0% for RD). We obtained data for this outcome directly from trial authors; data refer to survivors at time of assessment (<LINK REF="STD-Lindner-2005" TYPE="STUDY">Lindner 2005</LINK>; <LINK REF="CMP-001.11" TYPE="ANALYSIS">Analysis 1.11</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Moderate to severe BDP (Outcome 1.11.2)</HEADING>
<P>Five included trials (N = 683) (<LINK REF="STD-El_x002d_Chimi-2017" TYPE="STUDY">El-Chimi 2017</LINK>; <LINK REF="STD-Jiravisitkul-2017" TYPE="STUDY">Jiravisitkul 2017</LINK>; <LINK REF="STD-Lista-2015" TYPE="STUDY">Lista 2015</LINK>; <LINK REF="STD-Ngan-2017" TYPE="STUDY">Ngan 2017</LINK>; <LINK REF="STD-Schwaberger-2015" TYPE="STUDY">Schwaberger 2015</LINK>) reported this outcome (typical RR 0.95, 95% CI 0.74 to 1.22; typical RD -0.01, 95% CI -0.07 to 0.05; participants = 683; studies = 5; I² = 47% for RR and I² = 57% for RD; <LINK REF="CMP-001.11" TYPE="ANALYSIS">Analysis 1.11</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Air leaks (pneumothorax, pneumomediastinum, pneumopericardium, pulmonary interstitial emphysema) reported individually or as a composite outcome (Outcome 1.12)</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">Pneumothorax in first 48 hours of life (Outcome 1.12.1)</HEADING>
<P>One trial (N = 81) (<LINK REF="STD-Jiravisitkul-2017" TYPE="STUDY">Jiravisitkul 2017</LINK>) reported this outcome (RR 0.88, 95% CI 0.06 to 13.65; RD -0.00, 95% CI -0.07 to 0.06). The test for heterogeneity was not applicable (<LINK REF="CMP-001.12" TYPE="ANALYSIS">Analysis 1.12</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Pneumothorax at any time (Outcome 1.12.2)</HEADING>
<P>Six included studies (N = 851) (<LINK REF="STD-El_x002d_Chimi-2017" TYPE="STUDY">El-Chimi 2017</LINK>; <LINK REF="STD-Lindner-2005" TYPE="STUDY">Lindner 2005</LINK>; <LINK REF="STD-Lista-2015" TYPE="STUDY">Lista 2015</LINK>; <LINK REF="STD-Mercadante-2016" TYPE="STUDY">Mercadante 2016</LINK>; <LINK REF="STD-Ngan-2017" TYPE="STUDY">Ngan 2017</LINK>; <LINK REF="STD-Schwaberger-2015" TYPE="STUDY">Schwaberger 2015</LINK>) reported this outcome (typical RR 1.44, 95% CI 0.76 to 2.72; typical RD 0.02, 95% CI -0.01 to 0.04; studies = 6; 851 infants; I² = 26% for RR and I² = 2% for RD; <LINK REF="CMP-001.12" TYPE="ANALYSIS">Analysis 1.12</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Cranial ultrasound abnormalities (Outcome 1.13)</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">Intraventricular haemorrhage (IVH), grade 3 or 4 according to the Papile classification (Papile 1978) (Outcome 1.13.1)</HEADING>
<P>Five included trials (N = 635) (<LINK REF="STD-Jiravisitkul-2017" TYPE="STUDY">Jiravisitkul 2017</LINK>; <LINK REF="STD-Lindner-2005" TYPE="STUDY">Lindner 2005</LINK>; <LINK REF="STD-Lista-2015" TYPE="STUDY">Lista 2015</LINK>; <LINK REF="STD-Ngan-2017" TYPE="STUDY">Ngan 2017</LINK>; <LINK REF="STD-Schwaberger-2015" TYPE="STUDY">Schwaberger 2015</LINK>) reported this outcome (typical RR 0.89, 95% CI 0.58 to 1.37; typical RD -0.01, 95% CI -0.06 to 0.03; studies = 5; 635 infants; I<SUP>2</SUP> = 4% for RR and I<SUP>2</SUP> = 0% for RD; <LINK REF="CMP-001.13" TYPE="ANALYSIS">Analysis 1.13</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">IVH any grade (Outcome 1.13.2)</HEADING>
<P>Two included trials (N = 152) (<LINK REF="STD-El_x002d_Chimi-2017" TYPE="STUDY">El-Chimi 2017</LINK>; <LINK REF="STD-Schwaberger-2015" TYPE="STUDY">Schwaberger 2015</LINK>) reported this outcome (typical RR 0.82, 95% CI 0.40 to 1.69; typical RD -0.03, 95% CI -0.15 to 0.08; studies = 3; 152 infants; I² = 0% for RR and I² = 0% for RD; <LINK REF="CMP-001.13" TYPE="ANALYSIS">Analysis 1.13</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Cystic periventricular leukomalacia (Outcome 1.13.3)</HEADING>
<P>Five included trials (N = 635) (<LINK REF="STD-Jiravisitkul-2017" TYPE="STUDY">Jiravisitkul 2017</LINK>; <LINK REF="STD-Lindner-2005" TYPE="STUDY">Lindner 2005</LINK>; <LINK REF="STD-Lista-2015" TYPE="STUDY">Lista 2015</LINK>; <LINK REF="STD-Ngan-2017" TYPE="STUDY">Ngan 2017</LINK>; <LINK REF="STD-Schwaberger-2015" TYPE="STUDY">Schwaberger 2015</LINK>) reported this outcome (typical RR 0.59, 95% CI 0.24 to 1.44; typical RD -0.04, 95% CI -0.04 to 0.01; studies = 5; 635 infants; I² = 0% for RR and I² = 0% for RD; <LINK REF="CMP-001.13" TYPE="ANALYSIS">Analysis 1.13</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Retinopathy of prematurity (ROP) &#8805; stage 3 (Outcome 1.14)</HEADING>
<P>Five trials (N = 632) (<LINK REF="STD-Jiravisitkul-2017" TYPE="STUDY">Jiravisitkul 2017</LINK>; <LINK REF="STD-Lindner-2005" TYPE="STUDY">Lindner 2005</LINK>; <LINK REF="STD-Lista-2015" TYPE="STUDY">Lista 2015</LINK>; <LINK REF="STD-Ngan-2017" TYPE="STUDY">Ngan 2017</LINK>; <LINK REF="STD-Schwaberger-2015" TYPE="STUDY">Schwaberger 2015</LINK>) reported this outcome (typical RR 0.69, 95% CI 0.44 to 1.10; typical RD -0.04, 95% CI -0.08 to 0.01; studies = 5; 632 infants; I² = 42% for RR and I² = 40% for RD; <LINK REF="CMP-001.14" TYPE="ANALYSIS">Analysis 1.14</LINK>). For <LINK REF="STD-Lindner-2005" TYPE="STUDY">Lindner 2005</LINK>, data refer to survivors at time of assessment (<LINK REF="CMP-001.14" TYPE="ANALYSIS">Analysis 1.14</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Patent ductus arteriosus (PDA) (Outcome 1.15)</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">Rate of PDA - pharmacological treatment (Outcome 1.15.1)</HEADING>
<P>Six included trials (N = 745) (<LINK REF="STD-El_x002d_Chimi-2017" TYPE="STUDY">El-Chimi 2017</LINK>; <LINK REF="STD-Jiravisitkul-2017" TYPE="STUDY">Jiravisitkul 2017</LINK>; <LINK REF="STD-Lindner-2005" TYPE="STUDY">Lindner 2005</LINK>; <LINK REF="STD-Lista-2015" TYPE="STUDY">Lista 2015</LINK>; <LINK REF="STD-Ngan-2017" TYPE="STUDY">Ngan 2017</LINK>; <LINK REF="STD-Schwaberger-2015" TYPE="STUDY">Schwaberger 2015</LINK>) reported this outcome (typical RR 1.08, 95% CI 0.90 to 1.30; typical RD 0.03, 95% CI -0.04 to 0.09; studies = 6; 745 infants; I² = 36% for RR and I² = 58% for RD; <LINK REF="CMP-001.15" TYPE="ANALYSIS">Analysis 1.15</LINK>). We obtained data for this outcome directly from trial authors (<LINK REF="STD-Schwaberger-2015" TYPE="STUDY">Schwaberger 2015</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Rate of PDA - surgical closure (Outcome 1.15.2)</HEADING>
<P>Three trials (N = 412) (<LINK REF="STD-Jiravisitkul-2017" TYPE="STUDY">Jiravisitkul 2017</LINK>; <LINK REF="STD-Lista-2015" TYPE="STUDY">Lista 2015</LINK>; <LINK REF="STD-Schwaberger-2015" TYPE="STUDY">Schwaberger 2015</LINK>) reported this outcome (typical RR 0.73, 95% CI 0.27 to 1.99; typical RD -0.01, 95% CI -0.05 to 0.03; studies = 3; 412 infants; I² = 0% for RR and I² = 26% for RD; <LINK REF="CMP-001.15" TYPE="ANALYSIS">Analysis 1.15</LINK>). We obtained data for this outcome directly from trial authors (<LINK REF="STD-Schwaberger-2015" TYPE="STUDY">Schwaberger 2015</LINK>).</P>
<P>The data refer to all randomised infants, unless otherwise specified.</P>
<P>No data were reported for the following outcomes: heart rate; need for supplemental oxygen at 28 days of life; seizures including clinical and electroencephalographic; hypoxic ischaemic encephalopathy in term and late preterm infants (grade 1 to 3; <LINK REF="REF-Sarnat-1976" TYPE="REFERENCE">Sarnat 1976</LINK>); and long-term neurodevelopmental outcomes.</P>
<P>Death to latest follow-up: No data were provided in addition to those already presented for death during hospitalisation (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Subgroup analysis for the primary comparison</HEADING>
<P>For the primary comparison, we were unable to conduct any of the four prespecified subgroup analyses because:</P>
<UL>
<LI>no term infants were included;</LI>
<LI>for ventilation devices, all trials used a T-piece except <LINK REF="STD-Lindner-2005" TYPE="STUDY">Lindner 2005</LINK> (mechanical ventilator): We did not perform a separate analysis because of the very small sample size and the presence of high or unclear risk of bias in most GRADE domains. Moreover, <LINK REF="STD-El_x002d_Chimi-2017" TYPE="STUDY">El-Chimi 2017</LINK> used a T-piece ventilator in the SLI group and a self-inflating bag in the control group; thus we could not include this as a subgroup;</LI>
<LI>for interface, all trials used a face mask, except <LINK REF="STD-Lindner-2005" TYPE="STUDY">Lindner 2005</LINK> (nasopharyngeal tube): As for ventilation devices, we did not perform a separate analysis for <LINK REF="STD-Lindner-2005" TYPE="STUDY">Lindner 2005</LINK>; and</LI>
<LI>no trials used SLI &lt; 5 seconds.</LI>
</UL>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Secondary comparison: use of initial sustained inflation versus standard inflations in newborns receiving resuscitation with chest compressions</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Death (Outcome 2.1)</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">Death in the delivery room (Outcome 2.1.1)</HEADING>
<P>The included trial (N = 9) did not report this outcome (<LINK REF="STD-Schm_x00f6_lzer-2015" TYPE="STUDY">Schmölzer 2015</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Death during hospitalisation (Outcome 2.1.2)</HEADING>
<P>One trial (N = 9) reported this outcome (RR 1.60, 95% CI 0.21 to 11.92; RD 0.15, 95% CI -0.45 to 0.75); thus, the test for heterogeneity was not applicable for this outcome (<LINK REF="STD-Schm_x00f6_lzer-2015" TYPE="STUDY">Schmölzer 2015</LINK>; <LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>). We obtained data for this outcome directly from trial authors (<LINK REF="STD-Schm_x00f6_lzer-2015" TYPE="STUDY">Schmölzer 2015</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Endotracheal intubation in the delivery room (Outcome 2.2) </HEADING>
<P>One trial (N = 9) reported this outcome (RR 1.00, 95% CI 0.68 to 1.46; RD 0.00, 95% CI -0.34 to 0.34); thus, the test for heterogeneity was not applicable for this outcome (<LINK REF="STD-Schm_x00f6_lzer-2015" TYPE="STUDY">Schmölzer 2015;</LINK> <LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>). We obtained data for this outcome directly from trial authors (<LINK REF="STD-Schm_x00f6_lzer-2015" TYPE="STUDY">Schmölzer 2015</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Surfactant administration in the delivery room (Outcome 2.3) </HEADING>
<P>One trial (N = 9) reported this outcome (RR 1.60, 95% CI 0.55 to 4.68; RD 0.30, 95% CI -0.30 to 0.90); thus, the test for heterogeneity was not applicable for this outcome (<LINK REF="STD-Schm_x00f6_lzer-2015" TYPE="STUDY">Schmölzer 2015</LINK>; <LINK REF="CMP-002.03" TYPE="ANALYSIS">Analysis 2.3</LINK>). We obtained data for this outcome directly from trial authors (<LINK REF="STD-Schm_x00f6_lzer-2015" TYPE="STUDY">Schmölzer 2015</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Chronic lung disease (2.4, 2.5, 2.6)</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">Moderate to severe BDP (Outcome 2.4)</HEADING>
<P>One trial (N = 9) reported this outcome (RR 0.89, 95% CI 0.33 to 2.37; RD -0.08, 95% CI -0.76 to 0.60); thus, the test for heterogeneity was not applicable for this outcome (<LINK REF="STD-Schm_x00f6_lzer-2015" TYPE="STUDY">Schmölzer 2015</LINK>; <LINK REF="CMP-002.03" TYPE="ANALYSIS">Analysis 2.3</LINK>). We obtained data for this outcome directly from trial authors (<LINK REF="STD-Schm_x00f6_lzer-2015" TYPE="STUDY">Schmölzer 2015</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Pneumothorax at any time (Outcome 2.5)</HEADING>
<P>One trial (N = 9) reported this outcome: No events occurred (<LINK REF="CMP-002.05" TYPE="ANALYSIS">Analysis 2.5</LINK>). We obtained data for this outcome directly from trial authors (<LINK REF="STD-Schm_x00f6_lzer-2015" TYPE="STUDY">Schmölzer 2015</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Cranial ultrasound abnormalities (Outcome 2.6)</HEADING>
<P>
<U>Intraventricular haemorrhage (IVH), grade 3 or 4 according to the Papile classification (Papile 1978) <I>(Outcome 2.6.1)</I>
</U>
</P>
<P>One trial (N = 9) reported this outcome (RR 0.40, 95% CI 0.05 to 2.98; RD -0.30, 95% CI -0.90 to 0.30); thus, the test for heterogeneity was not applicable for this outcome (<LINK REF="STD-Schm_x00f6_lzer-2015" TYPE="STUDY">Schmölzer 2015</LINK>; <LINK REF="CMP-002.06" TYPE="ANALYSIS">Analysis 2.6</LINK>). We obtained data for this outcome directly from trial authors (<LINK REF="STD-Schm_x00f6_lzer-2015" TYPE="STUDY">Schmölzer 2015</LINK>).</P>
<P>
<U>IVH any grade <I>(Outcome 2.6.2)</I>
</U>
</P>
<P>One trial (N = 9) reported this outcome (RR 0.28, 95% CI 0.07 to 1.15; RD -0.80, 95% CI -1.23 to -0.37); thus, the test for heterogeneity was not applicable for this outcome (<LINK REF="STD-Schm_x00f6_lzer-2015" TYPE="STUDY">Schmölzer 2015</LINK>; <LINK REF="CMP-002.06" TYPE="ANALYSIS">Analysis 2.6</LINK>). We obtained data for this outcome directly from trial authors (<LINK REF="STD-Schm_x00f6_lzer-2015" TYPE="STUDY">Schmölzer 2015</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Retinopathy of prematurity (ROP) &#8805; stage 3 (Outcome 2.7)</HEADING>
<P>One trial (N = 9) reported this outcome (RR 0.27, 95% CI 0.04 to 1.68; RD -0.55, 95% CI -1.10 to 0.00); thus, the test for heterogeneity was not applicable for this outcome (<LINK REF="STD-Schm_x00f6_lzer-2015" TYPE="STUDY">Schmölzer 2015</LINK>; <LINK REF="CMP-002.07" TYPE="ANALYSIS">Analysis 2.7</LINK>). We obtained data for this outcome directly from trial authors (<LINK REF="STD-Schm_x00f6_lzer-2015" TYPE="STUDY">Schmölzer 2015</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Rate of PDA - pharmacological treatment (Outcome 2.8)</HEADING>
<P>One trial (N = 9) reported this outcome (RR 0.46, 95% CI 0.17 to 1.25; RD -0.60, 95% CI -1.07 to -0.13); thus, the test for heterogeneity was not applicable for this outcome (<LINK REF="STD-Schm_x00f6_lzer-2015" TYPE="STUDY">Schmölzer 2015</LINK>; <LINK REF="CMP-002.08" TYPE="ANALYSIS">Analysis 2.8</LINK>). We obtained data for this outcome directly from trial authors (<LINK REF="STD-Schm_x00f6_lzer-2015" TYPE="STUDY">Schmölzer 2015</LINK>).</P>
<P>For the secondary comparison, investigators provided no data on other prespecified outcomes.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Subgroup analysis for the secondary comparison</HEADING>
<P>For the secondary comparison, we were unable to conduct any subgroup analysis, as we included only one trial.</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2017-07-12 06:21:57 -0400" MODIFIED_BY="[Empty name]">
<SUMMARY_OF_RESULTS MODIFIED="2017-07-12 06:16:13 -0400" MODIFIED_BY="[Empty name]">
<P>We evaluated the merits of sustained lung inflation (SLI) versus intermittent ventilation in infants requiring resuscitation and stabilisation at birth. Eight trials enrolling 941 preterm infants met review inclusion criteria (<LINK REF="STD-El_x002d_Chimi-2017" TYPE="STUDY">El-Chimi 2017</LINK>; <LINK REF="STD-Jiravisitkul-2017" TYPE="STUDY">Jiravisitkul 2017</LINK>; <LINK REF="STD-Lindner-2005" TYPE="STUDY">Lindner 2005</LINK>; <LINK REF="STD-Lista-2015" TYPE="STUDY">Lista 2015</LINK>; <LINK REF="STD-Mercadante-2016" TYPE="STUDY">Mercadante 2016</LINK>; <LINK REF="STD-Ngan-2017" TYPE="STUDY">Ngan 2017</LINK>; <LINK REF="STD-Schm_x00f6_lzer-2015" TYPE="STUDY">Schmölzer 2015</LINK>; <LINK REF="STD-Schwaberger-2015" TYPE="STUDY">Schwaberger 2015</LINK>). Whereas the two trials included in the previous version of this review enrolled infants at 25<SUP>+0</SUP> to 28<SUP>+6 </SUP>weeks (<LINK REF="STD-Lindner-2005" TYPE="STUDY">Lindner 2005</LINK>; <LINK REF="STD-Lista-2015" TYPE="STUDY">Lista 2015</LINK>), the five more recent trials enrolled larger infants (<LINK REF="STD-El_x002d_Chimi-2017" TYPE="STUDY">El-Chimi 2017</LINK>; <LINK REF="STD-Jiravisitkul-2017" TYPE="STUDY">Jiravisitkul 2017</LINK>; <LINK REF="STD-Mercadante-2016" TYPE="STUDY">Mercadante 2016</LINK>; <LINK REF="STD-Ngan-2017" TYPE="STUDY">Ngan 2017</LINK>; <LINK REF="STD-Schwaberger-2015" TYPE="STUDY">Schwaberger 2015</LINK>). One of the trials included in this update was not pooled with the other studies for analysis because investigators superimposed the intervention on chest compressions (<LINK REF="STD-Schm_x00f6_lzer-2015" TYPE="STUDY">Schmölzer 2015</LINK>).</P>
<P>Sustained lung inflation was not better than intermittent ventilation for reducing mortality - the primary outcome of this review. We rated the quality of evidence as moderate (GRADE) for death before discharge (limitations in study design of most included trials) and as low (GRADE) for death in the delivery room (limitations in study design and imprecision of estimates). When considering secondary outcomes, such as need for intubation, need for or duration of respiratory support, bronchopulmonary dysplasia, or pneumothorax, we found no benefit of SLI over intermittent ventilation. The quality of evidence for secondary outcomes was moderate (limitations in study design of most included trials - GRADE), except for pneumothorax (low quality: limitations in study design and imprecision of estimates - GRADE). Duration of mechanical ventilation was shorter in the SLI group (low quality: limitations in study design and imprecision of estimates - GRADE). The first version of this review reported an increased rate of patent ductus arteriosus (PDA) in the sustained lung inflation group. However, this effect was not seen when the most recent trials were added to the analysis. We identified six ongoing trials.</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2017-07-12 06:18:26 -0400" MODIFIED_BY="[Empty name]">
<P>To date, seven trials comparing sustained versus standard inflations for initial resuscitation have enrolled 941 newborns. Available data were insufficient for assessment of clinically important outcomes, which were identified <I>a priori</I>. Study authors did not report outcomes such as duration of supplemental oxygen requirement and long-term neurodevelopmental outcomes and did not enrol term infants. We could not perform an <I>a priori</I> subgroup analysis (gestational age, ventilation device, interface, duration of sustained inflation) to detect differential effects because of the paucity of included trials. Relevant questions such as the following remain unanswered: What is the optimal duration for an SLI? Which level of positive end-expiratory pressure (PEEP) should follow? Which is the optimal interface/device? (<LINK REF="REF-McCall-2016" TYPE="REFERENCE">McCall 2016</LINK>) We were able to summarise available evidence in a comprehensive way, as we obtained additional information about study design and outcome data from all included trials (<LINK REF="STD-El_x002d_Chimi-2017" TYPE="STUDY">El-Chimi 2017</LINK>; <LINK REF="STD-Jiravisitkul-2017" TYPE="STUDY">Jiravisitkul 2017</LINK>; <LINK REF="STD-Lindner-2005" TYPE="STUDY">Lindner 2005</LINK>; <LINK REF="STD-Lista-2015" TYPE="STUDY">Lista 2015</LINK>; <LINK REF="STD-Mercadante-2016" TYPE="STUDY">Mercadante 2016</LINK>; <LINK REF="STD-Ngan-2017" TYPE="STUDY">Ngan 2017</LINK>; <LINK REF="STD-Schm_x00f6_lzer-2015" TYPE="STUDY">Schmölzer 2015</LINK>; <LINK REF="STD-Schwaberger-2015" TYPE="STUDY">Schwaberger 2015</LINK>) and from two excluded trials (<LINK REF="STD-Harling-2005" TYPE="STUDY">Harling 2005</LINK>; <LINK REF="STD-te-Pas-2007" TYPE="STUDY">te Pas 2007</LINK>). The five ongoing trials that we identified reported important differences in choice of gestational age (<LINK REF="STD-NCT02139800" TYPE="STUDY">NCT02139800</LINK>; <LINK REF="STD-NCT02493920" TYPE="STUDY">NCT02493920</LINK>; <LINK REF="STD-NCT02846597" TYPE="STUDY">NCT02846597</LINK>; <LINK REF="STD-NCT02858583" TYPE="STUDY">NCT02858583</LINK>; <LINK REF="STD-NCT02887924" TYPE="STUDY">NCT02887924</LINK>). <LINK REF="STD-NCT02139800" TYPE="STUDY">NCT02139800</LINK> enrols infants at 23 to 26 weeks, <LINK REF="STD-NCT02493920" TYPE="STUDY">NCT02493920</LINK> at 25 to 36 weeks, <LINK REF="STD-NCT02887924" TYPE="STUDY">NCT02887924</LINK> at 26 to 29 weeks, and <LINK REF="STD-NCT02846597" TYPE="STUDY">NCT02846597</LINK> at &lt; 33 weeks, whereas <LINK REF="STD-NCT02858583" TYPE="STUDY">NCT02858583</LINK> enrols term and preterm infants. These differences among study populations might prove to be important, as trials have reported that sustained inflation was more effective in infants at 28 to 30 weeks than at &lt; 28 or &gt; 30 weeks of gestation (<LINK REF="STD-te-Pas-2007" TYPE="STUDY">te Pas 2007</LINK>).</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2017-07-12 06:19:05 -0400" MODIFIED_BY="[Empty name]">
<P>According to the GRADE approach, we rated the overall quality of evidence for clinically relevant outcomes as low to moderate (see <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>). We downgraded the overall quality of evidence for critical outcomes because of limitations in study design (i.e. selection bias due to lack of allocation concealment) and imprecision of results (few events for death in the delivery room and wide confidence intervals for pneumothorax). In addition, two trials did not report sample size calculations (<LINK REF="STD-El_x002d_Chimi-2017" TYPE="STUDY">El-Chimi 2017</LINK>; <LINK REF="STD-Schwaberger-2015" TYPE="STUDY">Schwaberger 2015</LINK>), and the other three did not achieve them (<LINK REF="STD-Jiravisitkul-2017" TYPE="STUDY">Jiravisitkul 2017</LINK>; <LINK REF="STD-Lindner-2005" TYPE="STUDY">Lindner 2005;</LINK> <LINK REF="STD-Ngan-2017" TYPE="STUDY">Ngan 2017)</LINK>. Results of smaller studies are subject to greater sampling variation, and hence are less precise. Indeed, imprecision is reflected in the confidence interval around the intervention effect estimate from each study and in the weight given to the results of each study included in the meta-analysis (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2017-07-12 06:20:17 -0400" MODIFIED_BY="[Empty name]">
<P>A major limitation of this Cochrane review is the definition of sustained lung inflation, as trials used different pressures, which may have impacted study results. No trials were blinded owing to the nature of the intervention. We excluded a potentially relevant trial (<LINK REF="STD-te-Pas-2007" TYPE="STUDY">te Pas 2007</LINK>) because sustained inflation was only one element of the intervention, and it is not possible to determine the relative contributions of various elements of this intervention to differences observed between groups. We excluded <LINK REF="STD-Harling-2005" TYPE="STUDY">Harling 2005</LINK> because the control group received 2 seconds of inflation (5 seconds for the intervention group), whereas we defined sustained as &gt; 1 second. For this update, we made a <I>post hoc</I> decision to add a comparison based on the presence of chest compressions during resuscitation.</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2017-07-12 06:21:57 -0400" MODIFIED_BY="[Empty name]">
<P>Several systematic reviews of SLI have been recently published. <LINK REF="REF-Schm_x00f6_lzer-2014" TYPE="REFERENCE">Schmölzer 2014</LINK> conducted a systematic review of randomised clinical trials comparing SLI versus intermittent positive-pressure ventilation (IPPV) as the primary respiratory intervention during respiratory support in preterm individuals at &lt; 33&#8197;weeks of gestational age in the delivery room. This review included four trials, including two that we excluded from our systematic review (<LINK REF="STD-Harling-2005" TYPE="STUDY">Harling 2005</LINK>; <LINK REF="STD-te-Pas-2007" TYPE="STUDY">te Pas 2007</LINK>). <LINK REF="REF-Schm_x00f6_lzer-2014" TYPE="REFERENCE">Schmölzer 2014</LINK> reported a significant reduction in the need for mechanical ventilation within 72&#8197;hours after birth (typical risk ratio (RR) 0.87, 95% confidence interval (CI) 0.74 to 1.03). As in our analysis, significantly more infants treated with SLI received treatment for PDA (RR 1.27, 95% CI 1.05 to 1.54). Results showed no differences in bronchopulmonary dysplasia (BPD), death at latest follow-up, or the combined outcome of death or BPD among survivors between groups. The findings of <LINK REF="REF-Schm_x00f6_lzer-2014" TYPE="REFERENCE">Schmölzer 2014</LINK> differ from the findings of this Cochrane review because of differences in the definition of duration of the intervention, and therefore in determination of included trials. A narrative review (<LINK REF="REF-Foglia-2016" TYPE="REFERENCE">Foglia 2016</LINK>) including five trials (<LINK REF="STD-Harling-2005" TYPE="STUDY">Harling 2005</LINK>; <LINK REF="STD-Lindner-2005" TYPE="STUDY">Lindner 2005</LINK>; <LINK REF="STD-Lista-2015" TYPE="STUDY">Lista 2015</LINK>; <LINK REF="STD-Mercadante-2016" TYPE="STUDY">Mercadante 2016</LINK>; <LINK REF="STD-te-Pas-2007" TYPE="STUDY">te Pas 2007</LINK>) concluded that at present, data are insufficient to support the use of SLI in clinical practice. An observational analytical cross-sectional case&#8211;control study of 78 preterm infants showed that SLI resulted in lower rates of intubation in the delivery room, lower rates of invasive mechanical ventilation, and higher rates of intraventricular haemorrhage (<LINK REF="REF-Grasso-2015" TYPE="REFERENCE">Grasso 2015</LINK>).</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2017-07-12 06:23:04 -0400" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2017-07-12 06:22:55 -0400" MODIFIED_BY="[Empty name]">
<P>Sustained lung inflation was not better than intermittent ventilation for reducing mortality in the delivery room (low-quality evidence - GRADE) and during hospitalisation (moderate-quality evidence - GRADE) - primary outcomes of this review. When considering secondary outcomes, such as need for intubation, need for or duration of respiratory support, or bronchopulmonary dysplasia, we found no benefit of sustained inflation over intermittent ventilation (moderate-quality evidence - GRADE). Duration of mechanical ventilation was shortened in the SLI group (low-quality evidence - GRADE); however, this result should be interpreted cautiously, as it might have been influenced by study characteristics other than the intervention.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2017-07-12 06:23:04 -0400" MODIFIED_BY="[Empty name]">
<P>Additional studies of SLI for infants receiving respiratory support at birth should provide more detailed monitoring of the procedure, such as measurements of lung volume and presence of apnoea before or during SLI. Future randomised controlled trials should aim to enrol infants who are at higher risk of morbidity and mortality, and should stratify participants by gestational age. Researchers should also measure long-term neurodevelopmental outcomes (e.g. Bayley Scales of Infant Development administered at two years of corrected age).</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2017-07-12 06:23:52 -0400" MODIFIED_BY="[Empty name]">
<P>We thank Drs. Lindner, te Pas, Harling, El-Farghali (for <LINK REF="STD-El_x002d_Chimi-2017" TYPE="STUDY">El-Chimi 2017</LINK>), Mercadante, Nuntnarumit (<LINK REF="STD-Jiravisitkul-2017" TYPE="STUDY">Jiravisitkul 2017</LINK>), Schmolzer (for <LINK REF="STD-Ngan-2017" TYPE="STUDY">Ngan 2017</LINK> and <LINK REF="STD-Schm_x00f6_lzer-2015" TYPE="STUDY">Schmölzer 2015</LINK>), and Schwaberger for their gracious assistance in providing extra data.</P>
<P>We acknowledge the help of Ms. Jennifer Spano and Ms. Colleen Ovelman in conducting literature searches for this update of the review.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2017-07-12 14:16:35 -0400" MODIFIED_BY="[Empty name]">
<P>MB, COD, PD, CM, LM, SZ, and MGC have no known conflicts of interest to declare.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2017-07-12 14:16:10 -0400" MODIFIED_BY="[Empty name]">
<P>Dr. Bruschettini and Dr. O'Donnell performed the literature search, extracted and analysed data, and wrote the manuscript. Prof. Davis performed the literature search, extracted data, checked the analysis, and reviewed the manuscript. Prof. Morley and Dr. Moja reviewed the manuscript. Dr. Zappettini performed the literature search, extracted data, and reviewed the manuscript. Dr. Calevo analysed data, checked the analysis, and reviewed the manuscript.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2017-07-12 06:24:45 -0400" MODIFIED_BY="[Empty name]">
<P>We added clinically relevant outcomes (surfactant administration, need for mechanical ventilation, retinopathy of prematurity, and PDA).</P>
<P>We planned subgroup analyses according to gestational age (&lt; 37 weeks, &#8805; 37 weeks), ventilation device used (self-inflating bag, flow-inflating bag, T-piece, mechanical ventilator), patient interface used (face mask, ETT, nasopharyngeal tube), and duration of sustained inflation (&gt; 1 second to 5 seconds, &gt; 5 seconds). We were unable to conduct any subgroup analyses as few trials met the inclusion criteria.</P>
<P>For this update, we made the <I>post hoc</I> decision to add a comparison based on use of chest compression during resuscitation. Moreover, we specified <LINK TAG="UNIT_OF_ANALYSIS" TYPE="SECTION">Unit of analysis issues</LINK> and <LINK TAG="SENSITIVITY_ANALYSIS" TYPE="SECTION">Sensitivity analysis</LINK>.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2017-07-21 18:59:48 +0100" MODIFIED_BY="Colleen Ovelman">
<STUDIES MODIFIED="2017-07-12 16:16:20 -0400" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2017-07-12 16:16:20 -0400" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-El_x002d_Chimi-2017" MODIFIED="2017-05-30 12:11:49 -0400" MODIFIED_BY="[Empty name]" NAME="El-Chimi 2017" YEAR="2017">
<REFERENCE MODIFIED="2017-05-30 12:11:20 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>El-Chimi MS, Awad HA, El-Gammasy TM, El-Farghali OG, Sallam MT, Shinkar DM</AU>
<TI>Sustained versus intermittent lung inflation for resuscitation of preterm infants: a randomized controlled trial</TI>
<SO>Journal of Maternal-fetal &amp; Neonatal Medicine</SO>
<YR>2017</YR>
<VL>11</VL>
<PG>1273-8</PG>
<IDENTIFIERS MODIFIED="2017-05-30 12:10:35 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6294340"/><IDENTIFIER MODIFIED="2017-05-30 12:10:35 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1080/14767058.2016.1210598"/><IDENTIFIER TYPE="PUBMED" VALUE="27384245"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6294339"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jiravisitkul-2017" MODIFIED="2017-05-30 12:15:22 -0400" MODIFIED_BY="[Empty name]" NAME="Jiravisitkul 2017" YEAR="2017">
<REFERENCE MODIFIED="2017-05-30 12:15:22 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jiravisitkul P, Rattanasiri S, Nuntnarumit P</AU>
<TI>Randomised controlled trial of sustained lung inflation for resuscitation of preterm infants in the delivery room</TI>
<SO>Resuscitation</SO>
<YR>2017</YR>
<VL>111</VL>
<PG>68-73</PG>
<IDENTIFIERS MODIFIED="2017-05-30 12:15:22 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6294342"/><IDENTIFIER MODIFIED="2017-05-30 12:15:22 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1016/j.resuscitation.2016.12.003"/><IDENTIFIER MODIFIED="2017-05-30 12:14:19 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="27987395"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-01-17 18:16:29 -0500" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6294341"/><IDENTIFIER MODIFIED="2017-01-17 18:16:29 -0500" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1016/j.resuscitation.2016.12.003"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lindner-2005" MODIFIED="2017-05-30 12:16:26 -0400" MODIFIED_BY="[Empty name]" NAME="Lindner 2005" YEAR="2005">
<REFERENCE MODIFIED="2017-05-30 12:16:26 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lindner W, Högel J, Pohlandt F</AU>
<TI>Sustained pressure-controlled inflation or intermittent mandatory ventilation in preterm infants in the delivery room? A randomized, controlled trial on initial respiratory support via nasopharyngeal tube</TI>
<SO>Acta Paediatrica</SO>
<YR>2005</YR>
<VL>94</VL>
<NO>3</NO>
<PG>303-9</PG>
<IDENTIFIERS MODIFIED="2017-05-30 12:16:26 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3364557"/><IDENTIFIER MODIFIED="2017-05-30 12:16:26 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="16028648"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2015-02-22 09:42:32 -0500" MODIFIED_BY="Matteo Bruschettini"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3364556"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lista-2015" MODIFIED="2017-05-30 12:18:44 -0400" MODIFIED_BY="[Empty name]" NAME="Lista 2015" YEAR="2015">
<REFERENCE MODIFIED="2017-05-30 12:18:44 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lista G, Boni L, Scopesi F, Mosca F, Trevisanuto D, Messner H, et al; SLI Trial Investigators</AU>
<TI>Sustained lung inflation at birth for preterm infants: a randomized clinical trial</TI>
<SO>Pediatrics</SO>
<YR>2015</YR>
<VL>135</VL>
<NO>2</NO>
<PG>e457-64</PG>
<IDENTIFIERS MODIFIED="2017-05-30 12:18:44 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3364559"/><IDENTIFIER MODIFIED="2017-05-30 12:18:33 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1542/peds.2014-1692"/><IDENTIFIER MODIFIED="2017-05-30 12:18:44 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="25624390"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2015-02-22 09:42:32 -0500" MODIFIED_BY="Matteo Bruschettini"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3364558"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mercadante-2016" MODIFIED="2017-05-30 12:20:37 -0400" MODIFIED_BY="[Empty name]" NAME="Mercadante 2016" YEAR="2016">
<REFERENCE MODIFIED="2017-05-30 12:20:37 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mercadante D, Colnaghi M, Polimeni V, Ghezzi E, Fumagalli M, Consonni D, et al</AU>
<TI>Sustained lung inflation in late preterm infants: a randomized controlled trial</TI>
<SO>Journal of Perinatology</SO>
<YR>2016</YR>
<VL>36</VL>
<NO>6</NO>
<PG>443-7</PG>
<IDENTIFIERS MODIFIED="2017-05-30 12:20:37 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6294344"/><IDENTIFIER MODIFIED="2017-05-30 12:20:37 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1038/jp.2015.222"/><IDENTIFIER TYPE="PUBMED" VALUE="26820220"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6294343"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ngan-2017" MODIFIED="2017-07-12 16:16:20 -0400" MODIFIED_BY="[Empty name]" NAME="Ngan 2017" YEAR="(accessed on 1 February 2015)">
<REFERENCE MODIFIED="2017-07-12 16:16:20 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ngan AY, Cheung PY, Mason AH, O&#8217;Reilly M, van Os S, Kumar M, et al</AU>
<TI>Using exhaled CO2 to guide initial respiratory support at birth: a randomised controlled trial</TI>
<SO>Archives of Disease in Childhood</SO>
<YR>2017</YR>
<IDENTIFIERS MODIFIED="2017-07-12 16:15:54 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6294345"/><IDENTIFIER MODIFIED="2017-07-12 16:15:54 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1136/archdischild-2016-312286"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3364568"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schm_x00f6_lzer-2015" MODIFIED="2017-05-30 12:39:02 -0400" MODIFIED_BY="[Empty name]" NAME="Schmölzer 2015" YEAR="2015">
<REFERENCE MODIFIED="2017-05-30 12:39:02 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schmölzer G, O&#8217;Reilly M, Kushniruk K, Aziz K, Cheung PY</AU>
<TI>Sustained inflation and chest compression versus 3:1 chest compression: ventilation ratio during neonatal CPR &#8211; a randomized controlled trial</TI>
<SO>Paediatrics and Child Health</SO>
<YR>2015</YR>
<VL>20</VL>
<NO>5</NO>
<PG>e31</PG>
<IDENTIFIERS MODIFIED="2017-05-30 12:39:02 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6294347"/><IDENTIFIER MODIFIED="2017-05-30 12:39:02 -0400" MODIFIED_BY="[Empty name]" TYPE="EMBASE" VALUE="72223281"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6294346"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schwaberger-2015" MODIFIED="2017-05-30 12:40:27 -0400" MODIFIED_BY="[Empty name]" NAME="Schwaberger 2015" YEAR="2015">
<REFERENCE MODIFIED="2017-05-30 12:40:27 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schwaberger B, Pichler G, Avian A, Binder-Heschl C, Baik N, Urlesberger B</AU>
<TI>Do sustained lung inflations during neonatal resuscitation affect cerebral blood volume in preterm infants? A randomized controlled pilot study</TI>
<SO>PloS One</SO>
<YR>2015</YR>
<VL>10</VL>
<NO>9</NO>
<PG>e0138964</PG>
<IDENTIFIERS MODIFIED="2017-05-30 12:40:27 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6294349"/><IDENTIFIER MODIFIED="2017-05-30 12:40:27 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1371/journal.pone.0138964"/><IDENTIFIER TYPE="PUBMED" VALUE="26406467"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6294348"/></IDENTIFIERS>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2017-05-30 12:45:46 -0400" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Bouziri-2011" MODIFIED="2017-05-30 12:43:08 -0400" MODIFIED_BY="[Empty name]" NAME="Bouziri 2011" YEAR="2011">
<REFERENCE MODIFIED="2017-05-30 12:43:08 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bouziri A, Hamdi A, Khaldi A, Bel Hadj S, Menif K, Ben Jaballah N</AU>
<TI>Management of meconium aspiration syndrome with high frequency oscillatory ventilation</TI>
<SO>Tunisie Medicale</SO>
<YR>2011</YR>
<VL>89</VL>
<NO>7</NO>
<PG>632-7</PG>
<IDENTIFIERS MODIFIED="2017-05-30 12:43:08 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3364561"/><IDENTIFIER MODIFIED="2017-05-30 12:43:08 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="21780039"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2015-02-22 09:42:32 -0500" MODIFIED_BY="Matteo Bruschettini"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3364560"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Harling-2005" MODIFIED="2017-05-30 12:44:31 -0400" MODIFIED_BY="[Empty name]" NAME="Harling 2005" YEAR="2005">
<REFERENCE MODIFIED="2017-05-30 12:44:31 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Harling AE, Beresford MW, Vince GS, Bates M, Yoxall CW</AU>
<TI>Does sustained lung inflation at resuscitation reduce lung injury in the preterm infant?</TI>
<SO>Archives of Disease in Childhood. Fetal and Neonatal Edition</SO>
<YR>2005</YR>
<VL>90</VL>
<NO>5</NO>
<PG>F406-10</PG>
<IDENTIFIERS MODIFIED="2017-05-30 12:44:31 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3364563"/><IDENTIFIER MODIFIED="2017-05-30 12:44:31 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1136/adc.2004.059303"/><IDENTIFIER MODIFIED="2017-05-30 12:44:18 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="15863490 "/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2015-02-22 09:42:32 -0500" MODIFIED_BY="Matteo Bruschettini"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3364562"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-te-Pas-2007" MODIFIED="2017-05-30 12:45:46 -0400" MODIFIED_BY="[Empty name]" NAME="te Pas 2007" YEAR="2007">
<REFERENCE MODIFIED="2017-05-30 12:45:46 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>te Pas AB, Walther FJ</AU>
<TI>A randomized, controlled trial of delivery-room respiratory management in very preterm infants</TI>
<SO>Pediatrics</SO>
<YR>2007</YR>
<VL>120</VL>
<NO>2</NO>
<PG>322-9</PG>
<IDENTIFIERS MODIFIED="2017-05-30 12:45:46 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3364565"/><IDENTIFIER MODIFIED="2017-05-30 12:45:46 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1542/peds.2007-0114"/><IDENTIFIER MODIFIED="2017-05-30 12:45:34 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="17671058"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2015-02-22 09:42:32 -0500" MODIFIED_BY="Matteo Bruschettini"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3364564"/></IDENTIFIERS>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2015-02-21 10:46:56 -0500" MODIFIED_BY="Matteo Bruschettini"/>
<ONGOING_STUDIES MODIFIED="2017-05-30 13:05:51 -0400" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-NCT02139800" MODIFIED="2017-05-30 12:54:56 -0400" MODIFIED_BY="[Empty name]" NAME="NCT02139800" YEAR="(accessed 1 February 2015)">
<REFERENCE MODIFIED="2017-05-30 12:47:56 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Foglia EE, Owen LS, Thio M, Ratcliffe SJ, Lista G, Te Pas A, et al</AU>
<TI>Sustained Aeration of Infant Lungs (SAIL) trial: study protocol for a randomized controlled trial</TI>
<SO>Trials</SO>
<YR>2015</YR>
<VL>16</VL>
<PG>95</PG>
<IDENTIFIERS MODIFIED="2017-05-30 12:47:56 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6294350"/><IDENTIFIER MODIFIED="2017-01-17 15:38:16 -0500" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1186/s13063-015-0601-9"/><IDENTIFIER MODIFIED="2017-05-30 12:47:56 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="25872563"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-05-30 12:54:56 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>NCT02139800</AU>
<TI>Sustained Aeration of Infant Lungs Trial (SAIL)</TI>
<SO>clinicaltrials.gov/show/NCT02139800</SO>
<YR>(first received 08 May 2014)</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3364571"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3364570"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT02493920" MODIFIED="2017-05-30 13:02:02 -0400" MODIFIED_BY="[Empty name]" NAME="NCT02493920" YEAR="2017">
<REFERENCE MODIFIED="2017-05-30 13:02:02 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>NCT02493920</AU>
<TI>Sustained Lung Inflation and Pulmonary Mechanics in Preterm Infant</TI>
<TO>Evaluation of pulmonary mechanics in preterm infant treated with sustained lung inflation at birth</TO>
<SO>clinicaltrials.gov/show/NCT02493920</SO>
<YR>(first received 23 June 2015)</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6294352"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6294351"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT02846597" MODIFIED="2017-05-30 13:00:55 -0400" MODIFIED_BY="[Empty name]" NAME="NCT02846597" YEAR="2017">
<REFERENCE MODIFIED="2017-05-30 13:00:55 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>NCT02846597</AU>
<TI>Proper pressure and duration of sustained lung inflation in preterm infants</TI>
<TO>Sustained lung inflation at birth for preterm infants at risk of respiratory distress syndrome: the proper pressure and duration: prospective randomized study</TO>
<SO>clinicaltrials.gov/show/NCT02846597</SO>
<YR>(first received 22 July 2016)</YR>
<IDENTIFIERS MODIFIED="2017-05-30 13:00:55 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6294354"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6294353"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT02858583" MODIFIED="2017-05-30 13:04:11 -0400" MODIFIED_BY="[Empty name]" NAME="NCT02858583" YEAR="2017">
<REFERENCE MODIFIED="2017-05-30 13:04:11 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>NCT02858583</AU>
<TI>SI + CC Versus 3:1 C:V Ratio During Neonatal CPR</TI>
<TO>SURV1VE-Trial - Sustained inflation and chest compression versus 3:1 chest compression to ventilation ratio during cardiopulmonary resuscitation of asphyxiated newborns: a randomized controlled trial</TO>
<SO>clinicaltrials.gov/show/NCT02858583</SO>
<YR>(first received 30 July 2016)</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6294356"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6294355"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT02887924" MODIFIED="2017-05-30 13:05:51 -0400" MODIFIED_BY="[Empty name]" NAME="NCT02887924" YEAR="2017">
<REFERENCE MODIFIED="2017-05-30 13:05:51 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>NCT02887924</AU>
<TI>SLI maneuver and respiratory morbidities</TI>
<TO>The effect of sustained lung inflation maneuver applied through nasal prong on early and late respiratory morbidities in preterm infants</TO>
<SO>clinicaltrials.gov/show/NCT02887924</SO>
<YR>(first received 15 August 2016)</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6294358"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6294357"/></IDENTIFIERS>
</STUDY>
</ONGOING_STUDIES>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2017-05-30 14:50:13 -0400" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2017-05-30 14:50:13 -0400" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Boon-1979" MODIFIED="2017-05-30 13:10:25 -0400" MODIFIED_BY="[Empty name]" NAME="Boon 1979" TYPE="JOURNAL_ARTICLE">
<AU>Boon AW, Milner AD, Hopkin IE</AU>
<TI>Lung expansion, tidal exchange, and formation of the functional residual capacity during resuscitation of asphyxiated neonates</TI>
<SO>Journal of Pediatrics</SO>
<YR>1979</YR>
<VL>95</VL>
<NO>6</NO>
<PG>1031-6</PG>
<IDENTIFIERS MODIFIED="2017-05-30 13:10:25 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-05-30 13:10:25 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="387935"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Deeks-2011" MODIFIED="2015-05-21 13:42:07 -0400" MODIFIED_BY="[Empty name]" NAME="Deeks 2011" TYPE="OTHER">
<AU>Deeks JJ, Higgins JPT, Altman DG (editors)</AU>
<TI>Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011</TI>
<SO>Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS MODIFIED="2015-02-22 09:42:32 -0500" MODIFIED_BY="Matteo Bruschettini"/>
</REFERENCE>
<REFERENCE ID="REF-Drew-1982" MODIFIED="2017-05-30 13:14:30 -0400" MODIFIED_BY="[Empty name]" NAME="Drew 1982" TYPE="JOURNAL_ARTICLE">
<AU>Drew JH</AU>
<TI>Immediate intubation at birth of the very-low-birth-weight infant. Effect on survival</TI>
<SO>American Journal of Diseases of Children (1960)</SO>
<YR>1982</YR>
<VL>136</VL>
<NO>3</NO>
<PG>207-10</PG>
<IDENTIFIERS MODIFIED="2017-05-30 13:14:30 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-05-30 13:14:30 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="7039303"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-EPOC-2015" MODIFIED="2015-06-23 16:29:56 -0400" MODIFIED_BY="Matteo Bruschettini" NAME="EPOC 2015" TYPE="OTHER">
<AU>Effective Practice and Organisation of Care (EPOC)</AU>
<TI>Cochrane EPOC Review Group data collection checklist. EPOC resources for review authors. Oslo: Norwegian Knowledge Centre for the Health Services; 2015</TI>
<SO>Available at: http://epoc.cochrane.org/sites/epoc.cochrane.org/files/uploads/datacollectionchecklist.pdf</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Foglia-2016" MODIFIED="2017-05-30 13:21:00 -0400" MODIFIED_BY="[Empty name]" NAME="Foglia 2016" TYPE="JOURNAL_ARTICLE">
<AU>Foglia EE, Te Pas AB</AU>
<TI>Sustained lung Inflation: physiology and practice</TI>
<SO>Clinics in Perinatology</SO>
<YR>2016</YR>
<VL>43</VL>
<NO>4</NO>
<PG>633-46</PG>
<IDENTIFIERS MODIFIED="2017-05-30 13:20:13 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-05-30 13:20:13 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1016/j.clp.2016.07.002"/><IDENTIFIER TYPE="PUBMED" VALUE="27837749"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Fuchs-2011" MODIFIED="2017-05-30 13:21:51 -0400" MODIFIED_BY="[Empty name]" NAME="Fuchs 2011" TYPE="JOURNAL_ARTICLE">
<AU>Fuchs H, Lindner W, Buschko A, Trischberger T, Schmid M, Hummler HD</AU>
<TI>Cerebral oxygenation in very low birth weight infants supported with sustained lung inflations after birth</TI>
<SO>Pediatric Research</SO>
<YR>2011</YR>
<VL>70</VL>
<NO>2</NO>
<PG>176&#8211;80</PG>
<IDENTIFIERS MODIFIED="2017-05-30 13:21:51 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-05-30 13:21:51 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1203/PDR.0b013e318220c1e0"/><IDENTIFIER MODIFIED="2017-05-30 13:21:38 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="21522035"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-GRADEpro-GDT" MODIFIED="2017-02-17 12:40:08 -0500" MODIFIED_BY="[Empty name]" NAME="GRADEpro GDT" TYPE="COMPUTER_PROGRAM">
<TI>GRADEpro GDT</TI>
<YR>2014</YR>
<EN>accessed 17 August 2017</EN>
<PB>GRADE Working Group, McMaster University</PB>
<CY>Hamilton (ON)</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Grasso-2015" MODIFIED="2017-05-30 13:24:21 -0400" MODIFIED_BY="[Empty name]" NAME="Grasso 2015" TYPE="JOURNAL_ARTICLE">
<AU>Grasso C, Sciacca P, Giacchi V, Carpinato C, Mattia C, Palano GM, et al</AU>
<TI>Effects of Sustained Lung Inflation, a lung recruitment maneuver in primary acute respiratory distress syndrome, in respiratory and cerebral outcomes in preterm infants</TI>
<SO>Early Human Development</SO>
<YR>2015</YR>
<VL>91</VL>
<NO>1</NO>
<PG>71-5</PG>
<IDENTIFIERS MODIFIED="2017-05-30 13:24:21 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-05-30 13:24:21 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1016/j.earlhumdev.2014.12.002"/><IDENTIFIER TYPE="PUBMED" VALUE="25549915"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2003" MODIFIED="2017-05-30 13:26:11 -0400" MODIFIED_BY="[Empty name]" NAME="Higgins 2003" TYPE="JOURNAL_ARTICLE">
<AU>Higgins JPT, Thompson SG, Deeks JJ, Altman DG</AU>
<TI>Measuring inconsistency in meta-analyses</TI>
<SO>BMJ</SO>
<YR>2003</YR>
<VL>327</VL>
<NO>7414</NO>
<PG>557-60</PG>
<IDENTIFIERS MODIFIED="2017-05-30 13:26:11 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-05-30 13:26:11 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1136/bmj.327.7414.557"/><IDENTIFIER MODIFIED="2017-05-30 13:25:59 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="12958120"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2017-02-17 12:31:53 -0500" MODIFIED_BY="[Empty name]" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins JP, Green S, editor(s)</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011</TI>
<SO>Available from handbook.cochrane.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hooper-2016" MODIFIED="2017-05-30 13:29:16 -0400" MODIFIED_BY="[Empty name]" NAME="Hooper 2016" TYPE="JOURNAL_ARTICLE">
<AU>Hooper SB, Te Pas AB, Kitchen MJ</AU>
<TI>Respiratory transition in the newborn: a three-phase process</TI>
<SO>Archives of Disease in Childhood. Fetal and Neonatal Edition</SO>
<YR>2016</YR>
<VL>101</VL>
<NO>3</NO>
<PG>F266-71</PG>
<IDENTIFIERS MODIFIED="2017-05-30 13:29:16 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-05-30 13:29:16 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1136/archdischild-2013-305704"/><IDENTIFIER TYPE="PUBMED" VALUE="26542877"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Karlberg-1962" MODIFIED="2017-05-30 13:34:32 -0400" MODIFIED_BY="[Empty name]" NAME="Karlberg 1962" TYPE="JOURNAL_ARTICLE">
<AU>Karlberg P, Cherry RB, Escardó FE, Koc G</AU>
<TI>Respiratory studies in newborn infants. II: Pulmonary ventilation and mechanics of breathing in the first minutes of life, including the onset of respiration</TI>
<SO>Acta Paediatrica</SO>
<YR>1962</YR>
<VL>51</VL>
<NO>2</NO>
<PG>121-36</PG>
<IDENTIFIERS MODIFIED="2017-05-30 13:34:32 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-05-30 13:34:32 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1111/j.1651-2227.1962.tb06521.x"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Klingenberg-2016" MODIFIED="2017-05-30 14:27:59 -0400" MODIFIED_BY="[Empty name]" NAME="Klingenberg 2016" TYPE="OTHER">
<AU>Klingenberg C, O'Donnell CP</AU>
<TI>Inflation breaths-A transatlantic divide in guidelines for neonatal resuscitation</TI>
<SO>Resuscitation</SO>
<YR>2016</YR>
<VL>101</VL>
<PG>e19</PG>
<IDENTIFIERS MODIFIED="2017-05-30 14:27:59 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-05-30 14:27:59 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1016/j.resuscitation.2015.12.021"/><IDENTIFIER TYPE="PUBMED" VALUE="26855292"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Lindner-1999" MODIFIED="2017-05-30 14:29:10 -0400" MODIFIED_BY="[Empty name]" NAME="Lindner 1999" TYPE="JOURNAL_ARTICLE">
<AU>Lindner W, Vossbeck S, Hummler H, Pohlandt F</AU>
<TI>Delivery room management of extremely low birth weight infants: spontaneous breathing or intubation</TI>
<SO>Pediatrics</SO>
<YR>1999</YR>
<VL>103</VL>
<NO>5 Pt 1</NO>
<PG>961-7</PG>
<IDENTIFIERS MODIFIED="2017-05-30 14:29:10 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-05-30 14:29:10 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="10224173"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Lista-2010" MODIFIED="2017-05-30 14:30:38 -0400" MODIFIED_BY="[Empty name]" NAME="Lista 2010" TYPE="JOURNAL_ARTICLE">
<AU>Lista G, Castoldi F</AU>
<TI>Alveolar recruitment in the delivery room: sustained lung inflation</TI>
<TO>Reclutamento alveolare in sala parto: la sustained lung inflation</TO>
<SO>Minerva Pediatrica</SO>
<YR>2010</YR>
<VL>62</VL>
<NO>3 Suppl 1</NO>
<PG>17-8</PG>
<IDENTIFIERS MODIFIED="2017-05-30 14:30:38 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-05-30 14:30:38 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="21089711"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Lista-2011" MODIFIED="2017-05-30 14:34:08 -0400" MODIFIED_BY="[Empty name]" NAME="Lista 2011" TYPE="JOURNAL_ARTICLE">
<AU>Lista G, Fontana P, Castoldi F, Cavigioli F, Dani C</AU>
<TI>Does sustained lung inflation at birth improve outcome of preterm infants at risk for respiratory distress syndrome?</TI>
<SO>Neonatology</SO>
<YR>2011</YR>
<VL>99</VL>
<NO>1</NO>
<PG>45-50</PG>
<IDENTIFIERS MODIFIED="2017-05-30 14:34:08 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-05-30 14:34:08 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1159/000298312"/><IDENTIFIER MODIFIED="2017-05-30 14:33:28 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="20616570"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Lista-2017" MODIFIED="2017-05-30 14:35:18 -0400" MODIFIED_BY="[Empty name]" NAME="Lista 2017" TYPE="JOURNAL_ARTICLE">
<AU>Lista G, Cavigioli F, La Verde PA, Castoldi F, Bresesti I, Morley CJ</AU>
<TI>Effects of Breathing and Apnoea during Sustained Inflations in Resuscitation of Preterm Infants</TI>
<SO>Neonatology</SO>
<YR>2017</YR>
<VL>111</VL>
<NO>4</NO>
<PG>360-6</PG>
<IDENTIFIERS MODIFIED="2017-05-30 14:35:18 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-05-30 14:35:18 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1159/000454799"/><IDENTIFIER TYPE="PUBMED" VALUE="28118641"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-McCall-2016" MODIFIED="2017-05-30 14:36:45 -0400" MODIFIED_BY="[Empty name]" NAME="McCall 2016" TYPE="JOURNAL_ARTICLE">
<AU>McCall KE, Davis PG, Owen LS, Tingay DG</AU>
<TI>Sustained lung inflation at birth: what do we know, and what do we need to know?</TI>
<SO>Archives of Disease in Childhood. Fetal and Neonatal Edition</SO>
<YR>2016</YR>
<VL>101</VL>
<NO>2</NO>
<PG>F175-80</PG>
<IDENTIFIERS MODIFIED="2017-05-30 14:36:45 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-05-30 14:36:45 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1136/archdischild-2015-309611"/><IDENTIFIER TYPE="PUBMED" VALUE="26527635"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Milner-1977" MODIFIED="2017-05-30 14:37:41 -0400" MODIFIED_BY="[Empty name]" NAME="Milner 1977" TYPE="JOURNAL_ARTICLE">
<AU>Milner AD, Saunders RA</AU>
<TI>Pressure and volume changes during the first breath of human neonates</TI>
<SO>Archives of Disease in Childhood</SO>
<YR>1977</YR>
<VL>52</VL>
<NO>12</NO>
<PG>918-24</PG>
<IDENTIFIERS MODIFIED="2017-05-30 14:37:41 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-05-30 14:37:41 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="606168"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-O_x0027_Donnell-2004a" MODIFIED="2017-05-30 14:38:42 -0400" MODIFIED_BY="[Empty name]" NAME="O'Donnell 2004a" TYPE="JOURNAL_ARTICLE">
<AU>O'Donnell CPF, Davis PG, Morley CJ</AU>
<TI>Neonatal resuscitation: review of ventilation equipment and survey of practice in Australia and New Zealand</TI>
<SO>Journal of Paediatrics and Child Health</SO>
<YR>2004</YR>
<VL>40</VL>
<NO>4</NO>
<PG>208-12</PG>
<IDENTIFIERS MODIFIED="2017-05-30 14:38:42 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-05-30 14:38:42 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="15009551"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-O_x0027_Donnell-2004b" MODIFIED="2017-05-30 14:39:37 -0400" MODIFIED_BY="[Empty name]" NAME="O'Donnell 2004b" TYPE="JOURNAL_ARTICLE">
<AU>O'Donnell CPF, Davis PG, Morley CJ</AU>
<TI>Positive pressure ventilation at neonatal resuscitation: review of equipment and international survey of practice</TI>
<SO>Acta Paediatrica</SO>
<YR>2004</YR>
<VL>93</VL>
<NO>5</NO>
<PG>583-8</PG>
<IDENTIFIERS MODIFIED="2017-05-30 14:39:37 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-05-30 14:39:37 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="15174776"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Papile-1978" MODIFIED="2017-05-30 14:40:40 -0400" MODIFIED_BY="[Empty name]" NAME="Papile 1978" TYPE="JOURNAL_ARTICLE">
<AU>Papile LA, Burstein J, Burstein R, Koffler H</AU>
<TI>Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm</TI>
<SO>Journal of Pediatrics</SO>
<YR>1978</YR>
<VL>92</VL>
<NO>4</NO>
<PG>529-34</PG>
<IDENTIFIERS MODIFIED="2017-05-30 14:40:40 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-05-30 14:40:40 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="305471"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2014" MODIFIED="2017-05-30 14:41:33 -0400" MODIFIED_BY="[Empty name]" NAME="RevMan 2014" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager 5 (RevMan 5)</TI>
<YR>2014</YR>
<EN>5.3</EN>
<PB>Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<CY>Copenhagen</CY>
<IDENTIFIERS MODIFIED="2015-02-22 09:42:32 -0500" MODIFIED_BY="Matteo Bruschettini"/>
</REFERENCE>
<REFERENCE ID="REF-Sarnat-1976" MODIFIED="2017-05-30 14:42:24 -0400" MODIFIED_BY="[Empty name]" NAME="Sarnat 1976" TYPE="JOURNAL_ARTICLE">
<AU>Sarnat HB, Sarnat MS</AU>
<TI>Neonatal encephalopathy following fetal distress. A clinical and electroencephalographic study</TI>
<SO>Archives of Neurology</SO>
<YR>1976</YR>
<VL>33</VL>
<NO>10</NO>
<PG>696&#8211;705</PG>
<IDENTIFIERS MODIFIED="2017-05-30 14:42:24 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-05-30 14:42:24 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="987769"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Saugstad-1998" MODIFIED="2017-05-30 14:43:25 -0400" MODIFIED_BY="[Empty name]" NAME="Saugstad 1998" TYPE="JOURNAL_ARTICLE">
<AU>Saugstad OD</AU>
<TI>Practical aspects of resuscitating asphyxiated newborn infants</TI>
<SO>European Journal of Pediatrics</SO>
<YR>1998</YR>
<VL>157</VL>
<NO>Suppl 1</NO>
<PG>S11-5</PG>
<IDENTIFIERS MODIFIED="2017-05-30 14:43:25 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-05-30 14:43:25 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="9462900"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Schm_x00f6_lzer-2014" MODIFIED="2017-05-30 14:44:20 -0400" MODIFIED_BY="[Empty name]" NAME="Schmölzer 2014" TYPE="OTHER">
<AU>Schmölzer GM, Kumar M, Aziz K, Pichler G, O'Reilly M, Lista G, et al</AU>
<TI>Sustained inflation versus positive pressure ventilation at birth: a systematic review and meta-analysis</TI>
<SO>Archives of Disease in Childhood. Fetal and Neonatal Edition</SO>
<YR>2015</YR>
<VL>100</VL>
<NO>4</NO>
<PG>F361-8</PG>
<IDENTIFIERS MODIFIED="2017-05-30 14:44:20 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2015-02-21 11:20:36 -0500" MODIFIED_BY="Matteo Bruschettini" TYPE="DOI" VALUE="10.1136/archdischild-2014-306836"/><IDENTIFIER MODIFIED="2017-05-30 14:44:20 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="25550472"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Sch_x00fc_nemann-2013" MODIFIED="2017-02-17 12:37:07 -0500" MODIFIED_BY="[Empty name]" NAME="Schünemann 2013" TYPE="OTHER">
<AU>Schünemann H, Bro&#380;ek J, Guyatt G, Oxman A, editors; GRADE Working Group</AU>
<TI>GRADE Handbook for Grading Quality of Evidence and Strength of Recommendations</TI>
<SO>Available from https://gdt.gradepro.org/app/handbook/handbook.html.</SO>
<YR>Updated October 2013</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-van-Vonderen-2014" MODIFIED="2017-05-30 14:46:04 -0400" MODIFIED_BY="[Empty name]" NAME="van Vonderen 2014" TYPE="JOURNAL_ARTICLE">
<AU>van Vonderen JJ, Hooper SB, Hummler HD, Lopriore E, te Pas AB</AU>
<TI>Effects of a sustained inflation in preterm infants at birth</TI>
<SO>Journal of Pediatrics</SO>
<YR>2014</YR>
<VL>165</VL>
<NO>5</NO>
<PG>903-8.e1</PG>
<IDENTIFIERS MODIFIED="2017-05-30 14:46:04 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-05-30 14:46:04 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1016/j.jpeds.2014.06.007"/><IDENTIFIER TYPE="PUBMED" VALUE="25039041"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Vyas-1981" MODIFIED="2017-05-30 14:47:18 -0400" MODIFIED_BY="[Empty name]" NAME="Vyas 1981" TYPE="JOURNAL_ARTICLE">
<AU>Vyas H, Milner AD, Hopkin IE, Boon AW</AU>
<TI>Physiologic responses to prolonged and slow-rise inflation in the resuscitation of the asphyxiated newborn infant</TI>
<SO>Journal of Pediatrics</SO>
<YR>1981</YR>
<VL>99</VL>
<NO>4</NO>
<PG>635-9</PG>
<IDENTIFIERS MODIFIED="2017-05-30 14:47:18 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-05-30 14:47:18 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="7277110"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Wyckoff-2015" MODIFIED="2017-05-30 14:48:56 -0400" MODIFIED_BY="[Empty name]" NAME="Wyckoff 2015" TYPE="JOURNAL_ARTICLE">
<AU>Wyckoff MH, Aziz K, Escobedo MB, Kapadia VS, Kattwinkel J, Perlman JM, et al</AU>
<TI>Part 13: Neonatal Resuscitation: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care</TI>
<SO>Circulation</SO>
<YR>2015</YR>
<VL>132</VL>
<NO>18 Suppl 2</NO>
<PG>S543-60</PG>
<IDENTIFIERS MODIFIED="2017-05-30 14:48:56 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-05-30 14:48:56 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1161/CIR.0000000000000267"/><IDENTIFIER TYPE="PUBMED" VALUE="26473001"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Wyllie-2015" MODIFIED="2017-05-30 14:50:13 -0400" MODIFIED_BY="[Empty name]" NAME="Wyllie 2015" TYPE="JOURNAL_ARTICLE">
<AU>Wyllie J, Bruinenberg J, Roehr CC, Rudiger M, Trevisanuto D, Urlesberger B</AU>
<TI>European Resuscitation Council Guidelines for Resuscitation 2015: Section 7. Resuscitation and support of transition of babies at birth</TI>
<SO>Resuscitation</SO>
<YR>2015</YR>
<VL>95</VL>
<PG>249-63</PG>
<IDENTIFIERS MODIFIED="2017-05-30 14:50:13 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-05-30 14:50:13 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1016/j.resuscitation.2015.07.029"/><IDENTIFIER TYPE="PUBMED" VALUE="26477415"/></IDENTIFIERS>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2017-03-27 09:49:42 -0400" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-O_x0027_Donnell-2004" MODIFIED="2015-05-21 12:11:49 -0400" MODIFIED_BY="[Empty name]" NAME="O'Donnell 2004" TYPE="COCHRANE_PROTOCOL">
<AU>O'Donnell CPF, Davis PG, Morley CJ</AU>
<TI>Sustained inflations for neonatal resuscitation</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2004</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2015-05-21 12:11:49 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2015-05-21 12:11:49 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD004953"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-O_x0027_Donnell-2015" MODIFIED="2017-03-27 09:49:42 -0400" MODIFIED_BY="[Empty name]" NAME="O'Donnell 2015" TYPE="COCHRANE_REVIEW">
<AU>O'Donnell CP, Bruschettini M, Davis PG, Morley CJ, Moja L, Calevo MG, et al</AU>
<TI>Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2015</YR>
<NO>7</NO>
<PG>CD004953</PG>
<IDENTIFIERS MODIFIED="2017-03-27 09:49:42 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-03-27 09:49:42 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD004953.pub2"/></IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES MODIFIED="2015-02-22 09:42:32 -0500" MODIFIED_BY="Matteo Bruschettini"/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2017-07-12 16:00:39 -0400" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2017-07-12 16:00:39 -0400" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2017-07-12 06:51:04 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-El_x002d_Chimi-2017">
<CHAR_METHODS MODIFIED="2017-07-11 06:25:58 -0400" MODIFIED_BY="[Empty name]">
<P>Prospective quasi-randomised parallel controlled trial</P>
<P>Setting: delivery room of Maternity Hospital, Ain Shams University, Cairo, Egypt</P>
<P>Conducted: April 2012 to March 2014</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-07-11 06:38:25 -0400" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria (as specified in the protocol): gestational age 26 to 33 weeks, birth weight &gt; 750 grams</P>
<P>Exclusion criteria (as specified in the protocol): major congenital anomalies; meconium aspiration syndrome, congenital diaphragmatic hernia, anterior abdominal wall defect, maternal chorioamnionitis</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-11 06:32:15 -0400" MODIFIED_BY="[Empty name]">
<UL>
<LI>SLI group: PIP of 20 cmH<SUB>2</SUB>O for 15 seconds, using a neonatal mask and a T-piece ventilator, followed by PEEP of 5 cmH<SUB>2</SUB>O. If response was not satisfactory (i.e. breathing remained insufficient and/or heart rate was &lt; 100 bpm and/or the infant was cyanotic): A second 15 second SLI of 25 cmH<SUB>2</SUB>O for 15 seconds, followed by PEEP of 6 cmH<SUB>2</SUB>O. If still not satisfactory, a third SLI of 30 cmH<SUB>2</SUB>O for 15 seconds, followed by PEEP of 7 cmH<SUB>2</SUB>O. If still not satisfactory, intubation inside DR and ventilation (rate of 40 to 60 breaths/min, PIP of 25 to 35 cmH<SUB>2</SUB>O, PEEP of 7 to 8 cmH<SUB>2</SUB>O) until transfer to NICU</LI>
<LI>Control group: intermittent bag/mask inflation: rate of 40 to 60 breaths/min, maximum PIP of 40 cmH<SUB>2</SUB>O for 30 seconds using a self-inflating bag with an oxygen reservoir. After adequate circulation and breathing achieved, CPAP of 5 to 7 cmH<SUB>2</SUB>O during transfer to NICU. In cases of poor response, intubation and ventilation (rate of 40 to 60 breaths/min, PIP of 25 to 35 cmH<SUB>2</SUB>O, PEEP of 7 to 8 cmH<SUB>2</SUB>O) until transfer to NICU</LI>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-07-12 06:51:04 -0400" MODIFIED_BY="[Empty name]">
<P>Primary outcome was either "success" (defined as no need for further ventilatory support, need for exclusive NCPAP, or need for intubation beyond the first 72 hours after delivery) or "failure" (defined as need for intubation within first 72 hours of life, including DR intubation)</P>
<P>Secondary outcomes were blood IL-1b and TNF-a levels, air leaks, BPD, IVH, PDA, and NEC</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-07-11 06:33:44 -0400" MODIFIED_BY="[Empty name]">
<P>Study was registered at ClinicalTrials.gov (Identifier: NCT01255826)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-07-11 06:50:48 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jiravisitkul-2017">
<CHAR_METHODS MODIFIED="2017-07-11 06:37:14 -0400" MODIFIED_BY="[Empty name]">
<P>Prospective randomised parallel controlled trial</P>
<P>Setting: delivery room of Ramathibodi Hospital, Mahidol University, Bangkok, Thailand</P>
<P>Conducted: November 2013 to March 2015</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-07-11 06:39:17 -0400" MODIFIED_BY="[Empty name]">
<P>Included: 81 preterm infants (25 to 32 weeks of gestational age) requiring positive-pressure ventilation or continuous positive airway pressure</P>
<P>Exclusion criteria: major congenital anomalies, hydrops foetalis, prenatal diagnosis of upper airway obstruction, meconium-stained amniotic fluid</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-11 06:44:49 -0400" MODIFIED_BY="[Empty name]">
<UL>
<LI>SLI group (n = 43): SLI at 25 cmH<SUB>2</SUB>O for 15 seconds with neonatal mask via a T-piece resuscitator, followed by delivery of CPAP at 6 cmH<SUB>2</SUB>O via a face mask for 5 to 10 seconds. Cardiorespiratory status was then re-evaluated: If HR was &#8805;100 beats/min and respiratory effort was improved, CPAP was continued via face mask. If HR was &lt; 60 beats/min, PPV was initiated. If HR was 60 to 100 beats/min and/or respiratory effort was poor, a second SLI manoeuvre similar to the first SLI manoeuvre was initiated. If HR was &lt; 100 beats/min or gasping/apnoea was present during the second SLI manoeuvre, PPV was initiated and additional resuscitation steps performed. If HR was &#8805; 100 beats/min and no apnoea/gasping was present during the second SLI manoeuvre, CPAP was performed via face mask</LI>
<LI>Non-SLI group (n = 38): standard resuscitation alone. PPV was given via a T-piece resuscitator with PIP of 15 to 20 cmH<SUB>2</SUB>O and positive end-expiratory pressure of 5 cmH<SUB>2</SUB>O for 30 seconds. Infants were placed on CPAP at 6 cmH<SUB>2</SUB>O via face mask if breathing was still laboured</LI>
</UL>
<P>All enrolled infants were resuscitated with an initial fraction of inspired oxygen (FiO<SUB>2</SUB>) of 0.3, which was adjusted by 0.1 every 30 seconds to achieve the target SpO<SUB>2</SUB>. Criteria for intubation included 1 of the following: remaining apnoeic after PPV, HR of 30 seconds before the start of chest compressions, or SpO<SUB>2</SUB> &lt; 80% despite CPAP via mask with FiO<SUB>2</SUB> of 1.0 for 5 to 10 minutes</P>
<P>Infants of multiple gestations were enrolled in the same intervention group</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-07-11 06:50:48 -0400" MODIFIED_BY="[Empty name]">
<P>Primary outcomes: change in oxygen requirements, HR, and SpO<SUB>2</SUB> during resuscitation; proportion of infants on room air during first 10 minutes after birth; need for intubation in the delivery room</P>
<P>Secondary outcomes: survival at discharge, duration of hospitalisation, proportion of infants on MV within first 72 hours of life, duration of MV, duration of oxygen supplementation, need for surfactant, need for postnatal steroids, pneumothorax within first 48 hours after NICU admission, moderate to severe BPD as defined by Jobe and Bancalari, Apgar score at 5 minutes, PDA and need for surgical closure, grade 3 to 4 IVH, cystic periventricular leukomalacia, stage &gt; 2 ROP, ROP requiring treatment</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-07-11 06:47:52 -0400" MODIFIED_BY="[Empty name]">
<P>Study was registered in the Thai Clinical Trials Registry (TCTR20140418001)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-07-12 16:00:39 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lindner-2005">
<CHAR_METHODS MODIFIED="2017-07-11 17:27:06 -0400" MODIFIED_BY="[Empty name]">
<P>Prospective randomised parallel controlled trial</P>
<P>Setting: Delivery Room, Ulm, Germany</P>
<P>Conducted: August 1999 to February 2002</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-07-12 16:00:39 -0400" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: newly born infants at 25 to 28 weeks of gestation inclusive</P>
<P>Exclusion criteria: severe malformations, oligo-anhydramnios before 20 weeks of gestation, foeto-foetal transfusion syndrome.</P>
<P>A total of 61 infants were enrolled (31 in sustained inflation group and 30 in control group).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-11 17:39:27 -0400" MODIFIED_BY="[Empty name]">
<UL>
<LI>SLI group: PIP 20 cmH<SUB>2</SUB>O for 15 seconds. Infants who did not respond satisfactorily (persistent poor or laboured respiratory effort, bradycardia or cyanosis, and low oxygen saturation (SpO<SUB>2</SUB>)): up to 2 additional inflations of 15 seconds at higher inflating pressures (25 and 30 cmH<SUB>2</SUB>O). Infants whose response remained unsatisfactory were intubated and mechanically ventilated</LI>
<LI>Control group: NIMV (PIP 20 cmH<SUB>2</SUB>O, PEEP 4 to 6 cmH<SUB>2</SUB>O; inflation time 0.5 seconds; inflation rate 60/min) for 30 seconds before the start of NCPAP at 4 to 6 cmH<SUB>2</SUB>O</LI>
</UL>
<P>Infants received support from a mechanical ventilator via a nasopharyngeal tube</P>
<P>Infants in both groups who had apnoea on NCPAP could be treated with NIMV (PIP 20 cmH<SUB>2</SUB>O; inflation time 0.3 seconds; inflation rate 60/min) for up to 4 minutes</P>
<P>Treatment was deemed to have failed if infants had shown persistently poor respiratory effort, bradycardia, or cyanosis/low SpO<SUB>2</SUB> in the delivery room; or if criteria combining clinical assessments of respiratory distress and evidence of impaired oxygenation, impaired ventilation (high CO<SUB>2</SUB>), or apnoea were met within 48 hours of birth</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-07-11 17:45:27 -0400" MODIFIED_BY="[Empty name]">
<P>Primary outcome: rate of infants reaching criteria for intubation and mechanical ventilation at &lt; 48 hours of life</P>
<P>Secondary outcomes: mortality, Apgar score, endotracheal intubation, surfactant administration, duration of respiratory support, chronic lung disease, air leak, intraventricular haemorrhage, cystic periventricular leukomalacia, retinopathy of prematurity, PDA</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-07-11 17:45:37 -0400" MODIFIED_BY="[Empty name]">
<P>Trial was stopped before target sample was recruited owing to slow enrolment. Clinical outcomes were reported for all randomised infants</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-07-12 06:34:09 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lista-2015">
<CHAR_METHODS MODIFIED="2017-07-11 17:49:38 -0400" MODIFIED_BY="[Empty name]">
<P>Multi-centre prospective randomised parallel controlled trial</P>
<P>Setting: Delivery Room, Italy</P>
<P>Conducted: October 2011 to January 2013</P>
<P>Infants were assigned immediately after birth before the first breath to receive SLI manoeuvres and NCPAP or NCPAP alone in a 1:1 ratio in permuted blocks of variable size. Randomisation was stratified according to centre and gestational age (25 or 26 weeks and 27 or 28 weeks). Group assignment was contained in sequentially numbered, sealed, opaque envelopes that were prepared by an independent statistician. The trial was not blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-07-11 17:50:10 -0400" MODIFIED_BY="[Empty name]">
<P>Newly born infants at 25 to 28 weeks of gestation inclusive without major congenital malformations (i.e. congenital heart, cerebral, lung, abdominal malformations), foetal hydrops, and lack of parental consent. A total of 294 infants were enrolled (150 in the sustained lung inflation group and 144 in the control group)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-11 17:52:21 -0400" MODIFIED_BY="[Empty name]">
<UL>
<LI>SLI group: PIP 25 cmH<SUB>2</SUB>O for 15 seconds, followed by delivery of 5 cmH<SUB>2</SUB>O CPAP, via a neonatal mask and a T-piece ventilator. Participants were observed for the next 6 to 10 seconds for evaluation of cardiorespiratory function. If respiratory failure persisted (i.e. apnoea, gasping) or heart rate was 60 and 100 beats/min despite CPAP, the SLI manoeuvre (again 25 cmH<SUB>2</SUB>O for 15 seconds) was repeated. If heart rate remained 60 and 100 beats/min after the second SLI manoeuvre, the infant was resuscitated according to AAP guidelines</LI>
</UL>
<UL>
<LI>Control group: NCPAP at 5 cmH<SUB>2</SUB>O with assistance according to AAP guidelines </LI>
</UL>
<P>Infants in both groups who were not intubated in the delivery room were transferred to the NICU on NCPAP at 5 cmH<SUB>2</SUB>O with a fraction of inspired oxygen (FiO<SUB>2</SUB>) of 0.21 to 0.40 (in agreement with local protocols)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-07-12 06:34:09 -0400" MODIFIED_BY="[Empty name]">
<P>Primary outcome: rate of infants reaching mechanical ventilation within the first 72 hours of life</P>
<P>Secondary outcomes: MV in the first 3 hours of life, highest FiO<SUB>2</SUB>, duration of NCPAP, need for and duration of bi-level NCPAP, nasal IMV, conventional or high-frequency ventilation, duration of hospitalisation, need for and number of doses of surfactant, occurrence of RDS, BPD, and mortality</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-02-22 09:42:33 -0500" MODIFIED_BY="Matteo Bruschettini"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-07-11 22:01:24 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mercadante-2016">
<CHAR_METHODS MODIFIED="2017-07-11 20:14:38 -0400" MODIFIED_BY="[Empty name]">
<P>Prospective randomised parallel controlled trial</P>
<P>Setting: Delivery Room, Neonatal Intensive Care Unit (NICU) in Milan, Italy</P>
<P>Conducted: September 2013 to June 2014</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-07-11 22:00:46 -0400" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: inborn infants with a gestational age of 34 to 36 weeks after parental consent is obtained</P>
<P>Exclusion criteria: major congenital anomalies</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-11 22:01:08 -0400" MODIFIED_BY="[Empty name]">
<UL>
<LI>SLI group: PIP 25 cmH<SUB>2</SUB>O for 15 seconds in the delivery room, followed by PEEP of 5 cmH<SUB>2</SUB>O. In case of persistent hearth failure (HR &lt; 100 bpm), a second SLI manoeuvre will be repeated</LI>
<LI>Control group: CPAP 5 cmH<SUB>2</SUB>O with mask</LI>
</UL>
<P>In both groups, mask and T-piece system were used</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-07-11 22:01:21 -0400" MODIFIED_BY="[Empty name]">
<P>Primary outcome: need for respiratory support</P>
<P>Secondary outcomes: air leak syndromes, NICU admission, NICU admission for respiratory disease, length of stay, exclusive breastfeeding at discharge</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-07-11 22:01:24 -0400" MODIFIED_BY="[Empty name]">
<P>Sample size described</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-07-11 22:06:23 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ngan-2017">
<CHAR_METHODS MODIFIED="2017-07-11 22:03:13 -0400" MODIFIED_BY="[Empty name]">
<P>Prospective randomised parallel controlled trial</P>
<P>Setting: Delivery Room, Neonatal Intensive Care Unit (NICU), Royal Alexandra Hospital (RAH), Edmonton, Canada</P>
<P>Conducted: June 2013 to August 2014</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-07-11 22:04:13 -0400" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: infants between 23<SUP>+0</SUP> and 32<SUP>+6</SUP> weeks of gestation who require respiratory support for resuscitation in the delivery room</P>
<P>Exclusion criteria: congenital abnormality or condition that might have an adverse effect on breathing or ventilation; absence of parents' consent for inclusion in the study</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-11 22:05:40 -0400" MODIFIED_BY="[Empty name]">
<UL>
<LI>SLI group: 2 PIPs of 24 cmH<SUB>2</SUB>O. Duration of first SLI was 20 seconds. Duration of second SLI was 20 or 10 seconds if ECO<SUB>2</SUB> value was &lt; or &gt; 20 mmHg, respectively. After SLIs, CPAP if breathing spontaneously or, if found to have apnoea or laboured breathing, mask IPPV at a rate of 40 to 60 bpm</LI>
</UL>
<UL>
<LI>Control group: mask IPPV, ventilation rate of 40 to 60 inflations/min until spontaneous breathing, at which time CPAP will be provided</LI>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-07-11 22:06:23 -0400" MODIFIED_BY="[Empty name]">
<P>Primary outcome: BPD (need for respiratory support or supplemental oxygen at corrected gestational age of 36 weeks)</P>
<P>Secondary outcomes: rate of endotracheal intubation in the DR or the NICU, duration of MV and non-invasive ventilation, neonatal death, air leak, PDA (medical or surgical), NEC, ROP, periventricular leukomalacia, abnormal cranial ultrasound (including IVH, parenchymal injury, and ventriculomegaly), surfactant administration, postnatal steroids, respiratory support or oxygen requirements at 28 days, neonatal death before discharge</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-03-29 06:37:50 -0400" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-07-11 22:16:25 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Schm_x00f6_lzer-2015">
<CHAR_METHODS MODIFIED="2017-07-11 22:14:20 -0400" MODIFIED_BY="[Empty name]">
<P>Prospective randomised parallel controlled trial</P>
<P>Pilot (5 infants randomised to each group)</P>
<P>Setting: Royal Alexandra Hospital, Edmonton, Alberta, Canada</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-07-11 22:15:03 -0400" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: inborn infants between 23<SUP>+0</SUP> and 32<SUP>+6</SUP> weeks of postmenstrual age who required chest compressions in the delivery room</P>
<P>Exclusion criteria: congenital abnormality or condition that might have an adverse effect on breathing or ventilation (e.g. congenital pulmonary or airway anomalies, congenital diaphragmatic hernia, congenital heart disease requiring intervention in neonatal period)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-11 22:15:31 -0400" MODIFIED_BY="[Empty name]">
<UL>
<LI>SLI group: SLI of 20 + 20 seconds, plus uninterrupted chest compression at a rate of 90/min</LI>
<LI>Control group: 3:1 compression:ventilation (C:V) ratio according to current resuscitation guidelines</LI>
</UL>
<P>Default settings for airway pressures: PIP of 24 cmH<SUB>2</SUB>O and PEEP of 6 cmH<SUB>2</SUB>O</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-07-11 22:16:06 -0400" MODIFIED_BY="[Empty name]">
<P>Primary outcome: return of spontaneous circulation</P>
<P>Secondary outcomes (we obtained the following information directly from trial authors): all mortality before discharge from hospital, delivery room interventions (rate of intubation, use of epinephrine), mechanical ventilation, use of inotropic agents, NEC, moderate to severe BPD, ROP, brain injury as indicated by abnormal neuroimaging</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-07-11 22:16:25 -0400" MODIFIED_BY="[Empty name]">
<P>Available as an abstract only (Canadian Paediatric Society 92nd Annual Conference)</P>
<P>Trial was registered at ClinicalTrials.gov: NCT02083705</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-07-11 22:22:42 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Schwaberger-2015">
<CHAR_METHODS MODIFIED="2017-07-11 22:18:57 -0400" MODIFIED_BY="[Empty name]">
<P>Prospective randomised parallel controlled trial</P>
<P>Setting: Delivery Room, Graz, Austria</P>
<P>Conducted: April 2012 to December 2013</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-07-11 22:19:46 -0400" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: preterm infants (28 weeks 0 days to 33 weeks 6 days) delivered by elective Caesarean section with HR &lt; 100 or irregular breathing and/or pronounced signs of respiratory distress (grunting, tachypnoea, and increased work of breathing)</P>
<P>Exclusion criteria: major congenital malformations, inherited disorders of metabolism and necessity of primary intubation within first 15 minutes after birth. In cases of multiple birth, only 1 of the infants was included</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-11 22:22:04 -0400" MODIFIED_BY="[Empty name]">
<P>Cord clamping within 30 seconds after delivery. Respiratory support with a T-piece system in the delivery room</P>
<UL>
<LI>SLI group: PIP 30 cmH<SUB>2</SUB>O for 15 seconds, with mask, to be repeated once or twice with HR remaining below 100 bpm. Infants with HR &gt; 100 bpm were supported by PPV at 30 cmH<SUB>2</SUB>O PIP or CPAP at a PEEP level of 5 cmH<SUB>2</SUB>O depending on respiratory rate</LI>
</UL>
<UL>
<LI>Control group: Respiratory support was provided according to AHA guidelines. CPAP (5 cmH<SUB>2</SUB>O PEEP) was applied in infants with respiratory rate &gt; 30 breaths per minute and signs of respiratory distress. Insufficient breathing efforts (HR &lt; 100 bpm, respiratory rate &lt; 30 breaths per minute or irregular breathing) indicated PPV at 30 cmH<SUB>2</SUB>O PIP via face mask</LI>
</UL>
<P>Initial fraction of inspired oxygen (FiO<SUB>2</SUB>) of 0.3 was adapted to achieve defined oxygen saturation targets (3&#8216;: &gt; 60%; 5&#8216;: &gt; 75%; 10&#8216;: &gt; 85%)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-07-11 22:22:29 -0400" MODIFIED_BY="[Empty name]">
<P>Primary outcome: changes in cerebral blood volume and cerebral tissue oxygenation index during immediate postnatal transition</P>
<P>Secondary outcomes: SpO<SUB>2</SUB>, HR, VT, face mask leak, FiO<SUB>2</SUB> within first 15 minutes after birth</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-07-11 22:22:42 -0400" MODIFIED_BY="[Empty name]">
<P>Trial was registered at the German Clinical Trials Register (DRKS00005161) in July 2013, after study initiation (April 2012)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>AAP: American Academy of Pediatrics<BR/>AHA: American Heart Association<BR/>BPD: bronchopulmonary dysplasia<BR/>C:V: compression:ventilation<BR/>CBMI: conventional bag/mask inflation<BR/>CPAP: continuous positive airway pressure<BR/>DR: delivery room<BR/>ECO2: enzymatic carbonate (measure of carbon dioxide in the blood)<BR/>FiO2: fraction of inspired oxygen<BR/>HR: heart rate<BR/>IL-1b: interleukin-1beta<BR/>IMV: intermittent mandatory ventilation<BR/>IPPV: intermittent positive pressure ventilation<BR/>IVH: intraventricular haemorrhage<BR/>MV: mandatory ventilation<BR/>NCPAP: nasal continuous positive airway pressure<BR/>NEC: necrotising enterocolitis<BR/>NICU: neonatal intensive care unit<BR/>NIMV: nasal intermittent mandatory ventilation<BR/>PDA: patent ductus arteriosus<BR/>PEEP: positive end-expiratory pressure<BR/>PIP: peak inspiratory pressure<BR/>PPV: positive pressure ventilation<BR/>RDS: respiratory distress syndrome<BR/>ROP: retinopathy of prematurity<BR/>SLI: sustained lung inflation<BR/>SpO2: blood oxygen saturation level<BR/>TNF-a: tumour necrosis factor-alpha<BR/>VT: ventricular tachycardia<BR/>
</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2017-07-12 13:17:59 -0400" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2017-07-11 22:24:43 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bouziri-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-07-11 22:24:43 -0400" MODIFIED_BY="[Empty name]">
<P>Not a clinical trial. Does not investigate sustained lung inflation</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-07-11 22:25:53 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Harling-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-07-11 22:25:53 -0400" MODIFIED_BY="[Empty name]">
<P>Control group consisted of inflation for 2 seconds (5 seconds for intervention): As we defined sustained if &gt; 1 second, this trial could not be included<BR/>
</P>
<P>Infants in the SLI group were born more preterm and had lower median birth weight than those in the conventional group, although the P value was not provided. Median birth weight (range) was 885 (518 to 1460) grams in the SLI group and 1095 (560 to 1562) grams in the conventional group. Median gestational age (range) was 27 (23 to 30) weeks in the SLI group and 28 (23 to 31) weeks in the conventional group</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-07-11 22:30:57 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-te-Pas-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-07-11 22:30:57 -0400" MODIFIED_BY="[Empty name]">
<P>This RCT enrolled newly born infants born at &lt; 33 weeks of gestation free of known major congenital anomalies with respiratory distress</P>
<P>Infants were randomised to inflation of 10 seconds at 20 cmH<SUB>2</SUB>O with a T-piece via a nasal tube, or to intermittent PPV with a self-inflating bag via a face mask. Infants randomised to the T-piece received inflation for 10 seconds at 20 cmH<SUB>2</SUB>O followed by NCPAP at 5 to 6 cmH<SUB>2</SUB>O. If the infant's clinical response was unsatisfactory, another inflation of 10 seconds at 25 cmH<SUB>2</SUB>O and NIMV (PIP 20 to 25 cmH<SUB>2</SUB>O, inflation rate 60 per minute) could be given. If the infants' condition improved (satisfactory heart rate and colour) but they had irregular breathing, they could receive NIMV for several minutes. Infants who were judged to have inadequate breathing, remain bradycardic, or remain cyanosed in the delivery room after these interventions were intubated and mechanically ventilated. Infants randomised to the self-inflating bag received initial inflations of 30 to 40 cmH<SUB>2</SUB>O, followed by inflations not &gt; 20 cmH<SUB>2</SUB>O (inflation time was not specified or recorded) for 30 seconds. Infants judged to have inadequate breathing, remain bradycardic, or remain cyanosed in the delivery room after this intervention were intubated and mechanically ventilated. Infants in the sustained lung inflation group who were not intubated were transferred to the neonatal intensive care unit (NICU) on NCPAP at 5 to 6 cmH<SUB>2</SUB>O; non-intubated infants in the control group were transferred to the NICU with supplemental oxygen and were monitored with pulse oximetry</P>
<P>The intervention in this trial was multi-faceted. In addition to a sustained inflation, many other aspects of respiratory care provided at birth differed between groups (ventilation device used; interface used; whether PEEP was used; whether NIMV was used; time allowed for stabilisation before intubation was considered; time of starting NCPAP). It is not possible to determine the relative contribution (if any) of each element of this intervention to differences in outcomes observed between groups</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>NCPAP: nasal continuous positive airway pressure<BR/>NICU: neonatal intensive care unit<BR/>NIMV: nasal intermittent mandatory ventilation<BR/>PEEP: positive end-expiratory pressure<BR/>PIP: peak inspiratory pressure<BR/>PPV: positive pressure ventilation<BR/>RCT: randomised controlled trial<BR/>SLI: sustained lung inflation<BR/>
</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2015-02-21 10:46:56 -0500" MODIFIED_BY="Matteo Bruschettini" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2017-07-12 13:20:38 -0400" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<ONGOING_CHAR MODIFIED="2017-07-11 22:37:57 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-NCT02139800">
<CHAR_STUDY_NAME MODIFIED="2017-07-11 22:33:14 -0400" MODIFIED_BY="[Empty name]">
<P>Sustained aeration of infant lungs trial (SAIL)</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2017-07-11 22:33:22 -0400" MODIFIED_BY="[Empty name]">
<P>Two-arm randomised controlled multi-centre clinical trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-07-11 22:34:37 -0400" MODIFIED_BY="[Empty name]">
<P>Infants of 23 to 26 weeks of gestational age requiring respiratory support at birth. Sample size: 600 infants</P>
<P>Inclusion criteria: gestational age at least 23 weeks but less than 27 completed weeks by best obstetrical estimate; requiring resuscitation/respiratory intervention at birth</P>
<P>Exclusion criteria: considered non-viable by attending neonatologist; refusal of antenatal informed consent; known major anomalies, pulmonary hypoplasia. Mothers unable to provide consent for medical care and who do not have a surrogate guardian will not be approached for consent</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-11 22:34:54 -0400" MODIFIED_BY="[Empty name]">
<P>SLI group: sustained inflation in the delivery room. The first sustained inflation will use inflation pressure of 20 cmH<SUB>2</SUB>O for 15 seconds</P>
<P>Control group: CPAP of 5 to 7 cmH<SUB>2</SUB>O in the delivery room</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-07-11 22:37:30 -0400" MODIFIED_BY="[Empty name]">
<P>Primary outcome: combined endpoint of death or BPD at 36 weeks of gestational age</P>
<P>Secondary outcomes: oxygen profile over first 24 hours; oxygen profile with highest fraction of inspired oxygen (FiO<SUB>2</SUB>) level up to 48 hours; highest FiO<SUB>2</SUB> level recorded during first 48 hours; heart rate in the delivery room (DR); detailed status on departure from DR; type of respiratory support (CPAP, PPV) and FiO<SUB>2 </SUB>on departure from DR; use of inotropic agents on arrival in NICU; circulatory support; need for intubation in DR or by 24 hours of age; pressure-volume characteristics in DR; chest x-ray reports showing pneumothorax or new chest drains in first 48 hours of life; duration of any chest drain in situ; head ultrasound and/or MRI findings of intraventricular haemorrhage; chest x-ray between days 7 and 10; death or need for positive pressure ventilation at 7 days; highest FiO<SUB>2</SUB> and area under the FiO<SUB>2</SUB> curve for first week of life; pneumothorax and pulmonary interstitial emphysema (PIE); survival to discharge home without BPD, retinopathy of prematurity (grades 3 and 4), or significant brain abnormalities on head ultrasound; duration of respiratory support (ventilation, CPAP, supplemental oxygen); death in hospital; retinopathy of prematurity (ROP) stage 3 or greater requiring treatment; use of postnatal steroids for treatment of BPD; length of hospital stay; neurodevelopmental and respiratory outcome at 22 to 26 months of corrected gestational age</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2015-06-24 11:51:41 -0400" MODIFIED_BY="Matteo Bruschettini">
<P>August 2014.</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2017-07-11 22:37:44 -0400" MODIFIED_BY="[Empty name]">
<P>Haresh Kirpalani, BM, MSc; <A HREF="mailto:kirpalanih%40email.chop.edu?subject=NCT02139800,%20819208,%20Sustained%20Aeration%20of%20Infant%20Lungs%20Trial">kirpalanih@email.chop.edu</A>
</P>
<P>Sarah J Ratcliffe, PhD; <A HREF="mailto:sratclif%40upenn.edu?subject=NCT02139800,%20819208,%20Sustained%20Aeration%20of%20Infant%20Lungs%20Trial">sratclif@upenn.edu</A>.</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2017-07-11 22:37:57 -0400" MODIFIED_BY="[Empty name]">
<P>Estimated enrolment: 600</P>
<P>Estimated primary completion date: December 2017</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2017-07-11 22:39:27 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-NCT02493920">
<CHAR_STUDY_NAME MODIFIED="2017-03-14 07:28:03 -0400" MODIFIED_BY="[Empty name]">
<P>Evaluation of pulmonary mechanics in preterm infant treated with sustained lung inflation at birth</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2017-06-13 13:43:07 -0400" MODIFIED_BY="[Empty name]">
<P>Prospective randomised parallel controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-07-11 22:38:09 -0400" MODIFIED_BY="[Empty name]">
<P>Preterm infants at 25 to 36 weeks</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-11 22:38:15 -0400" MODIFIED_BY="[Empty name]">
<P>SLI group: PIP of 25 cmH<SUB>2</SUB>O for 15 seconds followed by PEEP of 5 cmH<SUB>2</SUB>O; second SLI in case of poor response</P>
<P>Control group: CPAP of 5 cmH<SUB>2</SUB>O with mask</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-07-11 22:39:02 -0400" MODIFIED_BY="[Empty name]">
<P>Primary outcomes: change in reactance values measured by forced oscillation technique</P>
<P>Secondary outcomes: need for intubation within first 72 hours of life; duration of respiratory support;</P>
<P>death in hospital; number of surfactant doses; ROP stage 3 or greater requiring treatment; PDA requiring treatment; BPD; IVH</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2017-03-14 07:28:46 -0400" MODIFIED_BY="[Empty name]">
<P>July 2015</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2017-07-11 22:39:14 -0400" MODIFIED_BY="[Empty name]">
<P>Mariarosa Colnaghi, MD; <A HREF="mailto:mariarosa.colnaghi%40mangiagalli.it?subject=NCT02493920,%20MECCANICA%20SLI,%20Sustained%20Lung%20Inflation%20and%20Pulmonary%20Mechanics%20in%20Preterm%20Infant">mariarosa.colnaghi@mangiagalli.it</A>
</P>
<P>Domenica Mercadante, MD; <A HREF="mailto:domenica.mrc%40hotmail.it?subject=NCT02493920,%20MECCANICA%20SLI,%20Sustained%20Lung%20Inflation%20and%20Pulmonary%20Mechanics%20in%20Preterm%20Infant">domenica.mrc@hotmail.it</A>
</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2017-07-11 22:39:27 -0400" MODIFIED_BY="[Empty name]">
<P>Estimated enrolment: 48</P>
<P>Estimated primary completion date: December 2015</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2017-07-11 22:41:59 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-NCT02846597">
<CHAR_STUDY_NAME MODIFIED="2017-06-13 13:43:13 -0400" MODIFIED_BY="[Empty name]">
<P>Sustained lung inflation at birth for preterm infants at risk of respiratory distress syndrome: the proper pressure and duration: prospective randomised study</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2017-06-13 13:43:15 -0400" MODIFIED_BY="[Empty name]">
<P>Prospective randomised parallel controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-07-11 22:40:49 -0400" MODIFIED_BY="[Empty name]">
<P>Preterm infants &#8804; 32 weeks of gestation with respiratory distress syndrome at birth</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-11 22:41:20 -0400" MODIFIED_BY="[Empty name]">
<P>Five arms: evaluating 2 different pressures - 20 and 15 cmH<SUB>2</SUB>O, and for 2 different durations - 10 and 20 seconds, during application of sustained lung inflation in resuscitation of preterm infants with respiratory distress in the delivery room, plus a control group without any SLI (CPAP 5 cmH<SUB>2</SUB>O)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-07-11 22:41:44 -0400" MODIFIED_BY="[Empty name]">
<P>Primary outcome: need for endotracheal intubation in the delivery room</P>
<P>Secondary outcomes: need for mechanical ventilation; need for surfactant; neonatal mortality; death before hospital discharge; BPD; IVH; ROP; NEC; length of NICU and hospital stay; air leak syndrome</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2017-03-14 06:38:41 -0400" MODIFIED_BY="[Empty name]">
<P>March 2013</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2017-03-14 06:38:06 -0400" MODIFIED_BY="[Empty name]">
<P>Nehad Nasef, Associate Professor</P>
<P>Mansoura University Children Hospital, El Dakahlya, Egypt</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2017-07-11 22:41:59 -0400" MODIFIED_BY="[Empty name]">
<P>Estimated enrolment: 100</P>
<P>Estimated primary completion date: October 2016 (for primary outcome)</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2017-07-11 22:43:14 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-NCT02858583">
<CHAR_STUDY_NAME MODIFIED="2017-06-13 13:43:44 -0400" MODIFIED_BY="[Empty name]">
<P>SURV1VE-Trial - Sustained inflation and chest compression versus 3:1 chest compression to ventilation ratio during cardiopulmonary resuscitation of asphyxiated newborns: a randomised controlled trial</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2017-07-11 22:42:12 -0400" MODIFIED_BY="[Empty name]">
<P>Prospective randomised parallel controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-07-11 22:42:15 -0400" MODIFIED_BY="[Empty name]">
<P>Infants (term or preterm infants) requiring chest compressions in the delivery room</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-11 22:42:48 -0400" MODIFIED_BY="[Empty name]">
<P>SLI group: PIP of 25 to 30 cmH<SUB>2</SUB>O for 45 seconds while receiving chest compression. This will be followed by PEEP of 5 to 8 cmH<SUB>2</SUB>O. If heart rate &lt; 60/min, continue with chest compression + SLI for another 45 seconds. If heart rate remains &lt; 60/min, continue with CC + SI</P>
<P>Control group: chest compression at a rate of 90/min and 30 ventilations/min in a 3:1 C:V ratio</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-07-11 22:42:53 -0400" MODIFIED_BY="[Empty name]">
<P>Primary outcomes: return of spontaneous circulation; duration of chest compression heart rate is &gt; 60/min for 15 seconds</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2017-03-13 18:14:20 -0400" MODIFIED_BY="[Empty name]">
<P>January 2017</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2017-07-11 22:43:03 -0400" MODIFIED_BY="[Empty name]">
<P>Georg Schmolzer, MD, PhD; <A HREF="mailto:georg.schmoelzer%40me.com">georg.schmoelzer@me.com</A>
</P>
<P>University of Alberta</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2017-07-11 22:43:14 -0400" MODIFIED_BY="[Empty name]">
<P>Estimated enrolment: 118</P>
<P>Estimated primary completion date: December 2018</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2017-07-11 22:44:20 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-NCT02887924">
<CHAR_STUDY_NAME MODIFIED="2017-03-14 06:55:22 -0400" MODIFIED_BY="[Empty name]">
<P>The effect of sustained lung inflation maneuver applied through nasal prong on early and late respiratory morbidities in preterm infants</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2017-06-13 13:44:32 -0400" MODIFIED_BY="[Empty name]">
<P>Prospective randomised parallel controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-03-14 06:51:42 -0400" MODIFIED_BY="[Empty name]">
<P>Preterm infants of 26 weeks 0 days and 29 weeks 6 days</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-11 22:43:32 -0400" MODIFIED_BY="[Empty name]">
<P>SLI group: PIP 25 cmH<SUB>2</SUB>O for 15 seconds with T-piece and bi-nasal prongs; second SLI in case of poor response</P>
<P>Control group: CPAP</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-07-11 22:44:07 -0400" MODIFIED_BY="[Empty name]">
<P>Primary outcome: surfactant need, intubation and mechanical ventilation needs within first 72 hours of life</P>
<P>Secondary outcomes: heart rate, fractional inspiratory oxygen, CPAP pressure and oxygen saturation within first 72 hours of life in preterm infants; total non-invasive, invasive respiratory support time; BPD; PDA; IVH, NEC; ROP; feeding intolerance, reaching birth weight; transition to full oral feeding time</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2017-03-14 06:52:16 -0400" MODIFIED_BY="[Empty name]">
<P>August 2016</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2017-03-14 06:51:18 -0400" MODIFIED_BY="[Empty name]">
<P>Zekai Tahir Burak Women's Health Research and Education Hospital, Ankara, Turkey</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2017-07-11 22:44:20 -0400" MODIFIED_BY="[Empty name]">
<P>Estimated enrolment: 250</P>
<P>Estimated primary completion date: September 2017</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<FOOTNOTES>
<P>BPD: bronchopulmonary dysplasia<BR/>CC: chest compression<BR/>C:V: compression: ventilation<BR/>CPAP: continuous positive airway pressure<BR/>DR: delivery room<BR/>FiO2: fraction of inspired oxygen<BR/>IVH: intraventricular haemorrhage<BR/>NICU: neonatal intensive care unit<BR/>PEEP: positive end-expiratory pressure<BR/>PIE: pulmonary interstitial emphysema<BR/>PIP: peak inspiratory pressure<BR/>PPV: positive pressure ventilation<BR/>ROP: retinopathy of prematurity<BR/>SI: sustained inflation<BR/>SLI: sustained lung inflation<BR/>
</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2017-07-11 22:24:12 -0400" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2017-07-11 22:23:20 -0400" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-07-11 06:35:17 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-El_x002d_Chimi-2017">
<DESCRIPTION>
<P>For randomisation, sequentially numbered sheets were used to assign eligible infants to resuscitation: Odd-numbered sheets indicated those allocated to the SLI group, and even-numbered to the control group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-07-11 07:17:22 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jiravisitkul-2017">
<DESCRIPTION>
<P>Block of 4 randomisation stratified by GA: 25 to 28 weeks and 29 to 32 weeks. Random sequence was generated by computer random number generator (information provided by study authors)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-07-11 17:48:05 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lindner-2005">
<DESCRIPTION>
<P>Block randomised, stratified for gestational age (25 to 26 weeks, 27 to 28 weeks)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-07-11 17:57:07 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lista-2015">
<DESCRIPTION>
<P>Block randomised (1:1 ratio), stratified for gestational age (25 to 26 weeks, and 27 to 28 weeks)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-07-11 22:01:31 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mercadante-2016">
<DESCRIPTION>
<P>No information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-07-11 22:08:13 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ngan-2017">
<DESCRIPTION>
<P>Computer-generated randomisation scheme (1:1 ratio). Randomisation stratified according to gestational age (to infants 23<SUP>+0</SUP> to 27<SUP>+6</SUP> and 28<SUP>+0</SUP> to 32<SUP>+6</SUP> weeks). Twins and/or triplets were randomised as individuals</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-07-11 22:16:34 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schm_x00f6_lzer-2015">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-07-11 22:23:20 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schwaberger-2015">
<DESCRIPTION>
<P>Computer-generated blocked randomisation, 1:1 ratio, with a block size of 8 (www.randomizer.at)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2017-07-11 22:23:33 -0400" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-07-11 06:35:27 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-El_x002d_Chimi-2017">
<DESCRIPTION>
<P>No opaque envelopes were used (information provided by study authors)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-07-11 07:17:41 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jiravisitkul-2017">
<DESCRIPTION>
<P>Sequence numbers were kept in opaque sealed envelopes that were opened just before birth in the delivery room by a person not involved in resuscitation of infants</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-07-11 17:48:10 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lindner-2005">
<DESCRIPTION>
<P>Sealed opaque envelopes used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-07-11 17:57:13 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lista-2015">
<DESCRIPTION>
<P>Group assignment was contained in sequentially numbered, automatically generated, sealed, opaque envelopes that were prepared by an independent statistician and distributed to participating centres</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-07-11 22:01:33 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mercadante-2016">
<DESCRIPTION>
<P>Sealed opaque envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-07-11 22:08:54 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ngan-2017">
<DESCRIPTION>
<P>A sequentially numbered, brown, sealed envelope contained a folded card box with treatment allocation opened by the clinical team immediately before delivery.</P>
<P>Timing of randomisation resulted in many post-randomisation exclusions with the potential of inadequate allocation concealment, as more post-randomisation exclusions occurred in the SLI group than in the control group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-07-11 22:17:09 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schm_x00f6_lzer-2015">
<DESCRIPTION>
<P>Although not reported in the abstract, we obtained the following information directly from trial authors: A sequentially numbered, brown, sealed envelope contained a folded card box with treatment allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-07-11 22:23:33 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schwaberger-2015">
<DESCRIPTION>
<P>Sealed envelopes were used. We obtained the following information directly from trial authors: Envelopes were opaque</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2017-07-11 22:23:41 -0400" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2017-07-11 06:36:27 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-El_x002d_Chimi-2017">
<DESCRIPTION>
<P>Assigned intervention could not be blinded to the resuscitation team</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2017-07-11 07:17:49 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Jiravisitkul-2017">
<DESCRIPTION>
<P>Assigned intervention could not be blinded to the resuscitation team</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2017-07-11 17:48:17 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lindner-2005">
<DESCRIPTION>
<P>Assigned intervention could not be blinded to the resuscitation team</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2017-07-11 17:57:32 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lista-2015">
<DESCRIPTION>
<P>Assigned intervention could not be blinded to the resuscitation team</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2017-07-11 22:01:44 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Mercadante-2016">
<DESCRIPTION>
<P>Assigned intervention could not be blinded to the resuscitation team</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2017-07-11 22:09:01 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Ngan-2017">
<DESCRIPTION>
<P>Assigned intervention could not be blinded to the resuscitation team</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2017-07-11 22:17:25 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Schm_x00f6_lzer-2015">
<DESCRIPTION>
<P>Assigned intervention could not be blinded to the resuscitation team</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2017-07-11 22:23:41 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Schwaberger-2015">
<DESCRIPTION>
<P>Assigned intervention could not be blinded to the resuscitation team</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" MODIFIED="2017-07-11 22:23:55 -0400" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-08.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-07-11 06:35:34 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-El_x002d_Chimi-2017">
<DESCRIPTION>
<P>No information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-07-11 07:17:52 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jiravisitkul-2017">
<DESCRIPTION>
<P>No information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-07-11 17:48:20 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lindner-2005">
<DESCRIPTION>
<P>No information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-07-11 17:58:36 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lista-2015">
<DESCRIPTION>
<P>Staff performing the study also cared for infants later on. However, the decision to start MV was made by clinicians other than investigators involved in the study according to specific guidelines, and researchers assessing study endpoints were blinded to the nature of study treatments</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-07-11 22:02:06 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mercadante-2016">
<DESCRIPTION>
<P>The decision to start respiratory support was made by clinicians other than investigators involved in the study according to specific guidelines, and researchers assessing study endpoints were blinded to the nature of study treatments</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-07-11 22:09:29 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ngan-2017">
<DESCRIPTION>
<P>After admission into the NICU, the clinical team was not made aware of treatment allocation. In addition, both data collector and outcome assessor were unaware of group allocation. The research team was not involved in clinical care of the infants</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-07-11 22:17:54 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schm_x00f6_lzer-2015">
<DESCRIPTION>
<P>Although not reported in the abstract, we obtained the following information directly from trial authors: Both data collector and outcome assessor were unaware of group allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-07-11 22:23:55 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schwaberger-2015">
<DESCRIPTION>
<P>Cerebral ultrasound pictures were evaluated by a neonatologist blinded to participants. No information was provided for the other outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2017-07-11 22:23:59 -0400" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-07-11 06:35:54 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-El_x002d_Chimi-2017">
<DESCRIPTION>
<P>After enrolment (n = 202), infants referred to other NICUs were excluded from analysis owing to failure of follow-up. At study end, SLI group comprised 57 babies and CBMI group comprised 55 babies</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-07-11 07:17:56 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jiravisitkul-2017">
<DESCRIPTION>
<P>Unclear why 43 infants in SLI group and 38 in control group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-07-11 17:48:22 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lindner-2005">
<DESCRIPTION>
<P>All infants accounted for</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-07-11 20:09:28 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lista-2015">
<DESCRIPTION>
<P>Only 0.7% (control group) and 1.3% (SLI group) of participants were lost</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-07-11 22:02:09 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mercadante-2016">
<DESCRIPTION>
<P>All outcomes accounted for</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-07-11 22:09:43 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Ngan-2017">
<DESCRIPTION>
<P>Post-randomisation exclusion (27%) resulted in fewer included infants in the SLI group; this discrepancy might have yielded different results</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-07-11 22:18:03 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schm_x00f6_lzer-2015">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-07-11 22:23:59 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schwaberger-2015">
<DESCRIPTION>
<P>All outcomes accounted for</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2017-07-11 22:24:12 -0400" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-07-11 06:36:16 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-El_x002d_Chimi-2017">
<DESCRIPTION>
<P>Some outcomes were specified at</P>
<P>
<A HREF="https://clinicaltrials.gov/ct2/show/NCT01255826">https://clinicaltrials.gov/ct2/show/NCT01255826</A> but were not reported in the manuscript (e.g. duration of oxygen therapy, length of NICU stay)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-07-11 07:18:15 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jiravisitkul-2017">
<DESCRIPTION>
<P>According to the Thai Clinical Trials Registry (TCTR20140418001), the only primary outcome was intubation in DR; only a key secondary outcome was specified: BPD</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-07-11 17:48:25 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lindner-2005">
<DESCRIPTION>
<P>All reported outcomes provided with complete results</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-07-11 17:58:51 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lista-2015">
<DESCRIPTION>
<P>All outcomes reported </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-07-11 22:02:33 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Mercadante-2016">
<DESCRIPTION>
<P>We could not ascertain whether deviations from the original protocol were evident in the final publication</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-07-11 22:09:54 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ngan-2017">
<DESCRIPTION>
<P>Protocol was registered at Clinicaltrials.gov (NCT01739114)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-07-11 22:18:17 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Schm_x00f6_lzer-2015">
<DESCRIPTION>
<P>Trial was registered at ClinicalTrials.gov: NCT02083705. However, secondary outcomes were not specified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-07-11 22:24:12 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schwaberger-2015">
<DESCRIPTION>
<P>Protocol for this trial is available as supporting information. Reporting of the study conforms to Consolidated Standards of Reporting Trials (CONSORT) 2010 statement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2017-07-11 22:18:19 -0400" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-07-11 06:36:19 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-El_x002d_Chimi-2017">
<DESCRIPTION>
<P>Appears free of other bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-07-11 07:18:34 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jiravisitkul-2017">
<DESCRIPTION>
<P>Planned sample size: 40 infants in each group; however, only 38 in control group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-07-11 17:48:35 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lindner-2005">
<DESCRIPTION>
<P>Trial lacks power because only 61 infants were enrolled (instead of 110)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-07-11 17:58:54 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lista-2015">
<DESCRIPTION>
<P>Appears free of other bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-03-23 11:29:54 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mercadante-2016">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-07-11 22:12:30 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ngan-2017">
<DESCRIPTION>
<P>Planned sample size of 93 infants in each group was not achieved. Moreover, incidence of the primary outcome in the control group was lower than assumed for the sample size calculation, further underpowering the trial to detect the desired effect size</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-07-11 22:18:19 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schm_x00f6_lzer-2015">
<DESCRIPTION>
<P>Appears free of other bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-03-28 15:59:26 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schwaberger-2015">
<DESCRIPTION>
<P>Appears free of other bias.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" MODIFIED="2015-02-24 04:08:29 -0500" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2017-07-12 16:04:46 -0400" MODIFIED_BY="[Empty name]">
<SOF_TABLE ID="SOF-01" MODIFIED="2017-07-12 16:02:17 -0400" MODIFIED_BY="[Empty name]" NO="1" READONLY="YES">
<TITLE MODIFIED="2017-07-12 16:01:29 -0400" MODIFIED_BY="[Empty name]">Use of initial sustained inflation compared with standard inflations in newborns receiving resuscitation with no chest compressions during resuscitation</TITLE>
<TABLE COLS="7" ROWS="21">
<TR>
<TD COLSPAN="7">
<P>
<B>Use of initial sustained inflation compared with standard inflations in newborns receiving resuscitation with no chest compressions during resuscitation </B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population:</B> preterm infants resuscitated using PPV at birth</P>
<P>
<B>Settings:</B> delivery room in Europe (Austria, Germany, Italy), Canada, Egypt, Thailand<BR/>
<B>Intervention:</B> sustained inflation with no chest compressions<BR/>
<B>Comparison: </B>standard inflations with no chest compressions</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>No. of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Standard inflations in newborns receiving resuscitation with no chest compressions</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Use of initial sustained inflation</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>
<B>Death - death in the delivery room</B>
</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Study population</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>
<B>RR 2.66 </B>
<BR/>(0.11 to 63.4)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>479<BR/>(5 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
<SUP>a,b</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>0 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>0 per 1000</B>
<BR/>(0 to 0)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>
<B>Death - death before discharge</B>
</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Study population</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>
<B>RR 1.01 </B>
<BR/>(0.67 to 1.51)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>932<BR/>(7 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>a</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>82 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>83 per 1000</B>
<BR/>(55 to 124)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>
<B>Need for mechanical ventilation</B>
</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Study population</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>
<B>RR 0.87 </B>
<BR/>(0.74 to 1.03)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>484<BR/>(3 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>a</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>487 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>424 per 1000</B>
<BR/>(360 to 502)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>
<B>Chronic lung disease - BPD any grade</B>
</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Study population</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>
<B>RR 0.9 </B>
<BR/>(0.69 to 1.19)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>220<BR/>(2 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>a</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>483 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>435 per 1000</B>
<BR/>(333 to 575)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>
<B>Chronic lung disease - moderate to severe BPD</B>
</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Study population</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>
<B>RR 0.95 </B>
<BR/>(0.74 to 1.22)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>683<BR/>(5 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>a</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>257 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>244 per 1000</B>
<BR/>(190 to 314)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>
<B>Pneumothorax - any time</B>
</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Study population</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>
<B>RR 1.44 </B>
<BR/>(0.76 to 2.72)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>851<BR/>(6 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
<SUP>a,c</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>33 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>48 per 1000</B>
<BR/>(25 to 90)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>
<B>Cranial ultrasound abnormalities - intraventricular haemorrhage grade 3 to 4</B>
</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Study population</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>
<B>RR 0.89 </B>
<BR/>(0.58 to 1.37)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>635<BR/>(5 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>a</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>120 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>107 per 1000</B>
<BR/>(70 to 164)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI)<BR/>
<B>CI:</B> confidence interval; <B>RR:</B> risk ratio</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect<BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>Assumed risk is the risk of the control arm.</P>
<P>
<SUP>a</SUP>Limitations in study design: all studies at high or unclear risk of bias in at least one domain<BR/>
<SUP>b</SUP>Imprecision: few events<BR/>
<SUP>c</SUP>Imprecision: wide confidence intervals</P>
</FOOTNOTES>
</SOF_TABLE>
<SOF_TABLE ID="SOF-02" MODIFIED="2017-07-12 16:04:46 -0400" MODIFIED_BY="[Empty name]" NO="2" READONLY="YES">
<TITLE MODIFIED="2017-07-12 16:02:31 -0400" MODIFIED_BY="[Empty name]">Use of initial sustained inflation compared with standard inflations in newborns receiving resuscitation with chest compressions during resuscitation</TITLE>
<TABLE COLS="7" ROWS="6">
<TR>
<TD COLSPAN="7">
<P>
<B>Use of initial sustained inflation compared with standard inflations in newborns receiving resuscitation with chest compressions during resuscitation </B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population:</B> preterm infants resuscitated by PPV at birth</P>
<P>
<B>Settings:</B> delivery room in Europe (Austria, Germany, Italy), Canada, Egypt, Thailand<BR/>
<B>Intervention:</B> sustained inflation with chest compressions<BR/>
<B>Comparison: </B>standard inflations with chest compressions</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>No. of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Standard inflations in newborns receiving resuscitation with chest compressions</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Use of initial sustained inflation</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Death - death before discharge</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Not estimable</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>9<BR/>(1 study)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>very low<SUP>a,b</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Only 1 trial included</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Chronic lung disease - moderate to severe BPD</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Not estimable</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>7<BR/>(1 study)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>very low<SUP>a,b</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Only 1 trial included</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Pneumothorax - any time</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Not estimable</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>9<BR/>(1 study)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>very low<SUP>a,b</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Only 1 trial included</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Cranial ultrasound abnormalities - intraventricular haemorrhage grade 3 to 4</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Not estimable</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>9<BR/>(1 study)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>very low<SUP>a,b</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Only 1 trial included</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI)<BR/>
<B>CI:</B> confidence interval</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect<BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>Assumed risk is the risk of the control arm.</P>
<P>
<SUP>a</SUP>Limitations in study design: included study at high or unclear risk of bias in four domains<BR/>
<SUP>b</SUP>Imprecision (downgraded by two levels): extremely low sample size, few events</P>
</FOOTNOTES>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES MODIFIED="2017-07-11 23:13:32 -0400" MODIFIED_BY="[Empty name]">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2017-07-11 23:13:32 -0400" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2017-07-11 22:59:27 -0400" MODIFIED_BY="[Empty name]">Populations and interventions in included trials</TITLE>
<TABLE COLS="10" ROWS="10">
<TR>
<TD>
<P>
<B>Trial</B>
</P>
<P>
<B>(no. infants)</B>
</P>
</TD>
<TD COLSPAN="2">
<P>
<B>Antenatal steroids</B>
</P>
</TD>
<TD COLSPAN="2">
<P>
<B>Gestational age, weeks</B>
</P>
</TD>
<TD COLSPAN="2">
<P>
<B>Birth weight, grams</B>
</P>
</TD>
<TD>
<P>
<B>Device/Interface</B>
</P>
</TD>
<TD COLSPAN="2">
<P>
<B>Interventions/Controls</B>
</P>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>
<B>SLI</B>
</P>
</TD>
<TD>
<P>
<B>Control</B>
</P>
</TD>
<TD>
<P>
<B>SLI</B>
</P>
</TD>
<TD>
<P>
<B>Control</B>
</P>
</TD>
<TD>
<P>
<B>SLI</B>
</P>
</TD>
<TD>
<P>
<B>Control</B>
</P>
</TD>
<TD>
<P>
<B>SLI and control</B>
</P>
</TD>
<TD>
<P>
<B>SLI</B>
</P>
</TD>
<TD>
<P>
<B>Control</B>
</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-El_x002d_Chimi-2017" TYPE="STUDY">El-Chimi 2017</LINK> (112)</P>
</TD>
<TD>
<P>39%</P>
</TD>
<TD>
<P>34.5%</P>
</TD>
<TD>
<P>mean 31.1 (SD 1.7)</P>
</TD>
<TD>
<P>mean 31.3 (SD 1.7)</P>
</TD>
<TD>
<P>mean 1561 (SD 326)</P>
</TD>
<TD>
<P>mean 1510 (SD 319)</P>
</TD>
<TD>
<P>Mask and T-piece in SLI group</P>
<P/>
<P>Mask and self-inflating bag with an oxygen reservoir in control group</P>
</TD>
<TD>
<P>PIP of 20 cmH<SUB>2</SUB>O for 15 seconds, followed by PEEP of 5 cmH<SUB>2</SUB>O</P>
<P>If needed: a second SLI of 15 seconds of 25 cmH<SUB>2</SUB>O for 15 seconds, followed by PEEP of 6 cmH<SUB>2</SUB>O; then a third SLI of 15 seconds of 30 cmH<SUB>2</SUB>O for 15 seconds, followed by PEEP of 7 cmH<SUB>2</SUB>O</P>
<P>If still not satisfactory: intubated in delivery room</P>
</TD>
<TD>
<P>PIP maximum 40 cmH<SUB>2</SUB>O, rate of 40 to 60 breaths/min for 30 seconds</P>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Jiravisitkul-2017" TYPE="STUDY">Jiravisitkul 2017</LINK> (81)</P>
</TD>
<TD>
<P>63%</P>
</TD>
<TD>
<P>74%</P>
</TD>
<TD>
<P>25 to 28 weeks: <BR/>n = 17;</P>
<P>29 to 32 weeks: <BR/>n = 26</P>
</TD>
<TD>
<P>25 to 28 weeks: <BR/>n = 16;</P>
<P>29 to 32 weeks: <BR/>n = 22</P>
</TD>
<TD>
<P>mean 1206 (SD 367)</P>
</TD>
<TD>
<P>mean 1160 (SD 411)</P>
</TD>
<TD>
<P>Mask and T-piece</P>
</TD>
<TD>
<P>PIP of 25 cmH<SUB>2</SUB>O for 15 seconds</P>
<P>If HR 60 to 100 beats/min and/or poor respiratory effort: a second SLI (25 cmH<SUB>2</SUB>O, 15 seconds)</P>
</TD>
<TD>
<P>PIP 15 to 20 cmH<SUB>2</SUB>O, PEEP 5 cmH<SUB>2</SUB>O for 30 seconds, followed by resuscitation according to AHA guidelines</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Lindner-2005" TYPE="STUDY">Lindner 2005</LINK> (61)</P>
</TD>
<TD>
<P>81%</P>
</TD>
<TD>
<P>80%</P>
</TD>
<TD>
<P>median 27.0 (IQR 25.0 to 28.9)</P>
</TD>
<TD>
<P>median 26.7 (IQR 25.0 to 28.9)</P>
</TD>
<TD>
<P>median 870 (IQR 410 to 1320)</P>
</TD>
<TD>
<P>median 830 (IQR 370 to 1370)</P>
</TD>
<TD>
<P>Nasopharyngeal tube (fixed at 4 to 5 cm) and mechanical ventilator</P>
<P/>
</TD>
<TD>
<P>PIP of 20 cmH<SUB>2</SUB>O for 15 seconds</P>
<P>If response was not satisfactory: 2 further SLIs of 15 seconds (25 and 30 cmH<SUB>2</SUB>O). Then PEEP at 4 to 6 cmH<SUB>2</SUB>O</P>
</TD>
<TD>
<P>PIP 20 cmH<SUB>2</SUB>O, PEEP 4 to 6 cmH<SUB>2</SUB>O; inflation time 0.5 seconds; inflation rate 60 per min. Then, PEEP at 4 to 6 cmH<SUB>2</SUB>O</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Lista-2015" TYPE="STUDY">Lista 2015</LINK> (301)</P>
</TD>
<TD>
<P>87%</P>
</TD>
<TD>
<P>91%</P>
</TD>
<TD>
<P>mean 26.8 (SD 1.2);</P>
<P>25 to 26 weeks: <BR/>n = 55</P>
<P>27 to 28 weeks: <BR/>n = 88</P>
</TD>
<TD>
<P>mean 26.8 (SD 1.1);</P>
<P>25 to 26 weeks: <BR/>n = 52;</P>
<P>27 to 28 weeks: <BR/>n = 96</P>
</TD>
<TD>
<P>mean 894 (SD 247)</P>
</TD>
<TD>
<P>mean 893 (SD 241)</P>
</TD>
<TD>
<P>Mask and T-piece</P>
</TD>
<TD>
<P>PIP 25 cmH<SUB>2</SUB>O for 15 seconds. Then reduced to PEEP of 5 cmH<SUB>2</SUB>O</P>
</TD>
<TD>
<P>PEEP 5 cmH<SUB>2</SUB>O, followed by resuscitation according to AHA guidelines</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Mercadante-2016" TYPE="STUDY">Mercadante 2016</LINK> (185)</P>
</TD>
<TD>
<P>40%</P>
</TD>
<TD>
<P>32%</P>
</TD>
<TD>
<P>mean 35.2 (SD 0.8)</P>
</TD>
<TD>
<P>mean 35.2 (SD 0.8)</P>
</TD>
<TD>
<P>mean 2345 (SD 397)</P>
</TD>
<TD>
<P>mean 2346 (SD 359)</P>
</TD>
<TD>
<P>Mask and T-piece</P>
</TD>
<TD>
<P>PIP 25 cmH<SUB>2</SUB>O for 15 seconds, followed by PEEP of 5 cmH<SUB>2</SUB>O. In case of persistent heart failure (HR &lt; 100 bpm): SLI repeated</P>
</TD>
<TD>
<P>PEEP 5 cmH<SUB>2</SUB>O, followed by resuscitation according to AAP guidelines</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Ngan-2017" TYPE="STUDY">Ngan 2017</LINK> (162)</P>
</TD>
<TD>
<P>78%</P>
</TD>
<TD>
<P>70%</P>
</TD>
<TD>
<P>mean 28 (SD 2.5)</P>
</TD>
<TD>
<P>mean 28 (SD 2.5)</P>
</TD>
<TD>
<P>mean 1154 (SD 426)</P>
</TD>
<TD>
<P>mean 1140 (SD 406)</P>
</TD>
<TD>
<P>Mask and T-piece</P>
</TD>
<TD>
<P>Two PIPs of 24 cmH<SUB>2</SUB>O. Duration of first SLI was 20 seconds. Duration of second SLI was 20 or 10 seconds, guided by ECO<SUB>2 </SUB>values. After SLIs, CPAP if breathing spontaneously or, if found to have apnoea or laboured breathing, mask IPPV at a rate of 40 to 60 bpm</P>
<P/>
</TD>
<TD>
<P>IPPV, rate of 40 to 60 inflations/min until spontaneous breathing, at which time CPAP will be provided</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Schm_x00f6_lzer-2015" TYPE="STUDY">Schmölzer 2015</LINK> (9)</P>
</TD>
<TD>
<P>80%<SUP>a</SUP>
</P>
</TD>
<TD>
<P>100%<SUP>a</SUP>
</P>
</TD>
<TD>
<P>mean 24.6 (SD 1.3)<SUP>a</SUP>
</P>
</TD>
<TD>
<P>mean 25.6 (SD 2.3)<SUP>a</SUP>
</P>
</TD>
<TD>
<P>mean 707 (SD 208)<SUP>a</SUP>
</P>
</TD>
<TD>
<P>mean 808 (SD 192)<SUP>a</SUP>
</P>
</TD>
<TD>
<P>Mask and T-piece<SUP>a</SUP>
</P>
</TD>
<TD>
<P>PIP for 20 + 20 seconds<SUP>a</SUP> during chest compressions</P>
</TD>
<TD>
<P>3:1 compression:ventilation ratio according to resuscitation guidelines</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Schwaberger-2015" TYPE="STUDY">Schwaberger 2015</LINK> (40)</P>
</TD>
<TD>
<P>not reported</P>
</TD>
<TD>
<P>not reported</P>
</TD>
<TD>
<P>mean 32.1 (SD 1.4)</P>
</TD>
<TD>
<P>mean 32.1 (SD 1.6)</P>
</TD>
<TD>
<P>mean 1692 (SD 297)</P>
</TD>
<TD>
<P>mean 1722 (SD 604)</P>
</TD>
<TD>
<P>Mask and T-piece</P>
</TD>
<TD>
<P>PIP 30 cmH<SUB>2</SUB>O for 15 seconds, to be repeated once or twice with HR remaining &lt; 100 bpm. Infants with HR &gt; 100 bpm: PPV at 30 cmH<SUB>2</SUB>O PIP or CPAP at PEEP level of 5 cmH<SUB>2</SUB>O depending on respiratory rate</P>
</TD>
<TD>
<P>Resuscitation according to AHA guidelines</P>
<P>PEEP 5 cmH<SUB>2</SUB>O if respiratory rate &gt; 30 and signs of respiratory distress</P>
<P>PPV at 30 cmH<SUB>2</SUB>O PIP if</P>
<P>insufficient breathing efforts</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>a</SUP>Information provided by study authors</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2017-07-12 14:21:18 -0400" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2017-07-12 14:21:18 -0400" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Use of initial sustained inflation vs standard inflations in newborns receiving resuscitation with no chest compressions</NAME>
<DICH_OUTCOME CHI2="5.363590128627743" CI_END="1.5416720663508432" CI_START="0.686542047361975" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0287967227753374" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="38" I2="6.7788574426503905" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="0.18799200346821177" LOG_CI_START="-0.16333285918749396" LOG_EFFECT_SIZE="0.0123295721403589" METHOD="MH" MODIFIED="2017-04-06 06:32:31 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.37313568163181565" P_Q="0.5515519640607385" P_Z="0.8905819014029255" Q="0.35454460735201404" RANDOM="NO" SCALE="100.0" SORT_BY="EFFECT_SIZE" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="712" TOTAL_2="699" WEIGHT="200.0" Z="0.1375679316130484">
<NAME>Death</NAME>
<GROUP_LABEL_1>SLI</GROUP_LABEL_1>
<GROUP_LABEL_2>control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours SLI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="63.39802853151304" CI_START="0.11152972145332997" DF="0" EFFECT_SIZE="2.659090909090909" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-001.01.01" LOG_CI_END="1.8020757529732556" LOG_CI_START="-0.9526093824533072" LOG_EFFECT_SIZE="0.4247331852599742" MODIFIED="2017-03-28 03:54:03 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.5455797184626536" STUDIES="5" TAU2="0.0" TOTAL_1="244" TOTAL_2="235" WEIGHT="100.0" Z="0.604397021962818">
<NAME>Death in the delivery room</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2017-03-23 07:38:50 -0400" MODIFIED_BY="[Empty name]" ORDER="65" O_E="0.0" SE="0.0" STUDY_ID="STD-El_x002d_Chimi-2017" TOTAL_1="57" TOTAL_2="55" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-12-06 06:02:21 -0500" MODIFIED_BY="[Empty name]" ORDER="47" O_E="0.0" SE="0.0" STUDY_ID="STD-Lindner-2005" TOTAL_1="31" TOTAL_2="30" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2017-03-15 15:53:54 -0400" MODIFIED_BY="[Empty name]" ORDER="276" O_E="0.0" SE="0.0" STUDY_ID="STD-Mercadante-2016" TOTAL_1="93" TOTAL_2="92" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2017-03-15 16:13:23 -0400" MODIFIED_BY="[Empty name]" ORDER="278" O_E="0.0" SE="0.0" STUDY_ID="STD-Schwaberger-2015" TOTAL_1="20" TOTAL_2="20" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="63.39802853151304" CI_START="0.11152972145332997" EFFECT_SIZE="2.659090909090909" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8020757529732556" LOG_CI_START="-0.9526093824533072" LOG_EFFECT_SIZE="0.4247331852599742" MODIFIED="2017-03-28 03:54:03 -0400" MODIFIED_BY="[Empty name]" ORDER="87" O_E="0.0" SE="1.6181156844609004" STUDY_ID="STD-Jiravisitkul-2017" TOTAL_1="43" TOTAL_2="38" VAR="2.618298368298368" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="4.939745059192568" CI_END="1.514419348488196" CI_START="0.6690125829648201" DF="4" EFFECT_SIZE="1.0065612748481774" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="38" I2="19.02416112434302" ID="CMP-001.01.02" LOG_CI_END="0.18024614961394012" LOG_CI_START="-0.17456571383038888" LOG_EFFECT_SIZE="0.0028402178917756042" MODIFIED="2017-03-29 07:25:39 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.2935361527372714" P_Z="0.9749677198211899" STUDIES="7" TAU2="0.0" TOTAL_1="468" TOTAL_2="464" WEIGHT="100.0" Z="0.03137845911964497">
<NAME>Death before discharge</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2017-03-12 18:11:03 -0400" MODIFIED_BY="[Empty name]" ORDER="84" O_E="0.0" SE="0.0" STUDY_ID="STD-Schwaberger-2015" TOTAL_1="20" TOTAL_2="20" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2017-03-15 15:54:16 -0400" MODIFIED_BY="[Empty name]" ORDER="277" O_E="0.0" SE="0.0" STUDY_ID="STD-Mercadante-2016" TOTAL_1="93" TOTAL_2="92" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.133472080080371" CI_START="0.3276575132560835" EFFECT_SIZE="0.6094182825484764" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="19" LOG_CI_END="0.054410826962432685" LOG_CI_START="-0.48457986912933604" LOG_EFFECT_SIZE="-0.21508452108345172" MODIFIED="2017-03-23 07:38:28 -0400" MODIFIED_BY="[Empty name]" ORDER="64" O_E="0.0" SE="0.3166058029312804" STUDY_ID="STD-El_x002d_Chimi-2017" TOTAL_1="57" TOTAL_2="55" VAR="0.10023923444976074" WEIGHT="49.75603312581604"/>
<DICH_DATA CI_END="5.972426601440367" CI_START="0.13076136964877114" EFFECT_SIZE="0.8837209302325582" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.7761508211619235" LOG_CI_START="-0.8835205390874763" LOG_EFFECT_SIZE="-0.05368485896277636" MODIFIED="2017-03-12 11:52:58 -0400" MODIFIED_BY="[Empty name]" ORDER="57" O_E="0.0" SE="0.9748991725162287" STUDY_ID="STD-Jiravisitkul-2017" TOTAL_1="43" TOTAL_2="38" VAR="0.9504283965728274" WEIGHT="5.4632207182592945"/>
<DICH_DATA CI_END="3.759118951266205" CI_START="0.34063059209555363" EFFECT_SIZE="1.131578947368421" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" LOG_CI_END="0.5750860684808177" LOG_CI_START="-0.4677163505552649" LOG_EFFECT_SIZE="0.053684858962776354" MODIFIED="2017-03-29 07:25:39 -0400" MODIFIED_BY="[Empty name]" ORDER="89" O_E="0.0" SE="0.6125473028970201" STUDY_ID="STD-Ngan-2017" TOTAL_1="76" TOTAL_2="86" VAR="0.3752141982864137" WEIGHT="12.06990623801472"/>
<DICH_DATA CI_END="2.762873596545569" CI_START="0.6781456475339738" EFFECT_SIZE="1.3688063063063063" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="12" LOG_CI_END="0.4413610160860709" LOG_CI_START="-0.16867702128456383" LOG_EFFECT_SIZE="0.1363419974007535" MODIFIED="2015-02-24 06:31:36 -0500" MODIFIED_BY="[Empty name]" ORDER="52" O_E="0.0" SE="0.3583393628884975" STUDY_ID="STD-Lista-2015" TOTAL_1="148" TOTAL_2="143" VAR="0.12840709899533428" WEIGHT="31.404023001914368"/>
<DICH_DATA CI_END="125.9509737107974" CI_START="0.36510516915962377" EFFECT_SIZE="6.78125" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1002015293219576" LOG_CI_START="-0.43758201826471055" LOG_EFFECT_SIZE="0.8313097555286235" MODIFIED="2013-12-06 06:02:40 -0500" MODIFIED_BY="[Empty name]" ORDER="48" O_E="0.0" SE="1.4907066180835706" STUDY_ID="STD-Lindner-2005" TOTAL_1="31" TOTAL_2="30" VAR="2.2222062211981566" WEIGHT="1.3068169159955785"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="2.3425353606942108" CI_END="0.09493844577999203" CI_START="-0.25853144415657725" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.0817964991882926" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.02" MODIFIED="2017-07-12 04:42:58 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.6730360220585313" P_Q="1.0" P_Z="0.3643481723455917" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="263" TOTAL_2="266" UNITS="" WEIGHT="99.99999999999999" Z="0.9071108857350347">
<NAME>Apgar at 1 minute</NAME>
<GROUP_LABEL_1>SLI</GROUP_LABEL_1>
<GROUP_LABEL_2>control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SLI</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.59019121333754" CI_START="-0.7501912133375401" EFFECT_SIZE="0.41999999999999993" ESTIMABLE="YES" MEAN_1="4.77" MEAN_2="4.35" MODIFIED="2017-03-28 03:05:57 -0400" MODIFIED_BY="[Empty name]" ORDER="84" SD_1="2.59" SD_2="2.76" SE="0.5970473042198015" STUDY_ID="STD-Jiravisitkul-2017" TOTAL_1="43" TOTAL_2="38" WEIGHT="2.28103102576826"/>
<CONT_DATA CI_END="1.353729322359345" CI_START="-0.5537293223593441" EFFECT_SIZE="0.40000000000000036" ESTIMABLE="YES" MEAN_1="4.2" MEAN_2="3.8" MODIFIED="2012-11-23 10:12:04 -0500" MODIFIED_BY="[Empty name]" ORDER="164" SD_1="1.9" SD_2="1.9" SE="0.4866055345313688" STUDY_ID="STD-Lindner-2005" TOTAL_1="31" TOTAL_2="30" WEIGHT="3.433954904431328"/>
<CONT_DATA CI_END="0.10197400830402048" CI_START="-0.30197400830401977" EFFECT_SIZE="-0.09999999999999964" ESTIMABLE="YES" MEAN_1="8.4" MEAN_2="8.5" MODIFIED="2017-03-23 08:33:32 -0400" MODIFIED_BY="[Empty name]" ORDER="69" SD_1="0.67" SD_2="0.73" SE="0.10304985698572286" STUDY_ID="STD-Mercadante-2016" TOTAL_1="93" TOTAL_2="92" WEIGHT="76.56916114006248"/>
<CONT_DATA CI_END="0.6171341397804261" CI_START="-0.6171341397804261" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="4.0" MEAN_2="4.0" MODIFIED="2017-04-03 16:20:37 -0400" MODIFIED_BY="[Empty name]" ORDER="106" SD_1="2.0" SD_2="2.0" SE="0.31487014284359377" STUDY_ID="STD-Ngan-2017" TOTAL_1="76" TOTAL_2="86" WEIGHT="8.201356938343821"/>
<CONT_DATA CI_END="0.2729669020253431" CI_START="-0.8729669020253445" EFFECT_SIZE="-0.3000000000000007" ESTIMABLE="YES" MEAN_1="7.6" MEAN_2="7.9" MODIFIED="2017-03-30 15:02:22 -0400" MODIFIED_BY="[Empty name]" ORDER="101" SD_1="1.14" SD_2="0.64" SE="0.29233542378576016" STUDY_ID="STD-Schwaberger-2015" TOTAL_1="20" TOTAL_2="20" WEIGHT="9.51449599139411"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="9.209895695168077" CI_END="0.0842341357158945" CI_START="-0.1257050643111666" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.020735464297636053" ESTIMABLE="YES" I2="45.71056865906501" I2_Q="0.0" ID="CMP-001.03" MODIFIED="2017-07-12 04:43:09 -0400" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.10097940085087342" P_Q="1.0" P_Z="0.6986325931892128" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="320" TOTAL_2="321" UNITS="" WEIGHT="100.0" Z="0.3871669818770789">
<NAME>Apgar at 5 minutes</NAME>
<GROUP_LABEL_1>Sustained inflations</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard inflations</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SLI</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.6530743992587049" CI_START="0.08692560074129535" EFFECT_SIZE="0.3700000000000001" ESTIMABLE="YES" MEAN_1="7.61" MEAN_2="7.24" MODIFIED="2017-03-23 07:40:04 -0400" MODIFIED_BY="[Empty name]" ORDER="66" SD_1="0.65" SD_2="0.86" SE="0.14442836781265345" STUDY_ID="STD-El_x002d_Chimi-2017" TOTAL_1="57" TOTAL_2="55" WEIGHT="13.750734475729276"/>
<CONT_DATA CI_END="1.2333996443434543" CI_START="-0.7133996443434529" EFFECT_SIZE="0.2600000000000007" ESTIMABLE="YES" MEAN_1="7.36" MEAN_2="7.1" MODIFIED="2017-03-28 03:08:43 -0400" MODIFIED_BY="[Empty name]" ORDER="85" SD_1="2.1" SD_2="2.34" SE="0.4966415975097021" STUDY_ID="STD-Jiravisitkul-2017" TOTAL_1="43" TOTAL_2="38" WEIGHT="1.1629062863489055"/>
<CONT_DATA CI_END="1.0039256024835204" CI_START="-1.0039256024835204" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="8.0" MEAN_2="8.0" MODIFIED="2012-11-23 10:14:38 -0500" MODIFIED_BY="[Empty name]" ORDER="166" SD_1="2.0" SD_2="2.0" SE="0.5122163521382829" STUDY_ID="STD-Lindner-2005" TOTAL_1="31" TOTAL_2="30" WEIGHT="1.0932614256184474"/>
<CONT_DATA CI_END="0.025384395161485107" CI_START="-0.2253843951614844" EFFECT_SIZE="-0.09999999999999964" ESTIMABLE="YES" MEAN_1="9.4" MEAN_2="9.5" MODIFIED="2017-03-23 08:34:18 -0400" MODIFIED_BY="[Empty name]" ORDER="70" SD_1="0.43" SD_2="0.44" SE="0.06397280569974799" STUDY_ID="STD-Mercadante-2016" TOTAL_1="93" TOTAL_2="92" WEIGHT="70.08742526840297"/>
<CONT_DATA CI_END="0.4787671815054848" CI_START="-0.4787671815054848" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="7.0" MEAN_2="7.0" MODIFIED="2017-04-03 16:27:21 -0400" MODIFIED_BY="[Empty name]" ORDER="107" SD_1="1.0" SD_2="2.0" SE="0.24427345873798662" STUDY_ID="STD-Ngan-2017" TOTAL_1="76" TOTAL_2="86" WEIGHT="4.807046676022856"/>
<CONT_DATA CI_END="0.297997111083385" CI_START="-0.3979971110833864" EFFECT_SIZE="-0.05000000000000071" ESTIMABLE="YES" MEAN_1="8.7" MEAN_2="8.75" MODIFIED="2017-03-30 16:15:50 -0400" MODIFIED_BY="[Empty name]" ORDER="204" SD_1="0.47" SD_2="0.64" SE="0.17755280904564702" STUDY_ID="STD-Schwaberger-2015" TOTAL_1="20" TOTAL_2="20" WEIGHT="9.098625867877557"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="12.549561009539424" CI_END="1.0613525671780626" CI_START="0.7951989088302615" CI_STUDY="95" CI_TOTAL="95" DF="9" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9186873261911216" ESTIMABLE="YES" EVENTS_1="197" EVENTS_2="215" I2="28.28434402479306" I2_Q="0.0" ID="CMP-001.04" LOG_CI_END="0.02585967470741052" LOG_CI_START="-0.09952422454801851" LOG_EFFECT_SIZE="-0.03683227492030397" METHOD="MH" MODIFIED="2017-03-29 11:55:35 -0400" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.1840695603316841" P_Q="0.638591657937359" P_Z="0.2495256158753104" Q="0.8969802091010326" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="818" TOTAL_2="819" WEIGHT="300.0" Z="1.1515024295968033">
<NAME>Endotracheal intubation</NAME>
<GROUP_LABEL_1>Favours SLI</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard inflations</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours SLI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="8.299544557344154" CI_END="1.1890181702211506" CI_START="0.6220063857399954" DF="3" EFFECT_SIZE="0.8599865665453389" ESTIMABLE="YES" EVENTS_1="49" EVENTS_2="58" I2="63.85343823059134" ID="CMP-001.04.01" LOG_CI_END="0.07518849142818249" LOG_CI_START="-0.20620515666383235" LOG_EFFECT_SIZE="-0.06550833261782493" MODIFIED="2017-03-29 07:26:57 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.04021019991057406" P_Z="0.36147521116448866" STUDIES="5" TAU2="0.0" TOTAL_1="300" TOTAL_2="301" WEIGHT="99.99999999999999" Z="0.912557717551769">
<NAME>Endotracheal intubation in the delivery room</NAME>
<DICH_DATA CI_END="0.7389105272352375" CI_START="0.06710264180119534" EFFECT_SIZE="0.22267206477732793" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="13" LOG_CI_END="-0.13140814601721865" LOG_CI_START="-1.173260381513625" LOG_EFFECT_SIZE="-0.6523342637654219" MODIFIED="2017-03-12 13:42:35 -0400" MODIFIED_BY="[Empty name]" ORDER="70" O_E="0.0" SE="0.61198916038233" STUDY_ID="STD-El_x002d_Chimi-2017" TOTAL_1="57" TOTAL_2="55" VAR="0.37453073242546925" WEIGHT="22.920893053661885"/>
<DICH_DATA CI_END="1.3409694050677259" CI_START="0.3595346169244884" EFFECT_SIZE="0.6943521594684385" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="14" LOG_CI_END="0.12741886930436766" LOG_CI_START="-0.4442592882699463" LOG_EFFECT_SIZE="-0.15842020948278937" MODIFIED="2017-03-12 12:20:02 -0400" MODIFIED_BY="[Empty name]" ORDER="69" O_E="0.0" SE="0.3358065796116714" STUDY_ID="STD-Jiravisitkul-2017" TOTAL_1="43" TOTAL_2="38" VAR="0.11276605891048977" WEIGHT="25.74795976824943"/>
<DICH_DATA CI_END="3.1553125521491503" CI_START="0.6057321941029925" EFFECT_SIZE="1.3824884792626728" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="7" LOG_CI_END="0.49904238511757215" LOG_CI_START="-0.21771934337530627" LOG_EFFECT_SIZE="0.14066152087113293" MODIFIED="2008-07-23 06:52:56 -0400" MODIFIED_BY="[Empty name]" ORDER="138" O_E="0.0" SE="0.42102938734449463" STUDY_ID="STD-Lindner-2005" TOTAL_1="31" TOTAL_2="30" VAR="0.1772657450076805" WEIGHT="12.324271250109478"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2017-03-23 11:08:45 -0400" MODIFIED_BY="[Empty name]" ORDER="75" O_E="0.0" SE="0.0" STUDY_ID="STD-Mercadante-2016" TOTAL_1="93" TOTAL_2="92" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.881146948280585" CI_START="0.7385918812400379" EFFECT_SIZE="1.1787280701754386" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="24" LOG_CI_END="0.27442272236307014" LOG_CI_START="-0.13159547051665427" LOG_EFFECT_SIZE="0.07141362592320795" MODIFIED="2017-03-29 07:26:57 -0400" MODIFIED_BY="[Empty name]" ORDER="90" O_E="0.0" SE="0.2384970963200189" STUDY_ID="STD-Ngan-2017" TOTAL_1="76" TOTAL_2="86" VAR="0.056880864953080375" WEIGHT="39.0068759279792"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="3.6779408112447576" CI_START="0.5329068901836568" DF="0" EFFECT_SIZE="1.4" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" I2="0.0" ID="CMP-001.04.02" LOG_CI_END="0.5656047358980815" LOG_CI_START="-0.2733486645416055" LOG_EFFECT_SIZE="0.146128035678238" MODIFIED="2017-03-23 11:09:54 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.49475282593972036" STUDIES="2" TAU2="0.0" TOTAL_1="113" TOTAL_2="112" WEIGHT="100.0" Z="0.6827689998296169">
<NAME>Endotracheal intubation within 24 hours</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2017-03-23 11:09:54 -0400" MODIFIED_BY="[Empty name]" ORDER="76" O_E="0.0" SE="0.0" STUDY_ID="STD-Mercadante-2016" TOTAL_1="93" TOTAL_2="92" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="3.6779408112447576" CI_START="0.5329068901836568" EFFECT_SIZE="1.4" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.5656047358980815" LOG_CI_START="-0.2733486645416055" LOG_EFFECT_SIZE="0.146128035678238" MODIFIED="2017-03-12 18:04:42 -0400" MODIFIED_BY="[Empty name]" ORDER="76" O_E="0.0" SE="0.49280538030458115" STUDY_ID="STD-Schwaberger-2015" TOTAL_1="20" TOTAL_2="20" VAR="0.24285714285714288" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.77125597636625" CI_END="1.0860380817336606" CI_START="0.7880671503319392" DF="4" EFFECT_SIZE="0.9251329289479494" ESTIMABLE="YES" EVENTS_1="141" EVENTS_2="152" I2="0.0" ID="CMP-001.04.03" LOG_CI_END="0.03584505397918508" LOG_CI_START="-0.1034367751803564" LOG_EFFECT_SIZE="-0.03379586060058565" MODIFIED="2017-03-29 07:33:28 -0400" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.43784724125131336" P_Z="0.3415303343088084" STUDIES="5" TAU2="0.0" TOTAL_1="405" TOTAL_2="406" WEIGHT="100.0" Z="0.951145888927269">
<NAME>Endotracheal intubation by 72 hours of age</NAME>
<DICH_DATA CI_END="1.834417074921054" CI_START="0.4264817599110271" EFFECT_SIZE="0.8845029239766082" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="12" LOG_CI_END="0.263498084193252" LOG_CI_START="-0.37009953832854664" LOG_EFFECT_SIZE="-0.05330072706764732" MODIFIED="2017-03-12 13:45:50 -0400" MODIFIED_BY="[Empty name]" ORDER="71" O_E="0.0" SE="0.3721783798281185" STUDY_ID="STD-El_x002d_Chimi-2017" TOTAL_1="57" TOTAL_2="55" VAR="0.13851674641148326" WEIGHT="8.015448060087147"/>
<DICH_DATA CI_END="1.530797993442643" CI_START="0.6816531236451286" EFFECT_SIZE="1.021505376344086" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="18" LOG_CI_END="0.1849178842832176" LOG_CI_START="-0.1664365708133923" LOG_EFFECT_SIZE="0.009240656734912641" MODIFIED="2008-07-23 06:54:48 -0400" MODIFIED_BY="[Empty name]" ORDER="140" O_E="0.0" SE="0.20638734615635138" STUDY_ID="STD-Lindner-2005" TOTAL_1="31" TOTAL_2="30" VAR="0.042595736653461606" WEIGHT="12.005882512779367"/>
<DICH_DATA CI_END="0.9951397004333279" CI_START="0.6769442086455104" EFFECT_SIZE="0.8207643126997965" ESTIMABLE="YES" EVENTS_1="79" EVENTS_2="93" LOG_CI_END="-0.002115947527113645" LOG_CI_START="-0.1694471228596649" LOG_EFFECT_SIZE="-0.08578153519338928" MODIFIED="2015-02-22 09:05:41 -0500" MODIFIED_BY="Matteo Bruschettini" ORDER="70" O_E="0.0" SE="0.0982911606930172" STUDY_ID="STD-Lista-2015" TOTAL_1="148" TOTAL_2="143" VAR="0.00966115227038053" WEIGHT="62.078526532286446"/>
<DICH_DATA CI_END="21.443642467096428" CI_START="0.18254552517566713" EFFECT_SIZE="1.978494623655914" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.331298557559911" LOG_CI_START="-0.7386288086487084" LOG_EFFECT_SIZE="0.29633487445560136" MODIFIED="2017-03-23 11:11:02 -0400" MODIFIED_BY="[Empty name]" ORDER="77" O_E="0.0" SE="1.215885581216656" STUDY_ID="STD-Mercadante-2016" TOTAL_1="93" TOTAL_2="92" VAR="1.4783777466105656" WEIGHT="0.6597827326842716"/>
<DICH_DATA CI_END="1.8311674356826222" CI_START="0.8027274386033295" EFFECT_SIZE="1.212406015037594" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="28" LOG_CI_END="0.26272805651822634" LOG_CI_START="-0.09543189183778718" LOG_EFFECT_SIZE="0.08364808234021957" MODIFIED="2017-03-29 07:33:28 -0400" MODIFIED_BY="[Empty name]" ORDER="91" O_E="0.0" SE="0.21038492658465996" STUDY_ID="STD-Ngan-2017" TOTAL_1="76" TOTAL_2="86" VAR="0.04426181733403276" WEIGHT="17.24036016216275"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.7368379741815945" CI_END="1.1450507041703635" CI_START="0.8927168140746552" CI_STUDY="95" CI_TOTAL="95" DF="7" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0110420449125286" ESTIMABLE="YES" EVENTS_1="209" EVENTS_2="207" I2="0.0" I2_Q="44.49455294238074" ID="CMP-001.05" LOG_CI_END="0.05882471816397983" LOG_CI_START="-0.04928628533247625" LOG_EFFECT_SIZE="0.004769216415751806" METHOD="MH" MODIFIED="2017-04-03 00:24:59 -0400" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.692041975351386" P_Q="0.17951631192925854" P_Z="0.86271118371971" Q="1.8016249809895541" RANDOM="NO" SCALE="33.31106177581977" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="632" TOTAL_2="635" WEIGHT="100.0" Z="0.17292397826382513">
<NAME>Surfactant administration</NAME>
<GROUP_LABEL_1>Sustained inflations</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard inflations</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours SLI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.2281127482406231" CI_END="2.493705600197605" CI_START="0.8245909501337838" DF="1" EFFECT_SIZE="1.433975965705451" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="18" I2="0.0" ID="CMP-001.05.01" LOG_CI_END="0.3968451805953998" LOG_CI_START="-0.08376143588019404" LOG_EFFECT_SIZE="0.15654187235760292" MODIFIED="2017-03-29 07:31:13 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.6329267623526083" P_Z="0.2016770530734503" STUDIES="3" TAU2="0.0" TOTAL_1="164" TOTAL_2="171" WEIGHT="8.356183630714039" Z="1.2767882146247926">
<NAME>Surfactant given in the delivery room</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2017-03-27 04:16:11 -0400" MODIFIED_BY="[Empty name]" ORDER="157" O_E="0.0" SE="0.0" STUDY_ID="STD-El_x002d_Chimi-2017" TOTAL_1="57" TOTAL_2="55" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="4.600467528111721" CI_START="0.6595719264242341" EFFECT_SIZE="1.7419354838709677" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="5" LOG_CI_END="0.6628019696296966" LOG_CI_START="-0.18073783765230508" LOG_EFFECT_SIZE="0.24103206598869584" MODIFIED="2008-07-23 08:10:40 -0400" MODIFIED_BY="[Empty name]" ORDER="156" O_E="0.0" SE="0.49549945838683696" STUDY_ID="STD-Lindner-2005" TOTAL_1="31" TOTAL_2="30" VAR="0.2455197132616488" WEIGHT="2.4575859233904462"/>
<DICH_DATA CI_END="2.5658098525282185" CI_START="0.6644175003198501" EFFECT_SIZE="1.305668016194332" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="13" LOG_CI_END="0.40922446846229504" LOG_CI_START="-0.17755893703905337" LOG_EFFECT_SIZE="0.11583276571162082" MODIFIED="2017-03-29 07:31:13 -0400" MODIFIED_BY="[Empty name]" ORDER="92" O_E="0.0" SE="0.34467947701619445" STUDY_ID="STD-Ngan-2017" TOTAL_1="76" TOTAL_2="86" VAR="0.11880394187615731" WEIGHT="5.898597707323593"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.3268497465064795" CI_END="1.1010749282898509" CI_START="0.8589010096903603" DF="5" EFFECT_SIZE="0.972478466421182" ESTIMABLE="YES" EVENTS_1="185" EVENTS_2="189" I2="0.0" ID="CMP-001.05.02" LOG_CI_END="0.0418168737724674" LOG_CI_START="-0.06605688671886913" LOG_EFFECT_SIZE="-0.012120006473200877" MODIFIED="2017-03-29 07:33:07 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.8023155773246892" P_Z="0.6596343479833147" STUDIES="7" TAU2="0.0" TOTAL_1="468" TOTAL_2="464" WEIGHT="91.64381636928596" Z="0.4404180603636938">
<NAME>Surfactant given at any time</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2017-03-27 04:16:48 -0400" MODIFIED_BY="[Empty name]" ORDER="158" O_E="0.0" SE="0.0" STUDY_ID="STD-El_x002d_Chimi-2017" TOTAL_1="57" TOTAL_2="55" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.430339098834606" CI_START="0.4011415907730599" EFFECT_SIZE="0.7574750830564784" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="14" LOG_CI_END="0.15543901039819352" LOG_CI_START="-0.3967023075849727" LOG_EFFECT_SIZE="-0.12063164859338958" MODIFIED="2017-03-12 11:56:45 -0400" MODIFIED_BY="[Empty name]" ORDER="59" O_E="0.0" SE="0.32433054332691547" STUDY_ID="STD-Jiravisitkul-2017" TOTAL_1="43" TOTAL_2="38" VAR="0.1051903013347322" WEIGHT="7.188169675726321"/>
<DICH_DATA CI_END="1.5797777322165596" CI_START="0.6646152486009872" EFFECT_SIZE="1.0246679316888045" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="17" LOG_CI_END="0.19859598792772334" LOG_CI_START="-0.17742969870687958" LOG_EFFECT_SIZE="0.010583144610421895" MODIFIED="2008-07-23 08:11:47 -0400" MODIFIED_BY="[Empty name]" ORDER="158" O_E="0.0" SE="0.2208793496863342" STUDY_ID="STD-Lindner-2005" TOTAL_1="31" TOTAL_2="30" VAR="0.04878768711785789" WEIGHT="8.355792139527516"/>
<DICH_DATA CI_END="1.092210769614769" CI_START="0.8392856838399454" EFFECT_SIZE="0.9574324324324325" ESTIMABLE="YES" EVENTS_1="109" EVENTS_2="110" LOG_CI_END="0.038306454529873316" LOG_CI_START="-0.07609018482486724" LOG_EFFECT_SIZE="-0.018891865147496963" MODIFIED="2015-02-20 06:04:06 -0500" MODIFIED_BY="[Empty name]" ORDER="23" O_E="0.0" SE="0.06719715222947209" STUDY_ID="STD-Lista-2015" TOTAL_1="148" TOTAL_2="143" VAR="0.004515457267750845" WEIGHT="54.10884444741346"/>
<DICH_DATA CI_END="34.73523983008747" CI_START="0.45077460181457446" EFFECT_SIZE="3.956989247311828" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" LOG_CI_END="1.5407703018147791" LOG_CI_START="-0.34604056157561397" LOG_EFFECT_SIZE="0.5973648701195825" MODIFIED="2017-03-23 08:39:11 -0400" MODIFIED_BY="[Empty name]" ORDER="74" O_E="0.0" SE="1.108322041019922" STUDY_ID="STD-Mercadante-2016" TOTAL_1="93" TOTAL_2="92" VAR="1.2283777466105656" WEIGHT="0.486203485384272"/>
<DICH_DATA CI_END="1.3742213985101723" CI_START="0.7183734931998793" EFFECT_SIZE="0.993581514762516" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="41" LOG_CI_END="0.1380567068177073" LOG_CI_START="-0.143649700797051" LOG_EFFECT_SIZE="-0.002796496989671883" MODIFIED="2017-03-29 07:33:07 -0400" MODIFIED_BY="[Empty name]" ORDER="93" O_E="0.0" SE="0.1654757383021164" STUDY_ID="STD-Ngan-2017" TOTAL_1="76" TOTAL_2="86" VAR="0.02738221996663051" WEIGHT="18.60326969232825"/>
<DICH_DATA CI_END="2.577326316861588" CI_START="0.38799898695703405" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.4111694083221442" LOG_CI_START="-0.41116940832214427" LOG_EFFECT_SIZE="0.0" MODIFIED="2017-03-12 18:06:13 -0400" MODIFIED_BY="[Empty name]" ORDER="77" O_E="0.0" SE="0.48304589153964794" STUDY_ID="STD-Schwaberger-2015" TOTAL_1="20" TOTAL_2="20" VAR="0.23333333333333334" WEIGHT="2.9015369289061397"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.004581205922671727" CI_END="1.027685756581313" CI_START="0.7366627599560792" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8700906997610889" ESTIMABLE="YES" EVENTS_1="105" EVENTS_2="115" I2="0.0" I2_Q="0.0" ID="CMP-001.06" LOG_CI_END="0.011860337377188074" LOG_CI_START="-0.1327312842028994" LOG_EFFECT_SIZE="-0.06043547341285567" METHOD="MH" MODIFIED="2017-07-12 14:21:18 -0400" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.9460367036927003" P_Q="1.0" P_Z="0.10133281530727944" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="248" TOTAL_2="236" WEIGHT="100.0" Z="1.6384262100859894">
<NAME>Need for mechanical ventilation</NAME>
<GROUP_LABEL_1>SLI</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours SLI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2017-03-23 07:48:28 -0400" MODIFIED_BY="[Empty name]" ORDER="68" O_E="0.0" SE="0.0" STUDY_ID="STD-El_x002d_Chimi-2017" TOTAL_1="57" TOTAL_2="55" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.4736843242202906" CI_START="0.5299389222615883" EFFECT_SIZE="0.8837209302325582" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="17" LOG_CI_END="0.16840446389498367" LOG_CI_START="-0.27577418182053637" LOG_EFFECT_SIZE="-0.05368485896277636" MODIFIED="2017-03-12 11:54:29 -0400" MODIFIED_BY="[Empty name]" ORDER="58" O_E="0.0" SE="0.26091273521305325" STUDY_ID="STD-Jiravisitkul-2017" TOTAL_1="43" TOTAL_2="38" VAR="0.06807545539635683" WEIGHT="15.330746029858492"/>
<DICH_DATA CI_END="1.0317951324503438" CI_START="0.7295723432440988" EFFECT_SIZE="0.8676227247655819" ESTIMABLE="YES" EVENTS_1="88" EVENTS_2="98" LOG_CI_END="0.01359347473428272" LOG_CI_START="-0.13693163767872638" LOG_EFFECT_SIZE="-0.06166908147222182" MODIFIED="2015-02-22 09:16:57 -0500" MODIFIED_BY="Matteo Bruschettini" ORDER="71" O_E="0.0" SE="0.088419196142725" STUDY_ID="STD-Lista-2015" TOTAL_1="148" TOTAL_2="143" VAR="0.007817954246525677" WEIGHT="84.66925397014151"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="4.880312243670097" CI_END="0.7212352581427439" CI_START="-0.1942760822501995" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="MD" EFFECT_SIZE="0.2634795879462722" ESTIMABLE="YES" I2="59.01901558462664" I2_Q="0.0" ID="CMP-001.07" MODIFIED="2017-03-23 08:35:42 -0400" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.08714729563862722" P_Q="1.0" P_Z="0.25926264233541974" Q="0.0" RANDOM="NO" SCALE="30.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="178" TOTAL_2="177" UNITS="days" WEIGHT="100.0" Z="1.1281356773024802">
<NAME>Duration of NCPAP</NAME>
<GROUP_LABEL_1>Sustained inflations</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard inflations</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours SLI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.1051665439603484" CI_START="-6.745166543960351" EFFECT_SIZE="-2.820000000000001" ESTIMABLE="YES" MEAN_1="6.89" MEAN_2="9.71" MODIFIED="2017-03-23 07:42:42 -0400" MODIFIED_BY="[Empty name]" ORDER="67" SD_1="10.39" SD_2="10.79" SE="2.0026727913990063" STUDY_ID="STD-El_x002d_Chimi-2017" TOTAL_1="57" TOTAL_2="55" WEIGHT="1.3600387681755073"/>
<CONT_DATA CI_END="1.7207807598860008" CI_START="-12.520780759885998" EFFECT_SIZE="-5.399999999999999" ESTIMABLE="YES" MEAN_1="14.5" MEAN_2="19.9" MODIFIED="2013-12-22 05:22:25 -0500" MODIFIED_BY="[Empty name]" ORDER="53" SD_1="9.5" SD_2="17.3" SE="3.6331181675039996" STUDY_ID="STD-Lindner-2005" TOTAL_1="28" TOTAL_2="30" WEIGHT="0.4132494041221531"/>
<CONT_DATA CI_END="0.7918691228709394" CI_START="-0.13186912287093927" EFFECT_SIZE="0.33000000000000007" ESTIMABLE="YES" MEAN_1="2.96" MEAN_2="2.63" MODIFIED="2017-03-23 08:35:42 -0400" MODIFIED_BY="[Empty name]" ORDER="71" SD_1="1.7" SD_2="1.5" SE="0.23565184182673968" STUDY_ID="STD-Mercadante-2016" TOTAL_1="93" TOTAL_2="92" WEIGHT="98.22671182770233"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="60.0677839821199" CI_END="-4.4339140463109405" CI_START="-6.307904305755487" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="MD" EFFECT_SIZE="-5.370909176033214" ESTIMABLE="YES" I2="95.00564229089424" I2_Q="0.0" ID="CMP-001.08" MODIFIED="2017-04-09 14:29:26 -0400" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="5.686562332130052E-13" P_Q="1.0" P_Z="2.756630130186509E-29" Q="0.0" RANDOM="NO" SCALE="91.1204761242066" SORT_BY="WEIGHT" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="259" TOTAL_2="265" UNITS="days" WEIGHT="100.00000000000001" Z="11.23462461579811">
<NAME>Duration of mechanical ventilation</NAME>
<GROUP_LABEL_1>SLI</GROUP_LABEL_1>
<GROUP_LABEL_2>control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours SLI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="3.5" MEAN_2="0.08" MODIFIED="2017-04-06 08:37:53 -0400" MODIFIED_BY="[Empty name]" ORDER="72" SD_1="2.8" SD_2="0.0" SE="0.0" STUDY_ID="STD-Mercadante-2016" TOTAL_1="93" TOTAL_2="92" WEIGHT="0.0"/>
<CONT_DATA CI_END="10.633994249100873" CI_START="-9.23399424910087" EFFECT_SIZE="0.7000000000000011" ESTIMABLE="YES" MEAN_1="15.3" MEAN_2="14.6" MODIFIED="2013-12-22 05:23:18 -0500" MODIFIED_BY="[Empty name]" ORDER="55" SD_1="20.5" SD_2="17.9" SE="5.068457546903387" STUDY_ID="STD-Lindner-2005" TOTAL_1="28" TOTAL_2="30" WEIGHT="0.889665723354281"/>
<CONT_DATA CI_END="-0.5465549183666054" CI_START="-4.713445081633394" EFFECT_SIZE="-2.63" ESTIMABLE="YES" MEAN_1="1.5" MEAN_2="4.13" MODIFIED="2017-03-28 03:24:27 -0400" MODIFIED_BY="[Empty name]" ORDER="86" SD_1="3.35" SD_2="5.65" SE="1.0630017174128419" STUDY_ID="STD-Jiravisitkul-2017" TOTAL_1="42" TOTAL_2="37" WEIGHT="20.226025603547303"/>
<CONT_DATA CI_END="0.5907746482863181" CI_START="-2.890774648286318" EFFECT_SIZE="-1.15" ESTIMABLE="YES" MEAN_1="0.75" MEAN_2="1.9" MODIFIED="2017-04-03 16:45:49 -0400" MODIFIED_BY="[Empty name]" ORDER="205" SD_1="2.02" SD_2="3.42" SE="0.8881666510289609" STUDY_ID="STD-Schwaberger-2015" TOTAL_1="20" TOTAL_2="20" WEIGHT="28.972739433773103"/>
<CONT_DATA CI_END="-7.713715417087518" CI_START="-10.36628458291248" EFFECT_SIZE="-9.04" ESTIMABLE="YES" MEAN_1="7.54" MEAN_2="16.58" MODIFIED="2017-04-05 18:18:03 -0400" MODIFIED_BY="Lorenzo Moja" ORDER="108" SD_1="3.8" SD_2="4.8" SE="0.6766882419136496" STUDY_ID="STD-Ngan-2017" TOTAL_1="76" TOTAL_2="86" WEIGHT="49.91156923932533"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.6333015553898619" CI_END="1.1582665512322046" CI_START="0.22876972905433607" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="0.6935181401432703" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.09" MODIFIED="2017-03-23 08:38:08 -0400" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.42614709221078806" P_Q="1.0" P_Z="0.00344738622856066" Q="0.0" RANDOM="NO" SCALE="30.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="121" TOTAL_2="122" UNITS="days" WEIGHT="100.0" Z="2.9247449692644607">
<NAME>Duration of respiratory support (NCPAP + MV)</NAME>
<GROUP_LABEL_1>Sustained inflations</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard inflations</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours SLI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="8.737841961437349" CI_START="-18.33784196143735" EFFECT_SIZE="-4.800000000000001" ESTIMABLE="YES" MEAN_1="29.8" MEAN_2="34.6" MODIFIED="2013-12-22 05:24:06 -0500" MODIFIED_BY="[Empty name]" ORDER="54" SD_1="25.7" SD_2="26.9" SE="6.907189146444587" STUDY_ID="STD-Lindner-2005" TOTAL_1="28" TOTAL_2="30" WEIGHT="0.11785199739508033"/>
<CONT_DATA CI_END="1.1650225110295982" CI_START="0.23497748897040138" EFFECT_SIZE="0.6999999999999997" ESTIMABLE="YES" MEAN_1="3.3" MEAN_2="2.6" MODIFIED="2017-03-23 08:38:08 -0400" MODIFIED_BY="[Empty name]" ORDER="73" SD_1="1.4" SD_2="1.8" SE="0.23726074290019436" STUDY_ID="STD-Mercadante-2016" TOTAL_1="93" TOTAL_2="92" WEIGHT="99.88214800260492"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.10" MODIFIED="2017-03-28 06:19:47 -0400" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="43" TOTAL_2="38" UNITS="days" WEIGHT="0.0" Z="0.0">
<NAME>Duration of supplemental oxygen requirement</NAME>
<GROUP_LABEL_1>SLI</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours SLI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Control</GRAPH_LABEL_2>
<CONT_DATA CI_END="5.599145334294768" CI_START="-25.05914533429477" EFFECT_SIZE="-9.73" ESTIMABLE="YES" MEAN_1="26.38" MEAN_2="36.11" MODIFIED="2017-03-28 06:19:33 -0400" MODIFIED_BY="[Empty name]" ORDER="88" SD_1="25.07" SD_2="42.06" SE="7.8211362327109635" STUDY_ID="STD-Jiravisitkul-2017" TOTAL_1="43" TOTAL_2="38" WEIGHT="0.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="7.72303283424936" CI_END="1.1262503890955453" CI_START="0.7739986227715813" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9336574586302567" ESTIMABLE="YES" EVENTS_1="128" EVENTS_2="143" I2="22.31031346400886" I2_Q="0.0" ID="CMP-001.11" LOG_CI_END="0.05163495402664798" LOG_CI_START="-0.11125981208614451" LOG_EFFECT_SIZE="-0.029812429029748275" METHOD="MH" MODIFIED="2017-03-30 09:03:16 -0400" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="0.2591050920243233" P_Q="0.7889730518898831" P_Z="0.47312024671355424" Q="0.07163352830414503" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="448" TOTAL_2="455" WEIGHT="100.0" Z="0.7174114747124988">
<NAME>Chronic lung disease</NAME>
<GROUP_LABEL_1>Sustained inflations</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard inflations</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours SLI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.19373391368421855" CI_END="1.1870602333886917" CI_START="0.6890713808933266" DF="1" EFFECT_SIZE="0.9044165158955803" ESTIMABLE="YES" EVENTS_1="45" EVENTS_2="56" I2="0.0" ID="CMP-001.11.01" LOG_CI_END="0.07447275633003171" LOG_CI_START="-0.1617357872035964" LOG_EFFECT_SIZE="-0.043631515436782356" MODIFIED="2017-03-29 07:38:01 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.6598269230664704" P_Z="0.46902048592637646" STUDIES="2" TAU2="0.0" TOTAL_1="104" TOTAL_2="116" WEIGHT="37.66408980528383" Z="0.7240737152661219">
<NAME>BPD any grade</NAME>
<DICH_DATA CI_END="2.2684740544814157" CI_START="0.22491069740239467" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.35573381641667534" LOG_CI_START="-0.6479898877731514" LOG_EFFECT_SIZE="-0.146128035678238" MODIFIED="2013-12-22 05:14:27 -0500" MODIFIED_BY="[Empty name]" ORDER="144" O_E="0.0" SE="0.5895922723535711" STUDY_ID="STD-Lindner-2005" TOTAL_1="28" TOTAL_2="30" VAR="0.3476190476190476" WEIGHT="4.139740033522085"/>
<DICH_DATA CI_END="1.220900947876864" CI_START="0.7052076125884998" EFFECT_SIZE="0.9278947368421052" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="50" LOG_CI_END="0.08668043091009475" LOG_CI_START="-0.15168300821710864" LOG_EFFECT_SIZE="-0.03250128865350696" MODIFIED="2017-03-29 07:38:01 -0400" MODIFIED_BY="[Empty name]" ORDER="95" O_E="0.0" SE="0.14001586406137245" STUDY_ID="STD-Ngan-2017" TOTAL_1="76" TOTAL_2="86" VAR="0.019604442188852732" WEIGHT="33.52434977176174"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="7.483784829286069" CI_END="1.223145443894421" CI_START="0.7399116782349114" DF="4" EFFECT_SIZE="0.9513251800080279" ESTIMABLE="YES" EVENTS_1="83" EVENTS_2="87" I2="46.55110894761537" ID="CMP-001.11.02" LOG_CI_END="0.08747810194644862" LOG_CI_START="-0.13082011803180327" LOG_EFFECT_SIZE="-0.021671008042677336" MODIFIED="2017-03-29 07:36:39 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.11242653768010036" P_Z="0.6971718364079362" STUDIES="5" TAU2="0.0" TOTAL_1="344" TOTAL_2="339" WEIGHT="62.33591019471616" Z="0.3891410133949509">
<NAME>Moderate to severe BPD</NAME>
<DICH_DATA CI_END="43.96187067702634" CI_START="0.6815273866910827" EFFECT_SIZE="5.473684210526316" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="1" LOG_CI_END="1.643076164357105" LOG_CI_START="-0.16651668766520214" LOG_EFFECT_SIZE="0.7382797383459514" MODIFIED="2017-03-12 13:50:09 -0400" MODIFIED_BY="[Empty name]" ORDER="72" O_E="0.0" SE="1.0629637989069876" STUDY_ID="STD-El_x002d_Chimi-2017" TOTAL_1="57" TOTAL_2="52" VAR="1.1298920377867747" WEIGHT="0.7473777059209269"/>
<DICH_DATA CI_END="1.351650475561787" CI_START="0.1444461228422433" EFFECT_SIZE="0.4418604651162791" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="8" LOG_CI_END="0.13086440154665874" LOG_CI_START="-0.8402941108001738" LOG_EFFECT_SIZE="-0.35471485462675756" MODIFIED="2017-03-28 17:51:39 -0400" MODIFIED_BY="[Empty name]" ORDER="61" O_E="0.0" SE="0.5704633174646968" STUDY_ID="STD-Jiravisitkul-2017" TOTAL_1="43" TOTAL_2="38" VAR="0.3254283965728274" WEIGHT="6.069671748150547"/>
<DICH_DATA CI_END="1.4903211428458956" CI_START="0.8141013671694257" EFFECT_SIZE="1.1014864864864864" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="50" LOG_CI_END="0.17327986273297316" LOG_CI_START="-0.0893215159198192" LOG_EFFECT_SIZE="0.04197917340657698" MODIFIED="2017-03-12 12:06:25 -0400" MODIFIED_BY="[Empty name]" ORDER="27" O_E="0.0" SE="0.15425334971843904" STUDY_ID="STD-Lista-2015" TOTAL_1="148" TOTAL_2="143" VAR="0.02379409589935906" WEIGHT="36.34381489092781"/>
<DICH_DATA CI_END="1.1459490282515161" CI_START="0.39238902722042923" EFFECT_SIZE="0.6705653021442495" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="27" LOG_CI_END="0.0591653006667875" LOG_CI_START="-0.40628314574735985" LOG_EFFECT_SIZE="-0.17355892254028618" MODIFIED="2017-03-29 07:36:39 -0400" MODIFIED_BY="[Empty name]" ORDER="94" O_E="0.0" SE="0.27340672143063843" STUDY_ID="STD-Ngan-2017" TOTAL_1="76" TOTAL_2="86" VAR="0.07475123532345074" WEIGHT="18.10314887675134"/>
<DICH_DATA CI_END="7.723921203524791" CI_START="0.014385324265142151" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8878378346245852" LOG_CI_START="-1.84208034406391" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2017-03-12 18:07:36 -0400" MODIFIED_BY="[Empty name]" ORDER="78" O_E="0.0" SE="1.6035674514745464" STUDY_ID="STD-Schwaberger-2015" TOTAL_1="20" TOTAL_2="20" VAR="2.5714285714285716" WEIGHT="1.0718969729655399"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="6.773276521219845" CI_END="2.6097492095519836" CI_START="0.7559430748270193" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="RR" EFFECT_SIZE="1.4045717646300988" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="15" I2="11.416579831005933" I2_Q="0.0" ID="CMP-001.12" LOG_CI_END="0.4165987747172684" LOG_CI_START="-0.12151090716985326" LOG_EFFECT_SIZE="0.1475439337737076" METHOD="MH" MODIFIED="2017-07-12 04:44:54 -0400" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="0.34232454286871405" P_Q="0.7330792152247116" P_Z="0.28246320944026737" Q="0.11630312102899881" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="468" TOTAL_2="464" WEIGHT="100.0" Z="1.0748024280837631">
<NAME>Pneumothorax</NAME>
<GROUP_LABEL_1>Sustained inflations</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard inflations</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours SLI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="13.648469942980103" CI_START="0.05721979722223551" DF="0" EFFECT_SIZE="0.8837209302325582" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" ID="CMP-001.12.01" LOG_CI_END="1.1350839676723166" LOG_CI_START="-1.2424536855978694" LOG_EFFECT_SIZE="-0.05368485896277636" MODIFIED="2017-07-12 04:44:45 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.9294696911989856" STUDIES="1" TAU2="0.0" TOTAL_1="43" TOTAL_2="38" WEIGHT="6.549934996889743" Z="0.08851207040816245">
<NAME>During first 48 hours</NAME>
<DICH_DATA CI_END="13.648469942980096" CI_START="0.05721979722223554" EFFECT_SIZE="0.8837209302325582" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1350839676723163" LOG_CI_START="-1.2424536855978692" LOG_EFFECT_SIZE="-0.05368485896277636" MODIFIED="2017-03-12 12:09:15 -0400" MODIFIED_BY="[Empty name]" ORDER="63" O_E="0.0" SE="1.3965773865320987" STUDY_ID="STD-Jiravisitkul-2017" TOTAL_1="43" TOTAL_2="38" VAR="1.9504283965728273" WEIGHT="6.549934996889743"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="6.717815101687821" CI_END="2.7248342052787184" CI_START="0.7621405712334318" DF="5" EFFECT_SIZE="1.4410783107546643" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="14" I2="25.57103873335584" ID="CMP-001.12.02" LOG_CI_END="0.4353400824206982" LOG_CI_START="-0.11796491884334048" LOG_EFFECT_SIZE="0.1586875817886789" MODIFIED="2017-07-12 04:44:54 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.2424869650135162" P_Z="0.2609140976618065" STUDIES="6" TAU2="0.0" TOTAL_1="425" TOTAL_2="426" WEIGHT="93.45006500311025" Z="1.124233268772296">
<NAME>At any time</NAME>
<DICH_DATA CI_END="2.1565608544155506" CI_START="0.1918807608353165" EFFECT_SIZE="0.6432748538011696" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.33376171769364815" LOG_CI_START="-0.7169685681615058" LOG_EFFECT_SIZE="-0.19160342523392881" MODIFIED="2017-03-12 13:51:05 -0400" MODIFIED_BY="[Empty name]" ORDER="73" O_E="0.0" SE="0.6172041711101163" STUDY_ID="STD-El_x002d_Chimi-2017" TOTAL_1="57" TOTAL_2="55" VAR="0.38094098883572564" WEIGHT="37.675726595481656"/>
<DICH_DATA CI_END="2.973697734020619" CI_START="0.17715149699853822" EFFECT_SIZE="0.7258064516129032" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.4732968219134476" LOG_CI_START="-0.751655173359268" LOG_EFFECT_SIZE="-0.1391791757229102" MODIFIED="2008-07-23 07:42:27 -0400" MODIFIED_BY="[Empty name]" ORDER="149" O_E="0.0" SE="0.7195428656333623" STUDY_ID="STD-Lindner-2005" TOTAL_1="31" TOTAL_2="30" VAR="0.5177419354838709" WEIGHT="25.081032065863734"/>
<DICH_DATA CI_END="19.777587543841104" CI_START="0.9558733557263689" EFFECT_SIZE="4.347972972972973" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="2" LOG_CI_END="1.2961733155576773" LOG_CI_START="-0.0195996438667813" LOG_EFFECT_SIZE="0.6382868358454481" MODIFIED="2015-02-22 10:26:00 -0500" MODIFIED_BY="Matteo Bruschettini" ORDER="56" O_E="0.0" SE="0.7728915495471195" STUDY_ID="STD-Lista-2015" TOTAL_1="148" TOTAL_2="143" VAR="0.5973613473613474" WEIGHT="12.550247061889912"/>
<DICH_DATA CI_END="132.22482699388263" CI_START="0.3627381740225613" EFFECT_SIZE="6.925531914893617" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1213130074501354" LOG_CI_START="-0.44040673751314857" LOG_EFFECT_SIZE="0.8404531349684933" MODIFIED="2017-03-12 18:26:42 -0400" MODIFIED_BY="[Empty name]" ORDER="85" O_E="0.0" SE="1.5047668589086824" STUDY_ID="STD-Mercadante-2016" TOTAL_1="93" TOTAL_2="92" VAR="2.2643232996699023" WEIGHT="3.101057397482807"/>
<DICH_DATA CI_END="24.46642956890696" CI_START="0.20934332253443363" EFFECT_SIZE="2.263157894736842" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3885705965827444" LOG_CI_START="-0.6791408873292294" LOG_EFFECT_SIZE="0.35471485462675756" MODIFIED="2017-03-29 07:38:52 -0400" MODIFIED_BY="[Empty name]" ORDER="96" O_E="0.0" SE="1.214583960986812" STUDY_ID="STD-Ngan-2017" TOTAL_1="76" TOTAL_2="86" VAR="1.4752141982864138" WEIGHT="5.788314648414191"/>
<DICH_DATA CI_END="7.723921203524791" CI_START="0.014385324265142151" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8878378346245852" LOG_CI_START="-1.84208034406391" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2017-03-12 18:08:13 -0400" MODIFIED_BY="[Empty name]" ORDER="79" O_E="0.0" SE="1.6035674514745464" STUDY_ID="STD-Schwaberger-2015" TOTAL_1="20" TOTAL_2="20" VAR="2.5714285714285716" WEIGHT="9.253687233977951"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="6.9416534892644" CI_END="1.1472545596477879" CI_START="0.5829008126121036" CI_STUDY="95" CI_TOTAL="95" DF="10" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8177625664529018" ESTIMABLE="YES" EVENTS_1="50" EVENTS_2="63" I2="0.0" I2_Q="0.0" ID="CMP-001.13" LOG_CI_END="0.05965979242983801" LOG_CI_START="-0.23440533923758625" LOG_EFFECT_SIZE="-0.08737277340387412" METHOD="MH" MODIFIED="2017-03-29 12:29:27 -0400" MODIFIED_BY="[Empty name]" NO="13" P_CHI2="0.7309415363894958" P_Q="0.7126985240209023" P_Z="0.24414416042231635" Q="0.6773937627121951" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="713" TOTAL_2="709" WEIGHT="300.0" Z="1.1646908841585906">
<NAME>Cranial ultrasound abnormalities</NAME>
<GROUP_LABEL_1>Sustained inflations</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard inflations</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours SLI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="3.112718640310441" CI_END="1.3667769241536183" CI_START="0.5845092103174092" DF="3" EFFECT_SIZE="0.8938085368898021" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="38" I2="3.6212280432515875" ID="CMP-001.13.01" LOG_CI_END="0.135697637819622" LOG_CI_START="-0.23320864111717513" LOG_EFFECT_SIZE="-0.04875550164877662" MODIFIED="2017-03-29 07:39:43 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.3745708534126232" P_Z="0.6044117425445854" STUDIES="5" TAU2="0.0" TOTAL_1="318" TOTAL_2="317" WEIGHT="100.0" Z="0.5180666892154312">
<NAME>Intraventricular haemorrhage grade 3-4</NAME>
<DICH_DATA CI_END="3.580652012124319" CI_START="0.008776507666285795" EFFECT_SIZE="0.17727272727272728" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5539621158854766" LOG_CI_START="-2.0566782634768908" LOG_EFFECT_SIZE="-0.7513580737957071" MODIFIED="2017-03-12 12:11:24 -0400" MODIFIED_BY="[Empty name]" ORDER="64" O_E="0.0" SE="1.5335030817157498" STUDY_ID="STD-Jiravisitkul-2017" TOTAL_1="43" TOTAL_2="38" VAR="2.3516317016317014" WEIGHT="7.122229571286508"/>
<DICH_DATA CI_END="8.08502074838146" CI_START="0.26062765778720987" EFFECT_SIZE="1.4516129032258065" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9076811387626443" LOG_CI_START="-0.5839794988805024" LOG_EFFECT_SIZE="0.161850819941071" MODIFIED="2012-11-20 10:05:12 -0500" MODIFIED_BY="[Empty name]" ORDER="152" O_E="0.0" SE="0.8762088423908257" STUDY_ID="STD-Lindner-2005" TOTAL_1="31" TOTAL_2="30" VAR="0.7677419354838709" WEIGHT="5.46214506316548"/>
<DICH_DATA CI_END="3.4406812169423775" CI_START="0.6105014863727602" EFFECT_SIZE="1.4493243243243243" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="8" LOG_CI_END="0.5366444366034268" LOG_CI_START="-0.21431327435185546" LOG_EFFECT_SIZE="0.16116558112578566" MODIFIED="2015-02-24 05:37:31 -0500" MODIFIED_BY="[Empty name]" ORDER="59" O_E="0.0" SE="0.4411162767157539" STUDY_ID="STD-Lista-2015" TOTAL_1="148" TOTAL_2="143" VAR="0.19458356958356957" WEIGHT="21.865534034035228"/>
<DICH_DATA CI_END="1.2541581425901642" CI_START="0.43648423518292173" EFFECT_SIZE="0.7398785425101214" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="26" LOG_CI_END="0.09835230214379048" LOG_CI_START="-0.3600314374033259" LOG_EFFECT_SIZE="-0.1308395676297677" MODIFIED="2017-03-29 07:39:43 -0400" MODIFIED_BY="[Empty name]" ORDER="97" O_E="0.0" SE="0.26925687764608147" STUDY_ID="STD-Ngan-2017" TOTAL_1="76" TOTAL_2="86" VAR="0.07249926615971689" WEIGHT="65.55009133151277"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2017-03-12 18:08:55 -0400" MODIFIED_BY="[Empty name]" ORDER="80" O_E="0.0" SE="0.0" STUDY_ID="STD-Schwaberger-2015" TOTAL_1="20" TOTAL_2="20" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.023265493869806954" CI_END="1.6921314411919575" CI_START="0.39632157374898286" DF="1" EFFECT_SIZE="0.818918918918919" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="13" I2="0.0" ID="CMP-001.13.02" LOG_CI_END="0.22843409509024773" LOG_CI_START="-0.4019522862196276" LOG_EFFECT_SIZE="-0.08675909556468994" MODIFIED="2017-03-12 18:09:17 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.8787687047942729" P_Z="0.5895463283584048" STUDIES="2" TAU2="0.0" TOTAL_1="77" TOTAL_2="75" WEIGHT="100.0" Z="0.5394935794289414">
<NAME>IVH any grade</NAME>
<DICH_DATA CI_END="1.7074029298656712" CI_START="0.37868417207533406" EFFECT_SIZE="0.804093567251462" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="12" LOG_CI_END="0.23233602232602107" LOG_CI_START="-0.4217228467777659" LOG_EFFECT_SIZE="-0.0946934122258724" MODIFIED="2017-03-12 13:54:15 -0400" MODIFIED_BY="[Empty name]" ORDER="74" O_E="0.0" SE="0.3841974173551826" STUDY_ID="STD-El_x002d_Chimi-2017" TOTAL_1="57" TOTAL_2="55" VAR="0.14760765550239235" WEIGHT="92.43243243243244"/>
<DICH_DATA CI_END="14.903914722906746" CI_START="0.06709646549862758" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1733003569528007" LOG_CI_START="-1.1733003569528007" LOG_EFFECT_SIZE="0.0" MODIFIED="2017-03-12 18:09:17 -0400" MODIFIED_BY="[Empty name]" ORDER="81" O_E="0.0" SE="1.378404875209022" STUDY_ID="STD-Schwaberger-2015" TOTAL_1="20" TOTAL_2="20" VAR="1.9" WEIGHT="7.567567567567568"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.1749279566955932" CI_END="1.435235923553973" CI_START="0.24398225078679647" DF="4" EFFECT_SIZE="0.5917534039097408" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="12" I2="0.0" ID="CMP-001.13.03" LOG_CI_END="0.1569232961055421" LOG_CI_START="-0.6126417665536079" LOG_EFFECT_SIZE="-0.2278592352240329" MODIFIED="2017-03-29 07:40:27 -0400" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.5289901294498304" P_Z="0.24578634524921728" STUDIES="5" TAU2="0.0" TOTAL_1="318" TOTAL_2="317" WEIGHT="100.0" Z="1.1606449311531388">
<NAME>Cystic periventricular leukomalacia</NAME>
<DICH_DATA CI_END="13.648469942980096" CI_START="0.05721979722223554" EFFECT_SIZE="0.8837209302325582" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1350839676723163" LOG_CI_START="-1.2424536855978692" LOG_EFFECT_SIZE="-0.05368485896277636" MODIFIED="2017-03-12 12:18:22 -0400" MODIFIED_BY="[Empty name]" ORDER="68" O_E="0.0" SE="1.3965773865320987" STUDY_ID="STD-Jiravisitkul-2017" TOTAL_1="43" TOTAL_2="38" VAR="1.9504283965728273" WEIGHT="8.433272199006941"/>
<DICH_DATA CI_END="2.448612244452278" CI_START="0.09561788068077279" EFFECT_SIZE="0.4838709677419355" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.3889200168814766" LOG_CI_START="-1.0194608864386594" LOG_EFFECT_SIZE="-0.3152704347785914" MODIFIED="2008-07-23 07:58:43 -0400" MODIFIED_BY="[Empty name]" ORDER="154" O_E="0.0" SE="0.8272899142081558" STUDY_ID="STD-Lindner-2005" TOTAL_1="31" TOTAL_2="30" VAR="0.6844086021505377" WEIGHT="32.29271291148522"/>
<DICH_DATA CI_END="1.6337720454113036" CI_START="0.02285689191711329" EFFECT_SIZE="0.19324324324324324" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="5" LOG_CI_END="0.21319146080949442" LOG_CI_START="-1.6409828253413232" LOG_EFFECT_SIZE="-0.7138956822659144" MODIFIED="2015-02-24 05:37:38 -0500" MODIFIED_BY="[Empty name]" ORDER="28" O_E="0.0" SE="1.0891511539957326" STUDY_ID="STD-Lista-2015" TOTAL_1="148" TOTAL_2="143" VAR="1.186250236250236" WEIGHT="40.397213746381844"/>
<DICH_DATA CI_END="6.116607392226742" CI_START="0.05233583063360841" EFFECT_SIZE="0.5657894736842105" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7865106052547821" LOG_CI_START="-1.2812008786571918" LOG_EFFECT_SIZE="-0.24734513670120484" MODIFIED="2017-03-29 07:40:27 -0400" MODIFIED_BY="[Empty name]" ORDER="98" O_E="0.0" SE="1.214583960986812" STUDY_ID="STD-Ngan-2017" TOTAL_1="76" TOTAL_2="86" VAR="1.4752141982864138" WEIGHT="14.90531830522157"/>
<DICH_DATA CI_END="97.99788802329087" CI_START="0.2551075385834674" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.991216716205615" LOG_CI_START="-0.5932767075335774" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2017-03-12 18:09:38 -0400" MODIFIED_BY="[Empty name]" ORDER="82" O_E="0.0" SE="1.5181442305531794" STUDY_ID="STD-Schwaberger-2015" TOTAL_1="20" TOTAL_2="20" VAR="2.304761904761905" WEIGHT="3.9714828379044316"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="5.189364764078617" CI_END="1.1048012964451954" CI_START="0.4353113782029714" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6934930244753639" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="39" I2="42.189456004974886" I2_Q="0.0" ID="CMP-001.14" LOG_CI_END="0.04328417520006809" LOG_CI_START="-0.3611999810709882" LOG_EFFECT_SIZE="-0.15895790293546003" METHOD="MH" MODIFIED="2017-06-13 17:33:44 -0400" MODIFIED_BY="[Empty name]" NO="14" P_CHI2="0.15844487532247276" P_Q="1.0" P_Z="0.1234411200375987" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="315" TOTAL_2="317" WEIGHT="100.00000000000003" Z="1.5404893367577828">
<NAME>Retinopathy of prematurity (ROP) stage &#8805; 3</NAME>
<GROUP_LABEL_1>Sustained inflations</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard inflations</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours SLI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.771660742221666" CI_START="0.005474674213823049" EFFECT_SIZE="0.09848484848484848" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.24838056185852003" LOG_CI_START="-2.2616417196565464" LOG_EFFECT_SIZE="-1.006630578899013" MODIFIED="2017-03-12 12:13:56 -0400" MODIFIED_BY="[Empty name]" ORDER="65" O_E="0.0" SE="1.4743995129726284" STUDY_ID="STD-Jiravisitkul-2017" TOTAL_1="43" TOTAL_2="38" VAR="2.173853923853924" WEIGHT="12.330376233501049"/>
<DICH_DATA CI_END="3.308616033895462" CI_START="0.34696053332060345" EFFECT_SIZE="1.0714285714285714" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" LOG_CI_END="0.5196463700501471" LOG_CI_START="-0.45971992329526074" LOG_EFFECT_SIZE="0.029963223377443202" MODIFIED="2013-12-22 05:24:51 -0500" MODIFIED_BY="[Empty name]" ORDER="165" O_E="0.0" SE="0.5752846086524313" STUDY_ID="STD-Lindner-2005" TOTAL_1="28" TOTAL_2="30" VAR="0.330952380952381" WEIGHT="12.47639949784763"/>
<DICH_DATA CI_END="2.353210450784812" CI_START="0.5399847003841024" EFFECT_SIZE="1.1272522522522523" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="12" LOG_CI_END="0.37166076845418883" LOG_CI_START="-0.2676185450527536" LOG_EFFECT_SIZE="0.05202111170071765" MODIFIED="2015-02-24 05:37:56 -0500" MODIFIED_BY="[Empty name]" ORDER="57" O_E="0.0" SE="0.375515833237616" STUDY_ID="STD-Lista-2015" TOTAL_1="148" TOTAL_2="143" VAR="0.14101214101214102" WEIGHT="31.54562983491136"/>
<DICH_DATA CI_END="0.9958497696370668" CI_START="0.19445851303328138" EFFECT_SIZE="0.44005847953216376" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="18" LOG_CI_END="-0.001806172759679117" LOG_CI_START="-0.7111730394928665" LOG_EFFECT_SIZE="-0.35648960612627284" MODIFIED="2017-03-29 07:41:13 -0400" MODIFIED_BY="[Empty name]" ORDER="99" O_E="0.0" SE="0.4166856089416961" STUDY_ID="STD-Ngan-2017" TOTAL_1="76" TOTAL_2="86" VAR="0.1736268966991121" WEIGHT="43.64759443373997"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2017-03-12 18:10:02 -0400" MODIFIED_BY="[Empty name]" ORDER="83" O_E="0.0" SE="0.0" STUDY_ID="STD-Schwaberger-2015" TOTAL_1="20" TOTAL_2="20" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="9.461969988361263" CI_END="1.2688941210892517" CI_START="0.8837683488384137" CI_STUDY="95" CI_TOTAL="95" DF="7" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0589657512147492" ESTIMABLE="YES" EVENTS_1="146" EVENTS_2="134" I2="26.01963429803328" I2_Q="0.0" ID="CMP-001.15" LOG_CI_END="0.10342538525855587" LOG_CI_START="-0.05366155625977114" LOG_EFFECT_SIZE="0.024881914499392366" METHOD="MH" MODIFIED="2017-03-30 16:41:44 -0400" MODIFIED_BY="[Empty name]" NO="15" P_CHI2="0.221167095710599" P_Q="0.4501580878728233" P_Z="0.534665296567436" Q="0.5702540834715147" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="586" TOTAL_2="571" WEIGHT="200.0" Z="0.6209001946800827">
<NAME>Patent ductus arteriosus (PDA)</NAME>
<GROUP_LABEL_1>Sustained inflations</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard inflations</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours SLI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="7.829660036567556" CI_END="1.2981025737624927" CI_START="0.9007190736700382" DF="5" EFFECT_SIZE="1.0813074251886208" ESTIMABLE="YES" EVENTS_1="140" EVENTS_2="126" I2="36.140266925408554" ID="CMP-001.15.01" LOG_CI_END="0.11330901099976735" LOG_CI_START="-0.045410640518216916" LOG_EFFECT_SIZE="0.033949185240775184" MODIFIED="2017-03-30 16:39:04 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.1658767149355126" P_Z="0.40177848981646436" STUDIES="6" TAU2="0.0" TOTAL_1="375" TOTAL_2="370" WEIGHT="100.0" Z="0.8384491742518562">
<NAME>PDA - pharmacological treatment</NAME>
<DICH_DATA CI_END="1.5514147499081745" CI_START="0.2947601137094657" EFFECT_SIZE="0.6762360446570973" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="11" LOG_CI_END="0.1907279161356755" LOG_CI_START="-0.530531284611643" LOG_EFFECT_SIZE="-0.1699016842379838" MODIFIED="2017-03-12 13:56:48 -0400" MODIFIED_BY="[Empty name]" ORDER="75" O_E="0.0" SE="0.4236712248095995" STUDY_ID="STD-El_x002d_Chimi-2017" TOTAL_1="57" TOTAL_2="53" VAR="0.17949730673166622" WEIGHT="8.921206648710331"/>
<DICH_DATA CI_END="1.9601545695354674" CI_START="0.6586108811672124" EFFECT_SIZE="1.1362126245847175" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="14" LOG_CI_END="0.2922903193409205" LOG_CI_START="-0.18137109841633722" LOG_EFFECT_SIZE="0.055459610462291635" MODIFIED="2017-03-12 12:15:08 -0400" MODIFIED_BY="[Empty name]" ORDER="66" O_E="0.0" SE="0.2782310614524453" STUDY_ID="STD-Jiravisitkul-2017" TOTAL_1="43" TOTAL_2="38" VAR="0.0774125235569544" WEIGHT="11.632155950885032"/>
<DICH_DATA CI_END="3.8801203836840794" CI_START="0.8324622456636341" EFFECT_SIZE="1.7972350230414746" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="7" LOG_CI_END="0.5888452001196337" LOG_CI_START="-0.07963545376369421" LOG_EFFECT_SIZE="0.2546048731779697" MODIFIED="2015-02-22 10:57:46 -0500" MODIFIED_BY="Matteo Bruschettini" ORDER="160" O_E="0.0" SE="0.3926688451236709" STUDY_ID="STD-Lindner-2005" TOTAL_1="31" TOTAL_2="30" VAR="0.15418882193075742" WEIGHT="5.567736102301242"/>
<DICH_DATA CI_END="1.5042238433036406" CI_START="0.9808564223511591" EFFECT_SIZE="1.2146718146718147" ESTIMABLE="YES" EVENTS_1="88" EVENTS_2="70" LOG_CI_END="0.17731246835537753" LOG_CI_START="-0.008394559943345046" LOG_EFFECT_SIZE="0.08445895420601623" MODIFIED="2015-02-24 05:38:09 -0500" MODIFIED_BY="[Empty name]" ORDER="58" O_E="0.0" SE="0.10908522768728542" STUDY_ID="STD-Lista-2015" TOTAL_1="148" TOTAL_2="143" VAR="0.011899586899586902" WEIGHT="55.72056482826251"/>
<DICH_DATA CI_END="1.300931176818817" CI_START="0.37719290181098414" EFFECT_SIZE="0.7005012531328321" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="21" LOG_CI_END="0.1142543216819368" LOG_CI_START="-0.42343648861054906" LOG_EFFECT_SIZE="-0.15459108346430614" MODIFIED="2017-03-29 07:42:41 -0400" MODIFIED_BY="[Empty name]" ORDER="100" O_E="0.0" SE="0.3158422435782431" STUDY_ID="STD-Ngan-2017" TOTAL_1="76" TOTAL_2="86" VAR="0.09975632282853825" WEIGHT="15.419369516289459"/>
<DICH_DATA CI_END="2.5983769423254333" CI_START="0.007854196568971131" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.4147021537028376" LOG_CI_START="-2.1048982337313515" LOG_EFFECT_SIZE="-0.8450980400142568" MODIFIED="2017-03-30 16:39:04 -0400" MODIFIED_BY="[Empty name]" ORDER="207" O_E="0.0" SE="1.4800257398019099" STUDY_ID="STD-Schwaberger-2015" TOTAL_1="20" TOTAL_2="20" VAR="2.1904761904761907" WEIGHT="2.7389669535514174"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.7536630294528951" CI_END="1.9925663566528953" CI_START="0.2671394863185667" DF="1" EFFECT_SIZE="0.7295842329518315" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="8" I2="0.0" ID="CMP-001.15.02" LOG_CI_END="0.29941279322916836" LOG_CI_START="-0.5732619134656584" LOG_EFFECT_SIZE="-0.13692456011824505" MODIFIED="2017-03-30 16:35:28 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.38531900017698006" P_Z="0.5385248563209026" STUDIES="3" TAU2="0.0" TOTAL_1="211" TOTAL_2="201" WEIGHT="100.0" Z="0.6150452267538847">
<NAME>PDA - surgical closure</NAME>
<DICH_DATA CI_END="63.39802853151304" CI_START="0.11152972145332997" EFFECT_SIZE="2.659090909090909" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8020757529732556" LOG_CI_START="-0.9526093824533072" LOG_EFFECT_SIZE="0.4247331852599742" MODIFIED="2017-03-12 12:15:36 -0400" MODIFIED_BY="[Empty name]" ORDER="67" O_E="0.0" SE="1.6181156844609004" STUDY_ID="STD-Jiravisitkul-2017" TOTAL_1="43" TOTAL_2="38" VAR="2.618298368298368" WEIGHT="6.116131990752241"/>
<DICH_DATA CI_END="1.8023453985096773" CI_START="0.20233483367767607" EFFECT_SIZE="0.6038851351351351" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="8" LOG_CI_END="0.2558380220995194" LOG_CI_START="-0.6939293432711602" LOG_EFFECT_SIZE="-0.2190456605858204" MODIFIED="2015-02-24 08:13:27 -0500" MODIFIED_BY="[Empty name]" ORDER="31" O_E="0.0" SE="0.5578980518430193" STUDY_ID="STD-Lista-2015" TOTAL_1="148" TOTAL_2="143" VAR="0.3112502362502363" WEIGHT="93.88386800924776"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2017-03-30 16:35:28 -0400" MODIFIED_BY="[Empty name]" ORDER="206" O_E="0.0" SE="0.0" STUDY_ID="STD-Schwaberger-2015" TOTAL_1="20" TOTAL_2="20" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2017-07-12 04:46:04 -0400" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Use of initial sustained inflation vs standard inflations in newborns receiving resuscitation with chest compressions</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="2" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2017-03-27 10:21:07 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="338.48131012387773" SORT_BY="EFFECT_SIZE" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="5" TOTAL_2="4" WEIGHT="0.0" Z="0.0">
<NAME>Death</NAME>
<GROUP_LABEL_1>SLI</GROUP_LABEL_1>
<GROUP_LABEL_2>control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours SLI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="2" EVENTS_2="1" I2="0.0" ID="CMP-002.01.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2017-03-27 10:11:02 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="5" TOTAL_2="4" WEIGHT="0.0" Z="0.0">
<NAME>Death before discharge</NAME>
<DICH_DATA CI_END="11.92180497808075" CI_START="0.2147325849321288" EFFECT_SIZE="1.6" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.076342013179071" LOG_CI_START="-0.6681020478672214" LOG_EFFECT_SIZE="0.2041199826559248" MODIFIED="2017-03-27 10:11:02 -0400" MODIFIED_BY="[Empty name]" ORDER="67" O_E="0.0" SE="1.02469507659596" STUDY_ID="STD-Schm_x00f6_lzer-2015" TOTAL_1="5" TOTAL_2="4" VAR="1.05" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="5" EVENTS_2="4" I2="0.0" I2_Q="0.0" ID="CMP-002.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2017-03-27 10:28:03 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="5" TOTAL_2="4" WEIGHT="0.0" Z="0.0">
<NAME>Endotracheal intubation</NAME>
<GROUP_LABEL_1>Favours SLI</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard inflations</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours SLI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="5" EVENTS_2="4" I2="0.0" ID="CMP-002.02.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2017-03-17 11:23:56 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="5" TOTAL_2="4" WEIGHT="0.0" Z="0.0">
<NAME>Endotracheal intubation in the delivery room</NAME>
<DICH_DATA CI_END="1.4606855634238305" CI_START="0.6846100386287185" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.16455673696984163" LOG_CI_START="-0.1645567369698416" LOG_EFFECT_SIZE="0.0" MODIFIED="2017-03-17 11:23:56 -0400" MODIFIED_BY="[Empty name]" ORDER="133" O_E="0.0" SE="0.19332288373014034" STUDY_ID="STD-Schm_x00f6_lzer-2015" TOTAL_1="5" TOTAL_2="4" VAR="0.037373737373737365" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="4" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-002.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2017-03-27 10:29:57 -0400" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="5" TOTAL_2="4" WEIGHT="0.0" Z="0.0">
<NAME>Surfactant administration</NAME>
<GROUP_LABEL_1>Sustained inflations</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard inflations</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours SLI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="4" EVENTS_2="2" I2="0.0" ID="CMP-002.03.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2017-03-17 11:25:58 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="5" TOTAL_2="4" WEIGHT="0.0" Z="0.0">
<NAME>Surfactant given in the delivery room</NAME>
<DICH_DATA CI_END="4.68103910129636" CI_START="0.5468871215562028" EFFECT_SIZE="1.6" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="0.6703422688579099" LOG_CI_START="-0.2621023035460603" LOG_EFFECT_SIZE="0.2041199826559248" MODIFIED="2017-03-17 11:25:58 -0400" MODIFIED_BY="[Empty name]" ORDER="139" O_E="0.0" SE="0.5477225575051662" STUDY_ID="STD-Schm_x00f6_lzer-2015" TOTAL_1="5" TOTAL_2="4" VAR="0.30000000000000004" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="2" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-002.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2017-03-27 10:49:03 -0400" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="3" TOTAL_2="4" WEIGHT="0.0" Z="0.0">
<NAME>Chronic lung disease</NAME>
<GROUP_LABEL_1>Sustained inflations</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard inflations</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours SLI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="2" EVENTS_2="3" I2="0.0" ID="CMP-002.04.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2017-03-27 10:34:39 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="3" TOTAL_2="4" WEIGHT="0.0" Z="0.0">
<NAME>Moderate to severe BPD</NAME>
<DICH_DATA CI_END="2.3683628991581314" CI_START="0.3336158732561568" EFFECT_SIZE="0.8888888888888888" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.37444824916004665" LOG_CI_START="-0.4767532940548093" LOG_EFFECT_SIZE="-0.05115252244738131" MODIFIED="2017-03-27 10:34:39 -0400" MODIFIED_BY="[Empty name]" ORDER="324" O_E="0.0" SE="0.49999999999999994" STUDY_ID="STD-Schm_x00f6_lzer-2015" TOTAL_1="3" TOTAL_2="4" VAR="0.24999999999999994" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-002.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2017-07-12 04:45:34 -0400" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="5" TOTAL_2="4" WEIGHT="0.0" Z="0.0">
<NAME>Pneumothorax</NAME>
<GROUP_LABEL_1>Sustained inflations</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard inflations</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours SLI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-002.05.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2017-07-12 04:45:34 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="5" TOTAL_2="4" WEIGHT="0.0" Z="0.0">
<NAME>At any time</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2017-03-27 10:47:19 -0400" MODIFIED_BY="[Empty name]" ORDER="87" O_E="0.0" SE="0.0" STUDY_ID="STD-Schm_x00f6_lzer-2015" TOTAL_1="5" TOTAL_2="4" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="2" EVENTS_2="6" I2="0.0" I2_Q="0.0" ID="CMP-002.06" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2017-07-12 04:46:04 -0400" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="10" TOTAL_2="8" WEIGHT="0.0" Z="0.0">
<NAME>Cranial ultrasound abnormalities</NAME>
<GROUP_LABEL_1>Sustained inflations</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard inflations</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours SLI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="1" EVENTS_2="2" I2="0.0" ID="CMP-002.06.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2017-07-12 04:46:04 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="5" TOTAL_2="4" WEIGHT="0.0" Z="0.0">
<NAME>Intraventricular haemorrhage grade 3 to 4</NAME>
<DICH_DATA CI_END="2.980451244520187" CI_START="0.05368314623303219" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.47428202185110857" LOG_CI_START="-1.2701620391951838" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2017-03-17 11:31:06 -0400" MODIFIED_BY="[Empty name]" ORDER="78" O_E="0.0" SE="1.02469507659596" STUDY_ID="STD-Schm_x00f6_lzer-2015" TOTAL_1="5" TOTAL_2="4" VAR="1.05" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="1" EVENTS_2="4" I2="0.0" ID="CMP-002.06.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2017-03-17 11:30:45 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="5" TOTAL_2="4" WEIGHT="0.0" Z="0.0">
<NAME>IVH any grade</NAME>
<DICH_DATA CI_END="1.1450325249959568" CI_START="0.0673871633711304" EFFECT_SIZE="0.2777777777777778" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.05881782311752037" LOG_CI_START="-1.1714228246520948" LOG_EFFECT_SIZE="-0.5563025007672873" MODIFIED="2017-03-17 11:30:45 -0400" MODIFIED_BY="[Empty name]" ORDER="140" O_E="0.0" SE="0.7226494462892933" STUDY_ID="STD-Schm_x00f6_lzer-2015" TOTAL_1="5" TOTAL_2="4" VAR="0.5222222222222221" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="1" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-002.07" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2017-06-13 17:33:59 -0400" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="5" TOTAL_2="4" WEIGHT="0.0" Z="0.0">
<NAME>Retinopathy of prematurity (ROP) stage &#8805; 3</NAME>
<GROUP_LABEL_1>Sustained inflations</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard inflations</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours SLI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.6825866390249744" CI_START="0.04226297146417291" EFFECT_SIZE="0.26666666666666666" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.22597743597578532" LOG_CI_START="-1.374039971431223" LOG_EFFECT_SIZE="-0.5740312677277188" MODIFIED="2017-03-27 10:55:59 -0400" MODIFIED_BY="[Empty name]" ORDER="98" O_E="0.0" SE="0.939858145324779" STUDY_ID="STD-Schm_x00f6_lzer-2015" TOTAL_1="5" TOTAL_2="4" VAR="0.8833333333333333" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="2" EVENTS_2="4" I2="0.0" I2_Q="0.0" ID="CMP-002.08" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2017-03-27 11:01:12 -0400" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="5" TOTAL_2="4" WEIGHT="0.0" Z="0.0">
<NAME>Patent ductus arteriosus (PDA)</NAME>
<GROUP_LABEL_1>Sustained inflations</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard inflations</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours SLI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="2" EVENTS_2="4" I2="0.0" ID="CMP-002.08.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2017-03-27 11:00:17 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="5" TOTAL_2="4" WEIGHT="0.0" Z="0.0">
<NAME>PDA - pharmacological treatment</NAME>
<DICH_DATA CI_END="1.2469525686537284" CI_START="0.1718868146739953" EFFECT_SIZE="0.46296296296296297" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.09584993418125012" LOG_CI_START="-0.7647574364831119" LOG_EFFECT_SIZE="-0.3344537511509309" MODIFIED="2017-03-27 11:00:17 -0400" MODIFIED_BY="[Empty name]" ORDER="99" O_E="0.0" SE="0.5055250296034367" STUDY_ID="STD-Schm_x00f6_lzer-2015" TOTAL_1="5" TOTAL_2="4" VAR="0.2555555555555556" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2017-07-12 16:07:59 -0400" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2017-07-12 04:46:20 -0400" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Study flow diagram: review update.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAoEAAAOQCAYAAABGrqsyAABxV0lEQVR42uzdD4SV+d8//pusjCRL
spJkSDJGRiQrGSOSZK0VKx9Zt9uSZI2VZY1kZAwZSZIlIx8ZK1ZuI0kk6yNZw0qSlUiSjMTIykje
v+/r+t3XcZ3TOee6zszUNjOPB0dz/l3nus55vV/Xs+s617n+KxX813/9l4uLS8XLp8Znov7Un8ty
rT/mOG6LAxjobKVnXvCZqz/1x6IOgT5MWLyN0PhVf+oPnz1z/Ax9iLBYG6Hxi/pDEEQIBCth1J/6
Qw0gBIKVMOpP/aEGEALBShj1p/5QAwiBYCWM+lN/qAEh0LsAVsKoP/WHGhACF979+/e902iCGjDq
7x9nfaQGqBAC//7773TkyJG0atWqtHLlynTw4MH06tWrOb1IPH8hC+1DFd1CTXe+0/mQz19MA3ax
zOunvBJ+8+ZN2rx583u3x1g+cOBA6urqysb4t99+m6anp5tO48qVK4u20S+HFdSnWH8zMzMf/CwT
ZdNrtc5oXB99zPdvKdajELhEQ+APP/yQzp8/n969e5ddfvrppywI/lNFspzCyz/9fJZGCHz79m36
5ptvmj5meHg4nTx5sja+//3vf6ehoaH3Hvf06dPU398vBFrGjl57cnJyzuuLDxECF8t/2tQfn0wI
/Pzzz7OVQ3GF0m6L3rVr19Jnn32WVqxYkXp7e9Pt27drBdL4P8Fmr1m8LV736NGjafXq1Wn9+vVp
YmKi7ZbAWKGtWbMm26IxODhYab6q/M9xfHw8bdy4MXtuTOP69eu1+2dnZ9Phw4ezLSlbtmxJd+7c
Kf0f6FyWtWz5qjx/rsvY7LmXLl1Ka9euzebl2LFj2Zam4v13795N69atS9u3b287/69fv04bNmyo
e37+vsbn1Oy9i/+IxDTiPY9g8uzZs8rvcyd1sFRCYLxHEeKaPWbPnj3pwYMHdeN737597z1u7969
6a+//qq0wq362VcZQ1U+78bXKxsLH7IGhMB6p06dSmfPnq08ncePH9e2TMdnFPVw9erVyn2u6jqj
yvqorO7a9cyy5RACWTQhsFE07Gi4rRQHw40bN1J3d3fLIilbYZ85cyaNjIxkAzt2Ue3atatlsLpw
4UI2KOOxsSKLwT86OlppvsoCUgzmvAHENGJauRMnTmS7yfL/9W7dunVOIbBsWcuWr+z581nGZs/t
6+vLHh+vFyv42GJcvD+CYdz3/Pnz0vmPrxuMjY3VvUYsT0y3cV7jcefOnattuYrpRoCo+j53UgdL
JQTevHmz5WNiZVn8T15+W+OKPN7zqltdOvnsy8ZQlc+78fXKxsKHrAEhsF5sgY7/aMR/AKKuIli1
s23btnT58uXa5x2ffXF9U/bZdrLOaLc+qlJ37Xpm2XIIgSzaEBi7i6JptxKFnjf0siIpW2HH/+wj
dOampqZaDuIIJY0rs2JzbzdfZQGp+D/AxvtjhdX4unMJgWXLWrZ8Zc+fzzI2e25xa018bzS25rWb
Xrv5f/jwYfb8/P74d9OmTbVpFOelp6enbjnj79giWfV97qQOlkoIbPeYZmG/eNsff/yRrcSrvk6n
n33ZGKryeTe+XtlY+JA1IATW++KLL7J1Rj6uf/nll7brj2ZiS1vVz7aTdUa79dFc6q7s/S8uhxDI
ogyBL1++zL44Hv+bbyX+Z51vKYrvGs0nBDauoKKJtBrE8djGTfzFQdduvuYT3sq2mC3UspYtX9nz
5zNvze5rXGkXX79V2Gg3/7t37862FoX4H3T8L7vZ9IrPqfraxds6qYPlEALbvZ+xqz5Wqi9evOgo
BHb62bcbQ3P5vMvGwoesASGwvfgsIhi2E7v3IygeOnQoC2Od9smq64x266P59pmy5RACWXQhMILf
v/71r5ZHDjYWf+zWie8RHT9+fMFCYLtB3GzQVp2vTzEEdrp8Zc9f6BDYaYMsm//4XOJ7MyG+p5Xv
wpxPTbRrzlXqYDmEwMZdv8Xbvvvuu/Tbb7919Dpz+ezbjaG5fN5VxsKHqgEhsLMte43iu8axZfji
xYtZD4hd/J2M/07qpd36aL59pmw5hEAWVQiMLYDxva0nT550NNF79+5VHnQhpl+8befOnXWb5OML
7K2mF8Ehfo5gLvM1n8EeP7sxl93BnS5r2fKVPX+hQ2C8h7n4mZFimGj23CqfT3zJOr7TE7uCW81L
TKdxN03xQKWy97mTOlgOITBCUOzOz8UBOvEl+PzxrS6dvEbZZ99uDHX6eXc6Fha6BoTAerELNbYo
Fz+//D97zUQfKdZKp32yk3VGu/XRXOqueFvZcgiBLJoQ+J///CfbVVfcJdRO/O8njr4LjV+WjSOl
4nsU+eAqfkE7jl6MXYDF+YjdgvGl9PxLvgMDAy0HUnyRN/9CcFzier4yK5uv+QSk2Nwfu5fCrVu3
Wh4YMt9lLVu+sucvdAiM147Xidf7+eefsy+At3tu2fyHOFggjugrHjTQ7HOOow3z6cTPFxV//67s
fe6kDpZDCIyDb4qfS2y5aLeLdC5bAss++3ZjqOzzbvZ6ZWPhQ9aAEFjvxx9/zGos//xibMdn2O4/
gvlRtBHgduzY0VGf7GSd0bg+6qTPlPXMsuUQAlk0ITC+sN/JloDYzRLff8gPm8+bbb6Sj/9N5f+j
yhtwPDYGWDy2cdqnT5/O/jcZR5fFEVrtBlL8vln8DyymHyv//GjBsvmaT0CKLSfxO1gxzZh+fBG5
2ePmu6xly1fl+QsZAqPBxXd74kv20eiLPyDe6rll8x9bnOO+xq8ctPrphrjEEXuPHj2q/D53UgfL
IQTGZxArynxc7t+/v+2Pwc/1N9naffbtxlDZ593q9dqNhQ9ZA0Jgvfhsv//+++xzj58bi/8MtPP7
779nBw3F5xJhvdkPlJf1uarrjMb1USd9pqxnli2HEMiiCYFgsC+NEIj6U3+oAYRADHYrYdSf+kMN
IATSmYU4B7QmqAGj/lB/CIGgCWrAqD/UH0IgaIIaMOoP9YcQCJqgBoz6Q/0hBIImqAGj/lB/CIGg
CWrAqD+EQIRAsBL+p9y/f/+T+Bw+lflQfyynOlYDQuCiLqI4a0D8untfX58Bw5JZCc/1DB9z0fjT
QcVpN46v+b5uu+e3m4+lXCtC4Ief3+U4nqzThMBloXjOWVguK+GFnOd201ro8VX1lIhCoBD4Med3
KY4nIXAZh8A4b3Cc+7EoTrbd29tbux4nB49zNMb5FQcHB98rijhPZ5xfdvv27XX/g4nzdsZ0bt++
3bKI8nM3xom+44TzcbLv4mPHx8ezE3Xn5wAtGxStplflvMjNlqXV8r9+/br0vWt8nVbv46ZNm7Jz
6oYnT55kz/vjjz+y6y9evMjuRwissiXw3bt36ejRo9k5fNevX58mJiYq12HZmGs2hor/trqvyutW
me/iPDZ7rbNnz7bsFa3Gdln/KfsMYplinuOcuefOnXvv3LHt5mkp1V/Vvlnsk3Gu3njft2zZku7c
udPReqHx9crqp906abmPJyFwmYfAI0eOpLGxsbrbzpw5kxVYiJNzRxFHUb19+zYrpjgpd7Eojh07
lt2fnzC+WOg3btzITrLdrIjidaNxxnPjEq8VjaH42DgRfd4AYpox7VaqTK+swBuXpd3yl713xddr
N51//etf6bfffsv+/vXXX7NdBPH4/HpxGRAC290e9TcyMpLV2fT0dNq1a1flOqwy5tptgWt3X9nr
ls13lS2B+/fvbzvfjWN7Lv2ieFssz/Hjx2vz/OWXX773frSbp6VUf530zXDixIl05cqV7O/Jycm0
devWjvp44+uV1U+7dZLxJAQu6xD48OHDbItWFEv+P4jY8pQXbXwfIb8v1xjqiv9LC/E/tHyAtyui
np6e7H+Exf8drl27tu202xVhlemVFXjj67Vb/rL3rvh67aZz6dKlLFCG//mf/0mHDh3KLuG7777L
BjhCYJUQGFtGimNgamqqch1WGXNzXWmVvW7ZfFcJgWXz3Xj/XPpF8badO3dmW+pbzXOn/Wsx118n
fTNE6Gu8fz7rhbL6abdOMp6EwGUdAsPu3buz/1WEy5cvZ/9zKf4PqnHTdGzWblcU8T+tuD0K9eTJ
ky2LqDid4utVbcKN5jK9smmXLX+7967xf6KtphNhctu2bdnfsavi3r17WbgMsaskdhEjBFYJgY1b
mmJFUbUOq4y5ua60yl63bL6rhMBO5nsh+k/jl/ob57nT/rUU6m+un/d8P5ey+mm3TjKehMBlHwJj
c3yEjTyE3Lx5s+2ArFIU8Z2NmO7evXuzXSZVBliVxl32RdpOp1c27bLlb/felQXeovhOUWy2z8Nf
fIfkwYMHtesIgXMJgZ3W4YdaaZW9btl8f4gQON/+U7aiXc4hcC6f93w+lyr102qdZDwJgcs+BOah
I75H0HgQQgSbmZmZORdFbNVqVdgx7cbN/sX/XXfaROcyvbJply1/u/eucVnbTeebb75J//3f/13b
DZzvEs6vIwRWWQnHLsriGIj/SHRShx9qpVX2umXz/SFCYKf9Ij9oK7djx47sP265P//8Uwis+Hlv
3ry55e7gufTxTuqncZ1kPAmBQuD/E18qjaOIil8uDfEl3fwLpnGJ63G0VruiiO97xNFYod0XYWNa
cfRcPu3z589nzWGuTXQu0yubdtnyt3vvGpe13XRivuN7LzHP4ZdffsmOjMt3NSMEVlkJx1cSTp06
VftC+MDAQEd1WDbmoibjO075CqbqSqvsdcvmu1G7+agaAsv6RfFggqdPn2Zf9Wh3YEgsjxBY7fOO
A0NiF224devWeweGdNrHy+qn3TrJeBIChcD/J36iJP63VfyfbW5oaCg71Dzuj0aYH5HVqihis3t8
uTc/JD4ffM0en/8UQFziCLBHjx7Nq4l2Or0q0263/O3eu8bptZvOf/7zn7qfhsm/yPvXX3+pXCGw
o5Xw6dOns/9QxM9HxFGEndRh2ZiL/+jE8/ItM1VXWlXGUdl8N/7Hq9V8VA2BZf0iDwvRxyKERB9r
nE6saGN+4z+BMc/z2ZOxlEJg2ecdP6118ODB7P2NdUX0u/n28Xb1026dZDwJgUIgsGhXwnwaIth8
6O/wqj+Wa/9DCAQhkE9GbGWJAw3y32qLrVftDjhQf+h/CIGgCWrAS0D8EkD8Hlvsjouj+3/88ccs
DKo/9D+EQNAENWDUH+oPIRA0QQ0Y9Yf6QwgETVADRv2h/hACQRPUgFF/qD+EQNAENWDUH+oPIRA0
wQ/32vfv3/fBqr85v/ZyrJ/lOmZkCCEQrIQXwWt38tjiWS6sCNRfp6/dWD+fYn0s9DwthmUWAhEC
QQhc8GXSR9Rfu9uXQwhcDMssBCIEwjJYCccZK44ePZqdRzTOYTsxMVH32MePH2fnFo2T1cd5U7ds
2ZKuXr1am2bxUvb4/Dlx0vs4p2s8Zt++fXXnfi17fpy3NT8nb29vb7p9+3bd8gwPD2fnO43zxg4O
Diq6T7j+mtVP/Hv27Nm0cePG2rl64zzMxefEuXzXrVuX/dh2Lj9fcNRNf39/VmNlr91YNzEG4oe7
z5079955eNvNUzOt5mcuy1xW163eE/WHEAiaYNvXPnPmTBoZGcnC4PT0dNq1a1fdY7dt25YuX76c
3R+XWEHGyqbVdKs8fufOnenFixfZ/b/99lv67rvvKj+/uIK8ceNG6u7urt0XJ7ofHx+vnYotAu3o
6KjC+4Trr9lWsf3799dCU3zW8ZkX7z927Fj2GT9//jy7bWxsLKuTvGaiDuI/GVVDYNRMnLIvHwNf
fvnleyGw3Tw16nR+yqZfVtfN3hP1hxAImmDpa8eWg9nZ2dr12CpXNp+xtaKTZWp8fHHLX6y4+vr6
Kj8/AuGVK1eaPi6mE9MrKoZE9bc4QmBxK17jY5rd39PTU1fD8Xecm7lqCMz/U9JqDJTNU6NO56ds
+mV13ez56g8hEDTB0tdu3KIRK5vGx8auphMnTqRDhw5lK7jGFWSjTh/fOA/tnh9b/+J6rBhPnjz5
3nQad7cVA6T6W5zfCSyrn2afcePWw3bTbDxQo3EMVNmdPJ/5KZt+WV0vlnWzDCEEgpXwJx4CGx97
6dKltHXr1nTx4sV08+bNbHdTuxVkp49vXAmXPT8PiZOTk2nv3r3Zbrx2K1+Wfggsq+EqIWshQ2Cn
81M2/bK6FgL5KJ+fDxEWbwNs9fqxK6y46+rBgwd1j40vy8/MzNSuP3nypO0KrcrjHz58WLser71h
w4bKzy+6d+9e3X1xoEjxuSyPEBife+Pu1+J/LBqf01hTO3bsyL4LmPvzzz/nFQI7nZ+y6ZfVtRDI
RwuBPkhYnM2v1TzEQRinTp2qfSl+YGCg7rFxxGJ+dG4ExFhhFu+Pox/j+0j5Sq/s8fH3nj170suX
L7PXjINSigeGlD0/thLGEcKh8Qv08YX8/CCXuMT1ODKTTzcENtbPXEJgfM5xdG3+uZ8/fz5t3ry5
dn/xYKKnT59mR5+3OzAkamY+IbBsfjpd5rK6FgL5qCEw/zBdXFyqXT71Bnz69Onsi+vxExRxJGLx
sb///nv2JfRYkUYAi4MyivfHUYqxlSPf0lH2+Pg7XiNeK54TgbD4pfay58eu4PieYP5TGnkgzA0N
DWVbE2PasbL/lI+WFALfr5+5hMCQ/yRLXOJI3EePHtXuy/+zEDUTYSxqpnE68R+hqMn4maSoz3Zb
7qq8l+3mp9NlLqtrIZCPHgIxyFAbqIGlWH9v3ryp+4oCehBCoEGG2kANLMH6i63gcaBR/jt8sRWv
eMARehBCoEGG2kANLMH6i6PQ4/cyY1drnDHkxx9/zMIgehBCoEGG2kANqD/UgBCIQYbaQA2oP9SA
EIhBhtpADag/1IAQiEGG2kANqD/UgBCIQYbaQA2oP9SAEIhBhtpACET9IQRikKE2OppH9S0Eov4Q
AjHIWIYhECEQ9YcQiEHGAtVGnEc1P69qb29vun37dt39w8PD2TlV4xyog4ODdfc9fvw4O49pV1dX
No0tW7akq1ev1r1mnOt33bp12Y/xhtnZ2excqvGcePydO3fqHn/27Nm0cePG2rmB47yvzZYh/h4f
H2/52Hze43yr8QPA586dW/bj41MMgWX1l5+DN+qlv7+/7jzTVc4z3En9ldV72bxi/SQEYpCxqGqj
GJ5u3LiRuru7a/dduHAhC1r56bQmJibS6Oho7f5t27aly5cvZ/fHJYJWrHCLr3ns2LHsvvyE9ydO
nEhXrlzJ/o5TdW3durXu8fv376+t6GO+Yv5areAjgLZ6bMx3nPorXnt6ejp9+eWXQuAnGALb1d/Y
2FhWU3l9RT1GgOskBHZSf2X13m5esX4SAjHIWHS1EaEtXyk26uvry1aIRWUrvthKUnzN4pabECvd
xmm2e3zjSr3qY3fu3JlevHhRuz41NSUEfoIhsF399fT0ZFvucvF3nOe3kxDYSf2V1Xu7ecX6SQjE
IGPR1UZs0Yj7YgV48uTJuvtiy0fcV7wUQ16I3W2xdeXQoUPZSrtVaCtOs5N5bBcC2z02zgNbFCt3
IfC/FlX9NdZaY/10Ui9V6q+s3tvNK9ZPQiAGGYuyNiLIxa6xvXv3ZrtQ262Eiy5dupRtWbl48WK6
efNmtsvtUwmBja8jBH66B4a0qr9mtdJJDXRaf2X13m5esX4SAjHIWNS1ce/evbrHxZffZ2ZmWj4+
Droo3v/kyZPSlfDmzZvb7g5eqBC4Y8eO7LuAuT///FMI/MSPDm5Wf427g4tbeBunOd/6K6v3dvOK
9ZMQiEHGoquN2JIXRz2GxoMr4ov5IyMjtS/mx/U4QjMXR+bmRwM/ePAgC15lK+HYdRy71cKtW7fe
OzBkoUJg44EhMd9C4H8tuvqLo8Xz+jt//nwW4nLFAzWePn2aHSg0n/orq/d284r1kxCIQcaiq43Y
vRXf5ct/ZiVfyeWGhoayLX6xBSZWsvlRluH333/Pvjgfz4sVZHxpvmwl/ObNm3Tw4MHsOfG6ccDG
hwiB4dSpU9nPfaxfvz478rPxe4Jq4NOvv/wnYuISRwY/evSodl8exOK5EQ7jufOpv7J6L5tXrJ+E
QAwy1MYnKFb+GzZsUAPqDzWAEGiQoTaWsvgpkfgCf/6bb7FFabl/kV8IRA9CCDTIUBtLXhytHGeJ
iN16ccaQH3/8MQuDakD9oQYQAg0y1AZqQP2hBhACDTLUBmpA/aEGEAINMtQGakD9oQYQAg0y1AZq
QP2hBoRADDLUBmpA/aEGhEAMMtQGakD9oQaEQAwyFlltxGm09u/fX7v+999/pyNHjmRnaYifWIkz
LLx69ap2f/wdZ1Po6urKHvPtt9/Wnac3Fz/QXDzNVy7Ozxrz03hp50PPU7P5iTND5GLacZox/UFv
Qg0IgRhkLJna6OvrSw8fPqxd/+GHH7LztObnUI0fWo7QlRseHk4nT56s3f/vf/87O91WUfwm3zff
fNP0deNHnIvTq+JDz1Oj//3f/617frw/8buD+oPehBoQAjHIWBK18Z///Cft2bOn7rb4ceUIUsXw
VDzvbjz+wYMHdffv27evbhr9/f3p6dOnTV83zul79uzZjub/Q89TUbzOtm3b0uvXr+tuj9eI90t/
0JtQA0IgBhmLvjZiC9ulS5faPnd2djatW7eudn316tV1gSy/rSjO2NHqdWNrXASqNWvWZM+LrXqd
Wuh5Krpw4cJ7WxHDxYsXs/dLf9CbUANCIAYZi742duzYUbcFrZnYtXrixIna9c8+++y9xzS7rdXr
fvHFF9k0QwS3X375pW76VSz0PBXFVsAnT568d3u8T/F+6Q96E2pACMQgY9HXRhxI0bgFrejly5fZ
QRbF8+4WD5iYb+DKg2AEw6o+5DzFd/9aBb2YzzjoRH/Qm1ADQiAGGYu+NpqFp1yErH/961/vHWXb
uJu11W2d1GQ+H2VHDH/oeYrvKrbbPd0qWOoPehNqQAjEIGNR1UarLYGxtS1+kqXZbtG9e/dmP9mS
i59diYMuqr7u2rVr6w66iO/3bdmypXQZPuQ85eL7inH0cqtQbEug/oTPXgjEQGNJ1Ebs+pyamqq7
LY6A3b17d3rx4kXT58TPsYyMjNR+jiUOmIifZ6n6uj/++GM2jfz5o6Oj2c+/tPOh5ynX3d2dnj9/
3vS+P//803cC9Sh85kIgBhtLozbiaNc4GrZow4YNbX/MOULSwMBA9hMtcYkfmi7+cHPZ68ZWuu+/
/z57bvz0S4S3Mh96nnKxu7fVdyTjABZHBy/MfLgsnwtCIEIgn2ht3Llzp+VuU+rt2rUr3b17V3/A
+48QiCbD0qiNOGPI/fv3vUltxM/DxPukP+D9RwhEk2HJ1Mb169fTV1995U1qI94f5w7G+48QiCaD
2kAN4P1HCESTQW2gBvD+IwSiyaA2UAN4/xEC0WRQG6gBvP8IgWgyqA3UgPcfhEA0GdQGasD7D0Ig
mgxqAzXg/QchEE0GtYEa8P6DEIgmg9pADXj/QQhEk0FtoAa8/yAEosmgNlAD3n8QAjUZUBuoAe8/
CIGaDGrDm6AGvAnefxACNRnUBz57fAYgBGoyqBF85vgcQAjUZFj6deKyfC7ozyAEajJgfID6AyFQ
kwHjA9QfCIGaDBgfoP5ACNRkwPgA9QdCoCYDxgeoP4RANBkwPkD9IQSiyYDxAeoPIRBNBowPUH8I
gWgyYHyg/tQfQiCaDBgfqD8QAtFkwPhA/YEQiCYDxgfqD4RANBkwPlB/IASiyYDxgfoDIRBNBowP
1B8IgWgyYHyg/kAI1GQA4wP1B0KgJgPGh/GB+gMhUJMB4wPUHwiBmgwYH6D+QAjUZGCJjg8Xl3/y
AkIgQiCgvwBCIJo0oL8AQiCaNKC/AEIgmjSgvwBCIJo0oL8AQiCaNKC/AEKgD0mTBvQXQAjUpAH0
F0AI1KQB9BdACNSkAfQXQAjUpAH0F0AI1KQB8r7iHLggBCIEAkKgNwWEQIRAYLkFQUAIRAgEhEBA
CEQIBIRAQAhECASEQEAIRAgE9BdACESTBvQXQAhEk4b6OnZxcal2ASEQIRA1DMYMCIGaAahfMHZA
CNQIQO2CMQRCoCYAaheMIRACNQFQu2AMgRCoCYDaBWMIhEBNANQuGEMIgWgCoHbBGEIIRBMAtbuI
3L9/35uwRN8HYwgh0IrUm8CSqt0XL16kr7/+Oq1cuTJ1dXWlgwcPpunp6brHTExMpE2bNmWP2bFj
R7p3756x+3+uXbuWPvvss9TX15ddj/dosS1PcVoLNd2P9T7o/wiBaAIwx9odGBhIv/76a3r37l12
ib/37NlTu/+PP/5IO3fuTE+ePMnuv3z5ctq6daux+38iAF6/fv2j94gPFQL1Sv0fIRBNgGVSuxFi
2t126NChdPr06Y5e5+7du2ndunVp+/bttduHh4fTmjVr0qpVq9Lg4GDdc2ZnZ9Phw4ezLZFbtmxJ
d+7cqbv/p59+yp4X9/f396dnz561fb0Iq0ePHk2rV69O69evz7ZkFpc/33q3YsWK1Nvbm27fvt1y
eR4/fpwOHDiQvXY8J+bv6tWrtdeucs7Zdsve6v0qKlueZp9t4/2XLl1Ka9euzebh2LFj6c2bNy0f
W+Vz6eR9qfI+dPKZ6P8IgWgCsAC1m28JzF25ciXt3r27dn3jxo0dfb8rXidCRgSX58+fZ7dduHAh
jY+PZ7e9ffs2CzGjo6O155w4cSJ73TA5OVm3pXFsbCydO3eutqUyphXBpN3rnTlzJo2MjGS3xa7t
Xbt21S1/cevdjRs3Und3d8vl2bZtW7b1M3/9mJcIbK3e18brZcvebP4blS1PlRAYu6sjPMc0Ioz9
8MMPpSGw3efS6ftS9j508pno/wiBaAKwALX78OHD9Pnnn9e22sTfcVtx5Rwr5djSk39n8NWrV21f
p7ilLkQAiZV/UXElH+Gi8f5cT09PtkUqF3/HFq12rxdb1IrPmZqaqlv+CCt5uJmL2FpVNQSWLXuz
+W9UtjxVQmBxK97ff/+dNmzYUBoC230unb4vZe/DfD8T/R8hEE0AOqzd2KUXW9vyLTqx6/ebb76p
e96RI0fSzMxMbUtc7CLu5HUiSDbuIiwGhma7pJsFi2aPb/V6RTHfxcdFqM23jp08ebL0vYvdtbFV
LJY7Qmm7ANZ4vWzZq/SUsuWpEgIbA1ir97Bxi+lCvS9l70Onn4n+jxCIJgDzrN04irMYEOLv2OKX
i++hFbdCxf3tjvxs9jrNgly7kFN2X1kAKntOHmBiF+fevXvT8ePHW75+fJcutohdvHgx3bx5M9tl
20kILFv2uYTAKu9BJ+/RXEJgp+9L2fvQyWei/yMEognAAtRuMfDlIS++uJ/bt2/fe/c3PqfsdeKL
/rElsZXNmze33O0Yz23cHVwMoc1eL45mLj7nwYMHLZc/fu6m3biOEFyc9zhKupMQWLbsVXpK2fI0
TqPZPBZ/1id258dylYXAdp9Lp+9L2fvQyWei/yMEognAAtRuHJQQW3Piy/qxwo+DEOJI1Fx8Tysu
+e7is2fPZr8V2MnrxO7m/MCGuMT1OMo3F7sUY3dguHXr1nsHhsRr5s89f/58Fk7avV4csHDq1Kna
gRRx8Evjd93iaNQQByO02+IVB8bkR71G+Iplbxd2IiDHd/zy0Fa27FV6StnyFA+qePr0abaLv3Ee
4zXjuTGNn3/++b1d/s3+bve5lL0vnb4PnXwm+j9CIJoALEDtxk+FRBCMrWtxiQBY/PmQECEsvrgf
90fA+Ouvvzp+naGhoWzrUT6N4pGw8XpxwEms+OO7ZXHgQ1H+EzFxiSODHz16VPp68d3GOIAkfpIk
vsdYfFzsdozXiV2U8Zp5+Gjm999/zw5giMdFUIlA3C4ExhGv+XtZZdmr9pR2y5OHplieCMixPI3z
GIHtiy++yD7HH3/8se7gnlbL0+5zKXtfOn0fOvlM9H+EQDQBULv47L2PCIFoAqB28dl7HxEC0QRA
7ZJZiufxNYYQAtEEQO2CMYQQiCYAaheMIYRANAFQu2AMIQSiCaB2AWMIIRBNALULGEMIgWgCqF3A
GEIIRBNA7VpOUFsIgWgCqF3LiTEEQqAmAEumduP2OG9rnFN2+/bttduHh4ez89TG+XoHBwffe87F
ixezc9l+/vnn6ddff01jY2PZeWHjvK9xLtui/Ny/XV1dqb+/Pz179iy9fv06bdiw4b3zFM/Ozqbe
3t5K8/Hu3bvsXMfxuuvXr08TExPGKPo/QiCaAFQNgceOHcsC1fPnz7PbLly4kMbHx7Pb3r59m4Wr
0dHRuud899132X3/+7//m4Ww77//PrseATCCYC7C4blz57JpxSWmffjw4ey+I0eOZPcXnTlzJgt+
VeYjHjsyMpLdPz09nXbt2mWMov8jBKIJQNUQGFvmivr6+rJgVdTd3d3yOXF9Zmam6Wv19PRkW/dy
8XdsQQwPHz7MtgbmrxX/btq0qTbtsvmILZfFaU9NTRmj6P8IgWgCUDUENooteXF78bJixYqWz2l3
vfi84vRzu3fvzrb2hcuXL6cDBw5Uno/idPIQaYyi/yMEognAHENgs+BWNfQ1Xm8Mao33T05Opi1b
tmR/x3cBb968WXk+yqYN+j9CIJoAareDEBhhrLh7dz4hMKbVuDt45cqVdY/fuHFj9v2+2BXcyXzs
3LmzbtoPHjwwRtH/EQLRBGCuITAO1sgPuIhLXI+jeucSAuO5Z8+erU3r/PnzafPmzXWPj4M94uje
4kEfVeYjdh+fOnWqdmDIwMCAMYr+jxCIJgBzDYFhaGgoO+o3ttrF9/TyI4c7DYEh/4mYuMSRwY8e
Paq7/+XLl9nrRJDrZD7C6dOnswNN4mdk4mhiYxT9HyEQTQDULhhDCIFoAqhdwBhCCEQTQO0CxhBC
IJoAahcwhhAC0QRQu4AxhBCIJoDaBWPIGEII1ARA7YIxBEKgJgBqF4whEAI1AVC7YAyBEKgJgNoF
YwiEQE0A1C4YQyAEagKgdsEYAtWlCYDaBWMIIRBNANQuGEMIgWgCoHbBGEIIRBMAtQvGEEIgmgCo
XzB2EALRCEANgzGDEIhmAA117OLiUu0CQiBCIKC/AEKgJg2gvwBCoCYNoL8AQqAmDaC/AEKgJg2g
vwBCoCYNoL8AQqAmDaC/gBCIJg3oL4AQiCYN6C+AEIgmDegvgBCIJg3oL4AQiCYN6C+AEIgmDegv
gBCIJg3oL4AQiCYN6C+AEIgmDegvgBCIJg3oL4AQiCYN6C+AEKhJA+gvgBCoSQPoL4AQqEkD6C+A
EKhJA+gvgBCoSQPoL4AQqEkD6C8gBKJJA/oLIASiSQP6CyAEokkD+gsgBKJJA/oLIASiSQP6CyAE
okkD+gsgBKJJA/oLIASiSQP6CyAEokkD/2hfabwAQiBCICAEAkIgQiCw1IMgIAQiBAJCICAEIgQC
QiAgBCIEAkIgIAQiBAL6CyAEokkD+gsgBKJJw+IaZy7L54K6V/dCoBAIGGM+c+8By/IzVwEGKhhf
+OwtO8vws1cFBisYW6gBy8wyrAGVYMCCsYUasMwIgRiwYGyhBiwzQiAGLBhbqAHLjBCIAQvGFmrA
MiMEYsCCsYUasMwIgRiwYGyhBiwzQiAGLCzSsfXixYv09ddfp5UrV6aurq508ODBND09XfeYiYmJ
tGnTpuwxO3bsSPfu3dNb9NclXfevXr1KBw4cyO5btWpV+vbbb98bFz5zIRAFC4t6bA0MDKRff/01
vXv3LrvE33v27Knd/8cff6SdO3emJ0+eZPdfvnw5bd26VW/RX5d03Q8PD6eTJ0/W7v/3v/+dhoaG
fOZCIAoWls7Y+uyzz9redujQoXT69OmOXufu3btp3bp1afv27XUr1TVr1mRbVQYHB+ueMzs7mw4f
PpxtddmyZUu6c+dO3f0//fRT9ry4v7+/Pz179qzt68VK++jRo2n16tVp/fr12ZbM4vJfu3YtW8YV
K1ak3t7edPv2bf1V3dfdFoHwwYMHtetv375N+/btW9R1LwSiSYGx1XSLSO7KlStp9+7dtesbN25M
9+/f7+h1jh07lq2Qnj9/nt124cKFND4+nt0WK9NYOY2Ojtaec+LEiex1w+TkZN2WxrGxsXTu3Lna
FpmYVqw4273emTNn0sjISHZb7MLbtWtX3fLHyv769evZ3zdu3Ejd3d36q7qvq/sIUlE/RXHbYq57
IRBNCoytOg8fPkyff/55dn9c4u+4rRiYIijFlor8u1Pxfal2r1PcYhH6+vreW6EWg1es/Brvz/X0
9GRbTIpbT9auXdv29WLLSPE5U1NTdcsfW0/yla8aUPet6r5Rs9sWU90LgWhSYGzViS+/x1aHfItD
7Pr95ptv6p535MiRNDMzU9siEbuIO3mdWHnmK9v8Ertiq6xci49r9vhWr1cU8118XITauB4r6fje
l/6q7hvrvqzuFmPdC4FoUmBs1YmjI4tbI+Lv2OKXi11gxa0LcX88p5PXabZCq7pybXZf8TWqrAyb
PS6+TxW74Pbu3ZuOHz+uv6r79+q+Udnu4MVQ90IgmhQYWzXFFV++Mowvo+cavwzfuLKs8jpx8EVs
SWxl8+bNLXeLxXMbd4sVQ2iz14ujmYvPiS/4t1r++Lmb5dJ3hMDqdR//Ofj7779r19+8eZMdnLFU
6l4IRJMCYyv7cvnFixezL67HCim+XB5HGObiu3NxyXebnT17NvutwE5eJ3a75V9Yj0tcL65Q4wvy
sYs23Lp1670vyMdr5s89f/58tvJs93rxMzanTp2qfUE+DgIoPi6mH0cIhzhApN0WGf11edZ9HNVb
rNl4bLuvDiyGuhcC0aTA2KoTWzhihRhbGeISK8K4rShWRnEwRdwf36X666+/On6d+I212J2WTyM/
ojGfhzjgJMJYfCE+vtBelP9URlziCMlHjx6Vvl58xyu+SB8/zxHfYyw+LnYFx+vE7rp4zTwQ6q/q
Phf1GSEqv3///v2lB0R96nUvBKJJgbGFGrDMCIEYsGBsoQYsM0IgBiwYW6gBy4wQiAELxhZqwDIj
BGLAgrGFGrDMCIEYsGBsoQYsM0IgBiwYW6gBy4wQiAELxhZq4GMsU7vlUvcIgZoUGFvGlhpYwiGw
8aLuEQI1KWCZjy09pcnKsEVwWqqXxVJr//TzhUA0bDC2LLf3YlEt06eyJVAIFALRpGBRja04b26c
uzTOo9vb25tu375du292djY7Z2lXV1fasmVLunPnTt304hy8cU7h7du3124fHh7Ozlsa5zsdHBx8
7/Xa3R/THB8fTxs3bqyd1/f69euVn//u3bvsHLBxrtb169eniYkJPWWZhMC5LHOrWvr222/TrVu3
6sbIvn37Ko2Jdq9bvK1Krap1IVCTAj7o2CoGrRs3bqTu7u7afSdOnEhXrlzJ/p6cnExbt26tm96x
Y8eyldHz58+z2+KE9RHi4ra3b99mK6bR0dHac8ruj2keOHAgPXv2LLse8xXzV/X5Z86cSSMjI9n9
09PTadeuXXrKMu+vrZa5XS1FPe/YsSO7782bN9mYePjwYaUxUTUEltWqWhcCNSngg4+t2JKXr9Qa
xQouVjKtppeHtVxfX997jy+GyrL7m02zON9lz48tkrGlJjc1NaWnCIFNby+rpQhhEbQieP3www+V
x0TVEFhWq2pdCNSkgA8+tmLrX9wXK52TJ0/W3VfcCldlevH4xu9mxW7dqveXrTirTL8oVqJ6ihDY
TFkt5UFs7dq16eXLlx2PiSq13K5W1boQqEkBH2VsxXf7YtfW3r170/Hjx+ccAhtXop3eX7biLHt+
s/nVU4TAudRi2L9/f7bl72OEQLUuBKKI4R8dW/fu3at73ObNmyvt+srFgSUzMzMtp192f9mKs+z5
O3furNtF9uDBAz1FCJxTLZ4/fz77Tt7FixfrdgdXHRONr/vkyZO628pqVa0LgZoU8MHHVmzpiKMf
Q+OBGPEl+NhdHOJoyVZfgs+NjY3Vvqwel7je399f+f6yEFj2/MuXL6dTp07Vviw/MDCgpwiBTW9v
V0txYMiXX35ZF8j++uuvjsZE8YCrp0+fZgc8Fe8vq1W1LgRqUsAHH1uxK7inp6f2kyx5IAxxZOTB
gwez2+Mx8eXzsukNDQ1lP1uxcuXKbMWXHzlc5f6yEFhl+qdPn86+xxU/rRFf7tdThMBWWtVS1Hzx
J2Li77i/kzGR/4cqxlVsPYxx1TgvZbWq1oVAAxYwtlADlhkh0IAFjC3UgGVGCDRgAWMLNWCZEQIN
WMDYQg2oe4RAAxYwthACUfdCoAELxhZqwDIjBGLAgrGFGrDMCIEYsGBsoQYsM0IgBiwYW6gBy4wQ
iAELxhZqwDIjBGLAgrGFGrDMCIEYsGBsoQYsM0IgBiwYW6gBy4wQiAELxhZqwDIjBGLAgrGFGrDM
CIEYsGBsoQYsM0IgBiwYX/jsLTsL/tmrAoMVjDFjzGfuPWAZfuYqwEAF/m+cuSyfC+pe3QuBQiCg
vwDLc/x7CzRpQH8BhEA0aUB/AYRANGlAfwGEQDRpQH8BhEA0aUB/AYRANGlAfwGEQDRpQH8BhEA0
aUB/AYRANGlAfwGEQDRpQH8BhEA0aUB/AYRATdqbAOgvgBCoSQPoL4AQqEkD6C+AEKhJA+gvgBCo
SQPoL4AQqEkD6C+AEKhJA/oLIASiSQP6CyAEokkD+gsgBKJJA/oLIASiSQP6CyAEokkD+gsgBKJJ
A/oLIASiSQP6CyAEokkD+gsgBKJJA/oLIASiSQP6CyAEokkD+gsgBGrSAPoLIARq0gD6CyAEatIA
FftK4wUQAhECASEQEAIRAoGlHgQBIRAhEBACASEQIRAQAgEhECEQEAIBIRAhENBfACEQTRrQXwAh
EE0aFtc4c1k+F0AIFAIBY8xnDkIgmhUYX/jsQQhEowJjCzUAQiCaFBhbqAEQAtGkwNhCDYAQiCYF
xhZqAIRANCkwtlADIASiSYGxhRoAIRBNCoytSu7fv/9JTedDT1MNgBCIJgX/6NiamJhImzZtSitX
rkw7duxI9+7da/nYa9eupc8++yz19fV1/Lpl4ztefyEs1HTaTbNqr/qUepr+ihCIEAjGVs0ff/yR
du7cmZ48eZLevXuXLl++nLZu3dpyOhEAr1+/PqfXLRvfCzX+P0Qfmes0hUAQAtGk4JMcW4cOHUqn
T5+uPI3Gc9I2m26r4NdufLc63+3w8HBas2ZNWrVqVRocHKzd/u2336Zbt27VrscWyn379lU6b+7j
x4/TgQMHUldXVxZqt2zZkq5evVo3L3fv3k3r1q1L27dvL13u2dnZdPjw4Wx6Ma07d+60XOZWy5Mv
Q8zPihUrUm9vb7p9+7b+CkKgFRXwYcbWxo0bO/q+W+N0FioENrv/woULaXx8PNtC+fbt22y39ejo
aHbf8+fPs13Xcd+bN29Sd3d3evjwYaXX2bZtW7bFM54bl3PnzmWBrzgfx44dy+6L1ylb7hMnTqQr
V65kf09OTtZtSS0+rt3yhOJW1hs3bmTLpL+CECgEAh9kbEXwiMARW7BiS9bBgwfTq1evPokQGN87
jMBUVAxGEarOnDmTBakffvhhXn0ktr4Vn//s2bPKyx2hr3E+mz2ubHkiiOZhUn8FIdCKCvigYytu
P3LkSJqZmckCSgSr2EX8KYTACKiNu2KLYS0PVmvXrk0vX77sqI/E7t7YghfL2tPTUzqf7ZY75rPK
MpUtT4TxuC2W6eTJk/orCIFWVMCHG1urV6/OvtOWiyDY7ujahQiBrb631zitxsDXzP79+7MtcZ2E
wEuXLmXPuXjxYrp582a2y/djhMAqyxPhNHYp7927Nx0/flx/BSHQigr4MGMrDqYoihAYu4XnGgLj
KOOF2hIYB0fEFspWzp8/n33HLsJcJ7uDI/gWp9tunqss9+bNmyvtDi5bnqL4mZ6F7of6K0IgQiAY
WzXxHbS45AdJnD17Njvgoup0igczPH36NDvqdq4hMMJnfBcv3zI5NjaWRkZGavMW1/v7+7P7Yuvd
l19+WRew/vrrr6bTaRQHw+RHAz948CBb3rL5bJxm44EhsSs3xBHLrQ4Mabc8IZ4XRwiHeE/bbWHU
X0EIFAKBeY+tCH5xUELsBo4Ql4epKtPJw0rs6owtYhFi5hoC4wCPmIfi7uihoaFsy10+b/nRunEA
S/EnYuLvuL/VdIp+//337ICMmO8IXhGCy+azcZrFx8TRyTE/Mb34fuHU1FTLabVanhC7guP58V7G
tPJAqL+CECgEAsYWagCEQE0KMLZQAyAEalKAsYUaACFQkwKMLdQACIGaFBhb3gQ14E1ACESTAmML
NQBCIJoUGFuoARAC0aTA2EINgBCIJgXGFmoAhEA0KTC2ls6yx1k54uwcfX19agCEQDQpMLaWy7IX
z32sBkAIRJOCZTO2Hj9+nJ3DtqurKwtEW7ZsSVevXq3dn28pi/PZ9vb2ptu3b1e6LwwPD6c1a9ak
VatWpcHBwbr7PtR03717l44ePZqdn3f9+vVpYmKi5bLH7cVL7qeffsqmHe9Jf39/evbsWd1z4hy/
ca7l7du3668gBKJJweIcW9u2bUuXL1/OwlNczp07lwWcXHFL2Y0bN1J3d3el+y5cuJDGx8ezab59
+zYLY6Ojox98umfOnEkjIyPZ/dPT02nXrl1t+0rjfWNjY9l7kL8f8XqHDx+ue/yxY8ey+54/f66/
ghCIJgVLZ2zFFrhcBMIrV640fVy7++I7dhGUioph7kNNN7bOzc7O1q5PTU11FAJ7enrqnh9/r127
tu7xxS2D+isIgWhSsGjHVuzePHHiRDp06FAWgoqPjS1xcT3C18mTJ+ue1+6+2JrXuLu1GC4/1HTj
/qIIjJ2EwOK0mk1zMfco/RUhEE0KjK2aS5cupa1bt6aLFy+mmzdvZrs4Gx8bIXFycjLt3bs3HT9+
vNJ9zcJUs/C50NNtDIFlfaXxvrLnC4EgBKJJwZIYW3EAxczMTO36kydPWj723r17le+LAzqK021n
Iae7c+fOut25Dx486CgExvQbdwevXLlSCAQhEE0KltbY2rhxY+1o4AhMO3bsqHtsbCWMo3VDHKxR
3FLW7r44wCI/QCMucT2OtP3Q042DXE6dOlU7MGRgYKDjA0POnj1bm/758+fT5s2bhUAQAtGkYGmN
rd9//z07sCKCVoSvOCCj+NjYLRvfE4zdsPGYPJyV3ReGhoayLY2xJS1+hqZ4NO2Hmm44ffp0djBH
/IxMHN3bSQgM+U/ExCWODH706JEQCEIgmhQYW6gBEALRpMDYQg2AEIgmBcYWagCEQDQpMLZQAyAE
okmBsYUaACEQTQqMLdQACIFoUmBsoQZACNSkAGMLNQBCoCYFLO+xdf/+fR+i/gpCoCYFfKyxVXxe
J9Po5HmtHlv8u3j+XvRXEAI1KeAjhsCP8dqtHqs36K8gBGpSwAKPreHh4ew8u3Gu3MHBwZbPa5xG
PC/O4fv555+nc+fOtd2i9+zZs+w8vF1dXWnfvn1pamqq9DXyv+Pf4mXbtm3vLcPbt2/Thg0b0uvX
r33Y+isIgZoUUDa2Lly4kMbHx9O7d++yIDUxMZFGR0dLA1o85/jx49nzpqen05dfftk2zO3cuTO9
ePEie/xvv/2Wvvvuu8ohsPHvgYGBdPv27brliPn5/vvvfdD6KwiBmhRQZWz19fVlwayou7u7NIjl
oS4XW/baBbjilr94vXjduYbAycnJtHfv3rp53r59e/rzzz990PorCIGaFFBlbH322Wfv7W5dsWJF
aRBrPFAjgl2VAFd83bmGwLBx48b08OHDWgCNEIj+CkKgJgVUHFvFwFf2vOLfxRA3lxBYDJFzCYGn
Tp1KR44cyf6O7xr+8ssvPmT9FYRATQqoOrZ6e3vTzMxMxyFwx44d2XcBc7Ertl2Ay7fahdnZ2ewg
jvmEwHjtOMgkdknHQS1v3rzxIeuvIARqUkDVsTU2NpZGRkayLXlxiev9/f2lQazxwJB4TrsAt2fP
nvTy5cvs8fF6nR4YEoEvjjCOAJmLLYBfffVVOnbsmA9YfwUhUJMCOh1bQ0ND2U+9xC7aAwcOpOfP
n5eGshC7ZGMr3Pr167OjjNvt4o3747HxmAiEEeg6CYFxxHI8t/gad+7cyR7jbCL6KwiBmhTwD42t
2B1b3MX7MURYjQNE0F9BCNSkgI80ttauXZv9VEv++4I//fRTtnv4Y4nXjS2YJ0+e9OHqryAEalLA
xxpbN2/ezH6WJXbPxhlDfvzxxywMfizxHcHYreyAEP0VhEBNCjC2UAMgBGpSgLGFGgAhUJMCY8ub
oAa8CQiBaFJgbKEGQAhEkwJjCzUAQiCaFBhbqAEQAtGkwNhCDYAQiCYFxhZqAIRANCkwtlADIASi
SYGxhRoAIRBNCowt1AAIgWhSYGyhBkAIRJMCYws1AEIgmhQYX/jsQQjUqABjDJ85CIGaFbCQ48xl
+VwAIVAIBPQXQAhEkwb0F0AIRJMG9BdACESTBvQXQAhEkwb0F0AIRJMG9BdACESTBvQXQAhEkwb0
F0AIRJMG9BdACESTBvQXQAhEkwb0F0AIRJMG9BdACNSkAfQXQAjUpAH0F0AI1KQB9BdACNSkAfQX
QAjUpAH0F0AI1KQB/UV/ASEQTRrQXwAhEE0a0F8AIRBNGtBfACEQTRrQXwAhEE0a0F8AIRBNGtBf
ACEQTRrQXwAhEE0a0F8AIRBNGtBfACEQTRrQXwAhEE0a0F8AIVCTBtBfACFQkwbQXwAhUJMG0F8A
IVCTBmjTVxovgBCIEAgIgYAQiBAILPUgCAiBCIGAEAgIgQiBgBAICIEIgYAQCAiBCIGA/gIIgWjS
gP4CCIFo0rC4xpnL8rkAQqAQCBhjPnMQAtGswPjCZw9CIBoVGFuoARAC0aTA2EINgBCIJgXGFmoA
hEA0KTC2UAMgBKJJgbGFGgAhEE0KjC3UAAiBaFJgbH109+/f96HrryAEalJAu7E1MTGRNm3alFau
XJl27NiR7t2713Y68fh20y87e0VPT0969uxZ3fOvXr2a3T85OVl3ezwuHt+pWJaFfM+WQm/SXxEC
0aTA2Kr5448/0s6dO9OTJ0/Su3fv0uXLl9PWrVvbTmf79u3pzZs3cw5MQ0ND6Zdffqm77dixY2nX
rl3phx9+qLs9Hvfzzz//I71kqfUj/RUhEE0KjK2aQ4cOpdOnT3c0nQhmJ0+enHMIvHPnTvrqq6/q
boutff/5z3/e2+oXj4vHN3Pt2rX02WefpRUrVqTe3t50+/bt2us3bn1sNk/F2yIAHz16NK1evTqt
X78+29rZbpmGh4fTmjVr0qpVq9Lg4GCl+dJfQQhEk4JPZmxt3Lixo+/P5dOJ3cbFXbqd7jqNoBXB
K7x48aK29XHLli3p+fPn2d9v375NX3zxRctpRNC6fv169veNGzdSd3d3y3koC4FnzpxJIyMj2TxN
T09nWyVbLdOFCxfS+Ph49tiYxwiMo6OjleZLfwUhEE0KPomxFYElgkqEr66urnTw4MH06tWr0un8
/vvv6dtvv20ZAtt9JzD893//d7bFLESIyncDx7+xSzrE9wO/++67lvOybt26dOXKlUrLWxYCYxf3
7Oxs7frU1FTLENjX11cLsLli0Gs3X/orCIFoUvBJjK24/ciRI2lmZiYLNrGVK3YRV5lOhMAIg81C
YJk4ECS+B5hPJ4JoiH/zcBm7Z+NxrcRj47UilLXbPV0lBEYYLor3otUyxWMbw23s+q0yX/orCIFo
UvBJjK34DlxxC1iEn3ZH1han8/Tp02y38FxCYOxG3bx5c/Z3cddw/BvftcvvL85bM3fv3s22GO7d
uzcdP358wUJgu2UqBr5O50t/BSEQTQo+ibG1b9++uusRwmK3cNXpxJauOFBkLj+ncuDAgfSvf/0r
ff3113W3x8Egcdv+/fsrL1/8rE27eWi8HkdDF2+LI6SLgfPBgwctpxcHe8SW07nMl/4KQiCaFHwS
Yyu+uxaXCH9xOXv2bG3rXpXpxE/FxG7PuYTAPDzGLugqtzeKg0ny7xXGgRjFrXkRZOPAlTzYFQ/W
iC2YEUCL8xnfQzx16lTtwJCBgYGWyzQ2NlY7iCQucb2/v7/SfOmvIASiScEnM7Yi+MXBDLEbOMLR
X3/91dF0mv2cStmBISGOAo7bIpQVxfW4vfEHpRvFLtf4SZnYPRtBKw9eIY7WjeXJd23nYSweG7uZ
47GN8xM/lbN27dpsd3QE0HbBNn7rMHal5+9ZfkRz2XzpryAEokmBsYUaACEQTQqMLdQACIGaFGBs
oQZACNSkAGMLNQBCoCYFGFuoARACNSnA2EINgBCoSQHGFmoAhEBNCjC2UAMIgWhSYGyhBkAIRJOC
5T62FmrMzXc6//Tz9VcQAtGkwNgSAtUACIFoUrC0x1bj+XHHx8fTxo0ba+e9jXPu5mZnZ9Phw4dT
V1dX2rJlS7pz507L6bR7nXfv3qWjR49m595dv379e+ceDsPDw9k5fFetWpUGBwfr7qvyfPRXEAI1
KaCDEHjgwIH07Nmz7HoEwAiCuRMnTqQrV65kf09OTqatW7fOKQSeOXMmjYyMZGFueno67dq1q+7+
CxcuZGE07n/79m0W8kZHRys/H/0VhEBNCugwBOYBsNn9EfoieFWZTrv7t2/fnm1VzE1NTdXd39fX
997rdHd3V34++isIgZoU0GEIbHd/cavgQk4nAl/j/XG9eInd01Wfj/4KQqAmBSyCENh4fzHwNVP2
fPRXEAI1KWABQ+DmzZvntDv4yZMndbft3LmzbnfugwcP6u7v7e1NMzMzLZel7PnoryAEalLAAobA
ODDkxo0b2d+3bt1qeWBI8ajip0+fZgebFO+/fPlyOnXqVO3AjoGBgbr7x8bGagd+xCWu9/f3V34+
+isIgZoUsIAh8M2bN+ngwYNZyOvp6ckOyGj2uPyo4titG1sPr1279t60T58+ndauXZv9DEwcDdx4
/9DQUPYTMCtXrsxC5PPnzzt6PvorCIGaFGBsoQYQAtGkwNhCDYAQiCYFxhZqAIRANCkwtlADIASi
SYGxhRoAIRBNCowt1AAIgWhSYGyhBkAIRJMCYws1AEIgmhQYW6gBEALRpMDYQg2AEIgmBcYWagCE
QDQpMLZQAyAEalKAsYUaACFQkwKMLdQACIGaFGBsoQZACNSkAGMLNQBCoCYFGF/47EEI1KgAY8xn
7jMHo0CzAv5vnLksnwsgBAqBgP4CCIFo0oD+AgiBaNKA/gIIgWjSgP4CCIFo0oD+AgiBaNKA/gII
gWjSgP4CCIFo0oD+AgiBaNKA/gIIgWjSgP4CCIFo0oD+AgiBaNKA/gIIgZo0gP4CCIGaNID+AgiB
mjSA/gIIgZo0gP4CCIGaNID+AgiBmjSgv+gvIASiSQP6CyAEokkD+gsgBPIPN2kXFxeXD3UBhEDA
lh0AhEBACARACASEQACEQEAIBEAIBIRAAIRAQAgEQAgEhEAAhEBACARACASEQACEQEAIBEAIBIRA
AIRAoHX4c05YAIRAEAK9KQAIgbDcgiAACIEgBAKAEAhCIABCICAEAiAEAos/CAKAEAhCIAAIgSyP
EOSyvC8ACIEswwAI6gBACMSKH/UAgBCIFT7qAgAhECt71AWAEAhW9qgLACEQrOxRFwBCIFjZoy4A
hECwskddAAiBYGW/WNy/f19dACAEsrRX9lXPKvH69ev0008/pS+++CJ99tlnacOGDdn1mZmZOU0v
3Lp1K7v95s2b8w4nL168SF9//XVauXJl6urqSgcPHkzT09Nzeq9iGgv5fn/KQUsIBBACWaYhsMpj
Zmdn065du9LIyEh6+fJldtu7d+/S3bt30549e94LglVfM0Lb8ePH01dffTXvcDIwMJB+/fXXbL7i
En/HvP1TwWixhCshEEAIRAhs+ZgIf2NjY03vu3TpUjpx4kTHr/n8+fNsa2LYtGlTtiVvPuEktk5W
uS137dq17P4VK1ak3t7edPv27drrNm69bDYvxdsidB49ejStXr06rV+/Pk1MTLTdEjg8PJzWrFmT
Vq1alQYHByvNlxAIIATCRw+B27Zta7m1L3a59vT0dPyap06dSj///HP299DQUBaM5hNO8i2BuStX
rqTdu3e3DY3Xr1/P/r5x40bq7u5u+dplIfDMmTNZUI4wGO9HbDVtFQIvXLiQxsfHs8e+ffs2C4yj
o6OV5ksIBBAC4aOGwLLvyLW6v91rbty4MT1+/Dj7+8mTJ9nWwPmEk4cPH6bPP/+8tgUv/o7bWlm3
bl0WFKvMd1kI3L59e7bLPDc1NdUyBPb19WUBsKgY9NrNlxAIIATCog6BsYWrv7+/7rbYklc8QKTT
cHLgwIFsl3X+ncDTp0+nb775puXjYx7iNSKUnTx5cl4hsHG3c7x+qxAYj23c5Ry7fqvMlxAIIATC
Rw2BEUji6OBm/v777+y7a51MLwJbs6OH4/a5hpMIosUtbPF3HCXcThzYMjk5mfbu3ZsdoLJQIbDx
/uLfxcDX6XwJgQBCIHzUEBhb2M6ePdv0vqtXr2bf6as6vWfPnmW7ght3icb1uD0/QKTTcNIY+GJ6
ceBFFffu3Wt7IEfj9dh9Xbxt586ddbuDHzx40HJ6EZhbfb+ybL6EQAAhED5qCIwDGGJ3bQTBPMBE
yIrf+du3b1969epV5enFLs5WRxrHLtz8AJFOw8mxY8fSxYsXs3mNeYuDNeKI3Va2bt2aHYkb4kCM
4ta8CJQRVvNgVzxY4+nTp7UtmbnLly9nB7rkB4bEe9UqBMay5weRxCWuF3eNt5svIRBACISPGgLD
mzdvsi1+sbUu/7Ho2FXZKgC2ml4caRzTaqa4a7mTH53O5y+CYOwWjksEwFavE2KXaxzVHLtnY3ny
4BXiaN18OsUwFo/dvHlz9tjG+YgAu3bt2uynX+II4HZbFuN9jJ+TielHoIyfy6kyX0IggBAIVvao
CwAhEKzsURcAQiBY2aMuAIRAsLJHXQAIgVjZg7oAEAKxskddACAEYmWPugBACMTKHnUBIASClT3q
AkAIhKWwsl+oEDDf6XzI5ws6QiCAEIiV/Sc6/X/6+eoCACGQZbWybzzH7fj4eHZ+4PzctXHe3Nzs
7Gw6fPhw6urqSlu2bEl37txpOZ12r/Pu3bvs3L5x/tz169eniYmJ954zPDycnYd31apVaXBwsO6+
Ks+f6zKqCwCEQJZlCDxw4EB69uxZdj3CUYSk3IkTJ9KVK1eyvycnJ9PWrVvnFALPnDmTRkZGsjA3
PT2ddu3aVXf/hQsXsqAW9799+zYLeaOjo5WfP59lVBcACIEsyxCYh6Nm90foi+BVZTrt7t++fXu2
VTE3NTVVd39fX997r9Pd3V35+fNZRnUBgBDIsgyB7e5vt8VsPtOJwNd4f1wvXmLXbdXnz2fe1AUA
QiBC4EcKgY33FwNfM2XPFwKFQAAhEBYwBG7evHlOu4OfPHlSd9vOnTvrduc+ePCg7v7e3t40MzPT
clnKni8ECoEAQiAsYAiMA0Nu3LiR/X3r1q2WB4YUj7h9+vRpdiBG8f7Lly+nU6dO1Q7sGBgYqLt/
bGysduBHXOJ6f39/5ecLgUIggBAICxgC37x5kw4ePJiFvJ6enuyAjGaPy4+4jd26sfXw2rVr7037
9OnTae3atdnPwMTRwI33Dw0NZT8Bs3LlyixEPn/+vKPnC4FCIIAQCFb2qAsAIRAre1AXAEIgVvao
CwCEQKzsURcACIFY2aMuAIRAsLJHXQAIgWBlj7oAEALByh51ASAEgpV9G/fv3/+gj0cIBBAC4R9c
2bc6W0ecCaQTjY8XXoRAACEQFkkInM/8CCtCIIAQCAu8sv/pp5+y8/SuW7cuXbp0qaNz7T5+/Dg7
t29XV1d2vuAtW7akq1evNn1s/nf8W7yUTafZ4+Pf169fpw0bNmTnNC6anZ1Nvb29tevDw8PZOYZX
rVqVBgcHFYMQCCAEYmV/5syZdOrUqfTu3bv0/PnztH379o5C4LZt29Lly5ez58fl3LlzWZhsFwKb
TbeT6RSvHzlyJI2Njb23TBH8woULF9L4+Hg2zbdv36aJiYk0OjqqIIRAACGQ5b2y7+vrq9uSdufO
nY5CYDMrVqzoOAR2Mp3i9YcPH2ZbAyPkhfh306ZN6dmzZ7Xly+/LdXd3KwghEEAIZHmv7GPXa1EE
pk5D4N27d9OJEyfSoUOHUk9PT6Xg12y6VafTeH337t3Z1r4QWxNjt3Jx+Rp3JxfDpbrQ4gCEQITA
imGteFt8h3Dr1q3p4sWL6ebNm9ku5bmEwE6m03h9cnIy+w5hiO8CxvNzAp8QCCAEYmXfxJdffple
vXpVu/7gwYO24evJkyd1t8UBJTMzMy3vrxoCO5lOs+sbN27MvgsYu4KLIhQWp4sQCCAEYmX///z2
22/Z0cGxG3h6ejoNDAzUPTa2FF6/fj37++nTp9mu1uL9Eb7yo3gjQO7YsaNS8IujgON7e3Ekb5Xp
ND6+cXniYI/169e/d9BHHDQyMjJSO+Akrvf39ysIIRBACMTKPo6gjSNxv/jiiyyIFR8bATCCYOxW
3bx5c7p27Vrd/b///nt2oEU8JnbnXrlypVIIjLAWPwCd/wh02XQaH9+4PC9fvszuiyDbaGhoKNvS
GPdHiI1dzQiBAEIgVvaCgboAQAjEyl4wUBcACIEsw5V9p+f1RQgEEALByh51ASAEgpU96gJACAQr
e9QFgBAIVvaoCwAhEKzsURcAQiAs5pX9/fv3venqAkAIhOW2sm/8mZkP+fqCjPcOQAiET2Rl3/h6
woa6ABAC4RNa2ce5gPNzA/f29qbbt2+nR48epW3btr332Ldv36YNGzak169fZ9MbHx9PGzduzJ4b
04jzDOevVbzkt509e7bp43PDw8NpzZo1adWqVWlwcLB0PpstW7vHIQQCCIFY2f+fYhi7ceNG6u7u
zv4eGBh4L0BF6Pv+++9r0ztw4EB69uxZdj2mEdNq9Xpxff/+/S0ff+HChWz67969y8LmxMREGh0d
LZ3Pxtdq9ziEQAAhECv7/7Nu3bp05cqV926fnJxMe/furbtt+/bt6c8//6xNLw90zV6jWQhs9/i+
vr4sABYVA1yr+WycTrvHIQQCCIFY2f+f2FoW90UIO3nyZN19sev24cOH2d9TU1NZCGw3vbIQ2O7x
sQWvcTdy7NKtMp/F6bR7HEIggBCIlX3B3bt3a1v+jh8/Xrv91KlT6ciRI9nfhw8fTr/88ssHC4HF
wNfpfDZOu9XjEAIBhECs7Ju4d+9e3eOmp6dTV1dXevHiRXbAxps3bz5YCIyDOGZmZiotS+N8tlq2
xschBAIIgVjZ/5+tW7dmR9SGxoM1QmwB/Oqrr9KxY8c6CnURHuM7gLOzs5UePzY2lkZGRrLvBcYl
rvf391eaz+J0ypYHIRBACMTKPv3/u057enpqP9uSB6jcnTt3suc2ngGkLNTFkb3xg9H5j0aXPT4M
DQ2l1atXZ8+JI4+fP39eaT6L0ylbHoRAACEQK/sKIojFASKoCwAhEJbJyj52y8bWOUfZqgsAIRCW
0co+vte3Z8+eugNCUBcAQiBY2aMuAIRAsLJHXQAIgWBlj7oAEALByh51ASAEgpU96gJACAQre9QF
gBAIVvaoCwAhEKzsURcAQiBY2aMuAIRAsLJHXQAIgWBlj7oAEALByh51ASAEYmUP6gJACMQKH/UA
gBCIFT/qAAAhkKUcAFyW9wUAIRCWZQgGACEQhEAAEAJBCAQAIRCEQACEQEAIBEAIBIRAAIRAQAgE
QAgEhEAAhEBACARACASEQACEQEAIBEAIBIRAAIRAQAgEQAgEhEAAhEBACARACASEQACEQEAIBEAI
BINaCARACAQhEACEQBACAUAIBCEQACEQEAIBEAIBIRAAIRAQAgEQAgEhEAAhEBACARACASEQACEQ
EAIBEAIBIRAAIRAQAgEQAgEhEAAhEBACARACgXbhr/ECAEIgCIEAIATCUg+CACAEghAIAEIgCIEA
CIGAEAiAEAgs/iAIAEIgCIEAIASyvMKQy/K5ACAEglDgMwdACEQYwGcPgBCIEIAaAEAIRABADQAI
gSAAoAYAhEAQAFADAEIgCACoAQAhEAQA1ACAEAgCwKJy//59NQAgBMLSDgBVzzTx+vXr9NNPP6Uv
vvgiffbZZ2nDhg3Z9ZmZmTlNL9y6dSu7/ebNm/MOLC9evEhff/11WrlyZerq6koHDx5M09PTc3qv
YhoL+X5/KuFLCAQQAhECO3rM7Oxs2rVrVxoZGUkvX77Mbnv37l26e/du2rNnz3tBsOprRmg7fvx4
+uqrr+YdWAYGBtKvv/6azVdc4u+Yt38qLH2KgUsIBBACEQI7ekyEv7Gxsab3Xbp0KZ04caLj13z+
/Hm2NTFs2rQp25I3n8ASWyer3Ja7du1adv+KFStSb29vun37du11G7deNpuX4m0ROo8ePZpWr16d
1q9fnyYmJtpuCRweHk5r1qxJq1atSoODg5XmSwgEEALho4fAbdu2tdzaF7tce3p6On7NU6dOpZ9/
/jn7e2hoKAtG8wks+ZbA3JUrV9Lu3bvbhsbr169nf9+4cSN1d3e3fO2yEHjmzJksKEcYjPcjtpq2
CoEXLlxI4+Pj2WPfvn2bBcbR0dFK8yUEAgiB8FFDYNl35Frd3+41N27cmB4/fpz9/eTJk2xr4HwC
y8OHD9Pnn39e24IXf8dtraxbty4LilXmuywEbt++PdtlnpuammoZAvv6+rIAWFQMeu3mSwgEEAJh
UYfA2MLV399fd1tsySseINJpYDlw4EC2yzr/TuDp06fTN9980/LxMQ/xGhHKTp48Oa8Q2LjbOV6/
VQiMxzbuco5dv1XmSwgEEALho4bACCRxdHAzf//9d/bdtU6mF4Gt2dHDcftcA0sE0eIWtvg7jhJu
Jw5smZycTHv37s0OUFmoENh4f/HvYuDrdL6EQAAhED5qCIwtbGfPnm1639WrV7Pv9FWd3rNnz7Jd
wY27RON63J4fINJpYGkMfDG9OPCiinv37rU9kKPxeuy+Lt62c+fOut3BDx48aDm9CMytvl9ZNl9C
IIAQCB81BMYBDLG7NoJgHmAiZMXv/O3bty+9evWq8vRiF2erI41jF25+gEingeXYsWPp4sWL2bzG
vMXBGnHEbitbt27NjsQNcSBGcWteBMoIq3mwKx6s8fTp09qWzNzly5ezA13yA0PivWoVAmPZ84NI
4hLXi7vG282XEAggBMJHDYHhzZs32Ra/2FqX/1h07KpsFQBbTS+ONI5pNVPctdzJj07n8xdBMHYL
xyUCYKvXCbHLNY5qjt2zsTx58ApxtG4+nWIYi8du3rw5e2zjfESAXbt2bfbTL3EEcLsti/E+xs/J
xPQjUMbP5VSZLyEQQAgEAQA1ACAEggCAGgAQAkEAQA0ACIEgAKAGAIRABADUAABCIAIAagAAIRAB
ADUAIASCAIAaABACQQBADQAIgbAUAsBCBYP5TudDPl/48T4ACIEIAJ/o9P/p56sBAIRAllUAaDzH
7fj4eHZ+4PzctXHe3Nzs7Gw6fPhw6urqSlu2bEl37txpOZ12r/Pu3bvs3L5x/tz169eniYmJ954z
PDycnYd31apVaXBwsO6+Ks+f6zIKgQDolizLEHjgwIH07Nmz7HqEowhJuRMnTqQrV65kf09OTqat
W7fOKQSeOXMmjYyMZGFueno67dq1q+7+CxcuZEEt7n/79m0W8kZHRys/fz7LKAQCoFuyLENgHo6a
3R+hL4JXlem0u3/79u3ZVsXc1NRU3f19fX3vvU53d3fl589nGYVAAHRLlmUIbHd/uy1m85lOBL7G
++N68RK7bqs+fz7zJgQCoFsiBH6kENh4fzHwNVP2fCFQCAQQAmEBQ+DmzZvntDv4yZMndbft3Lmz
bnfugwcP6u7v7e1NMzMzLZel7PlCoBAIIATCAobAODDkxo0b2d+3bt1qeWBI8Yjbp0+fZgdiFO+/
fPlyOnXqVO3AjoGBgbr7x8bGagd+xCWu9/f3V36+ECgEAgiBsIAh8M2bN+ngwYNZyOvp6ckOyGj2
uPyI29itG1sPr1279t60T58+ndauXZv9DEwcDdx4/9DQUPYTMCtXrsxC5PPnzzt6vhAoBAIIgSAA
oAYAhEAEANQAAEIgAgBqAAAhEAEANcD/197dRVS2PnAcvzgXIxmJJEmOSNIkiYxj/CVDF0kXY266
SFeRkWRkGEmSxMhIRiLpIkkcSUYSSY50EUnSRSIjSY5IRpI8f7/nnLWtvdp7vexdc3r5fshpt973
LMfXWvvZCwARCBAA4BwAACIQIADAOQAARCBAAIBzAACIQIAAAOcAABCBAAEQws7OTkrT7mJ+zgEA
ABEIAuA/oieCJNtP77R01gXeDwAgAkEAPJL9irrPRA7vDwAQgUCEAPj06ZN9Tm9ubq6ZnJyM9Kzd
g4MD+2zfjIwM+7zgkpISMzc3FzfvxMSEKSwstM8S1jx6trAzzf3jXneiaX7bSraui4sLU1BQYJ97
7HZ1dWXKy8tjr/v6+uxziDMzM01nZycRCABEIPC0A+Dr16+mv7/f3NzcmOPjY1NVVRUpAisqKszU
1JRdXj8jIyM2Jt3zKtyOjo7sawWgAi7Z+v22HWZbidbV1tZmhoaGbh23wk9GR0dtqGqd19fXZnp6
2gwODhKBAEAEAk83ACorK+Oukq2vr0eKwER0xc89rxOAYUIvaNtB20q0rr29PXs1UJEn+u/vv/8e
2y+9B840R1FREREIAEQg8HQDwH1VzgmkqBG4sbFhenp6TFNTkykrK4u0fNQIjLIt9+v//e9/9mqf
6Gqirk663wPv7WR3XBKBAEAEAk8+AsOEmPtv+gxhaWmpGR8fN8vLy/aW8n1FYNRtuV8vLCzYzxCK
Pguo5R1PMfiIQAAgAgHfAPjjjz/M2dlZ7PXu7q5vWB0eHsb9TQNKzs/Pk06/ywiMui3vaw1O0WcB
dSvYTVHoXi8RCABEIPDkA+DPP/+0o4N1G/j09NTU1tbGzesezfvjxw97G9U9XWHljNBVQFZXV0eK
QI301WfzNFo3aFrQtvzWJRrskZ+ff2vQhwaNDAwMxAac6HVNTQ0RCABEIPC0A0CjYzXKNi8vz0aW
e15nNK9umRYXF5vv37/HTV9bW7ODKDSPbtXOzs5GikAFmb7k2fmiZ79pQdvyW5f8/fffdppi16u7
u9teadR0ha5uNROBAEAEAs8qAIgFzgEAIAIBIhBEIAAQgcBzCICoz+wFEQgARCBAAIBzAACIQIAA
AOcAABCBAAEAzgEAIAIBAgCcAwBABAIEADgHAIAIBB5zAOzs7PCmE4EAQAQCzy0AvF8zc5/bJ254
nwCACAQeSAB4t0eAEIEAQAQCDygA9Cxg59nA5eXlZnV11ezv75uKiopb815fX5uCggJzcXFh1zcx
MWEKCwvtslqHnjPsbMv94/xteHg44fyOvr4+k5WVZTIzM01nZ2fgfiY6Nr/5OAf43xoAEIEgAP7l
jrGlpSVTVFRkf6+trb0VUIq+1tbW2PoaGhrM0dGRfa11aF3JtqfX9fX1SecfHR2167+5ubGxOT09
bQYHBwP307stv/k4B/jfGgAQgSAA/pWbm2tmZ2dv/X1hYcHU1dXF/a2qqspsbW3F1ucEXaJtJIpA
v/krKyttALq5Ay7ZfnrX4zcf5wD/WwMAIhAEwL90tUzTFGG9vb1x03Trdm9vz/6+ublpI9BvfUER
6De/ruB5byPrlm6Y/XSvx28+zgH+twYARCAIAJeNjY3Ylb+urq7Y3/v7+01bW5v9vbm52YyNjd1b
BLqDL+p+etedbD7OAf63BgBEIAiABLa3t+PmOz09NRkZGebk5MQO2Li8vLy3CNQgjvPz81DH4t3P
ZMfmnY9zgPcCAIhAEAD/Ki0ttSNqxTtYQ3QFsLGx0bS3t0eKOsWjPgN4dXUVav6hoSEzMDBgPxeo
H72uqakJtZ/u9QQdD+cAAIAIBAFg/rl1WlZWFvvaFiegHOvr63ZZ7xNAgqJOI3v1hdHOl0YHzS/d
3d3m5cuXdhmNPD4+Pg61n+71BB0P5wAAgAgEARCCQkwDREAEAgARCDyTANBtWV2dY5QtEQgARCDw
jAJAn+t7+/Zt3IAQEIEAQAQCBAA4BwCACAQIAHAOAAARCBAA4BwAACIQIADAOQAARCBAAIBzAACI
QOCpBoD3S6ZBBAIAEQg8kABYWloy9fX197Jd54khTz2Owq5DT0JZWVmJvG7vj56IQgQCABEIpBUA
lZWVZm9v78EG1mOIwLD0PldVVaW1jvn5efsl3kQgABCBQMoB8Ndff9kvhPbOOz4+bnJyckx2draZ
mZkxQ0ND9rm+eh7v4uJi3Px9fX0mKyvLZGZmms7Ozrj1uH/k4ODAXg3TF1FrXSUlJWZubs5334OW
0bonJibs4+2cZwa79zHM8vv7+6aiouLWtq+vr01BQYG5uLiwzyHW8tpGeXm5WV1dTfj++s0ner/1
vqcSZ3qKi/ZT+0MEAgARCKQcAB0dHWZycvLWvC0tLTaAdNVJ8dfa2mpfK64UOI7R0VEbYIoTTZ+e
njaDg4NJt6uAmZqasvPrZ2RkxOTm5vrue9Ay2oYi7+joyL727mOY5aW2tvZWsOnYdOzijkvdQi8q
Kkp4nH7ziQJb73sq9H6nchWQCAQAIhBEYJzq6mqzu7t7a14nqJzX5+fnCdelW8kKK7dkcZRMKp9v
cy/j3d8w2/UuLwsLC6auri5uPt263drasr8rHGdnZwPfX7/5RO+33vdUKGgPDw+JQAAgAoH0AkC3
SL0R553X77WuevkNWki03Y2NDdPT02OamppMWVlZqDjxWybR8t6/hV1et5Sdz0dubm7GfX5PV/U0
r8K3t7c36fb85hO937p1HpX2K9V4JAIBgAgEERgn0VW4KBEYdBXPu6xuPZeWltpbosvLy+b4+Dg2
T6LPEAYtEyYCoyzf399v2tra7O/Nzc1mbGzsVkw6Vwy7urp8ozPRfO54jmp4eNh8+vSJCAQAIhBI
PwDSvRKogQ/uW8VB29XnC93z69ZmUJwELRMUgVGWPz09te/JycmJHexyeXmZcJ+2t7cD9yHRfKLP
TqZyJfDdu3c2LIlAACACgbQDQLcXddsz1QjUqOGBgYHYoAu9rqmpiYtMfV7v6urKvtbtVmdkrvPZ
uKA4CVomKAKjLq8rgI2Njaa9vT3u77qaqJG/4h184l6H33yizximcltXn7XUVUwiEACIQCDtANAo
VY04TTUCRaNVdbVNXwytUbruUNFIYf3d+dLotbU1GzMKI8WSBlAExUnQMkERGHX59fV1+zfv0050
i1efJ3S+hsYJPe86/OYT3WJ2jw4OG2dal/eqLREIAEQgkFIAKHjcV+5gbMTq6uF9efPmjQ3Fh3IO
AACIQDzDCBSNYuUZv//QlTZd2Uw0qvcu6Ha03u+Hdg4AAIhAPMMI1OfW9Bk4/PMZRj3RI9mAkHTp
fY767GAiEACIQIAAAOcAABCBAAEAzgEAIAIBAgCcAwBABAIEADgHAIAIBAHAm8A5wJsAAEQgCIBg
z+FrY57TV+MQgQBABIIIDMV5ysddbfe+IiSd9XqP8SmHEhEIAEQgiMBfFg0PPTyCHolHBAIAEQg8
yQDQc231TFo957a8vNysrq7G5nf/JFuH+2962saHDx/sc4Tz8/PN9PS075XAvr4+k5WVZTIzM01n
Z2eo/Qo6Nv0+MTFhH/vmPLtXX4adbLlExzg8POy7vN9+E4EAQAQCjyIA3JGztLRkioqKki4TFIFf
v341AwMDNgZPT0/tM3KTReDo6KiNNc17fX1tg3FwcDDUfgVFYENDgzk6OrKvtQ6tK+z7otf19fVJ
lw/abyIQAIhA4FEEQG5urpmdnQ0dSH7zVFVVmaurq9jrzc3NpBGo5+cqpNzcoee3X0ER6ARcmPhJ
dIx+ywftNxEIAEQg8CgCQFfZNE1x09vbm1YEeq+4KZaSRaDm9d6O1e3XMPsVFIFR4ieVY/TbbyIQ
AIhA4NEEwMbGhllYWDB1dXWmq6vrziLQL9DChFOy/fovI/CxBB8RCABEIBA6ALa3t32Dyvv68PAw
7m+vX7+Oux28u7ubdH0a7HF+fh5q37379V9GYJT9JgIBgAgEHmwAlJaW2pG44h0EkZGRYT8f54Sd
e7DGjx8/7AAM93qnpqZMf39/bGBIbW1t0kAbGhqKDSLRj17X1NSE2q+7jEDvMQYtH7TfRCAAEIHA
owgA3XItKyuLfR2KE16iUa/6MmXnC5WdGNO8xcXFdl7ver98+WJycnLsV6hoJK1foHV3d9uvk9H6
FZTHx8eh9usuI9B7jGGW99tvIhAAiECAAADnAAAQgQABAM4BACACAQIAnAMAQAQCBAA4BwCACAQI
AHAOAAARCBAA4BwAACIQIADAOQAARCBAAIBzAACIQIAAAOcAABCBwN0HADHBOQAARCBAAIBzAACI
QOCxBYD+Pjk5aZ/3m5mZadrb283l5WXcdD3HNzc311RVVd1al34fHx+3y2dnZ5uZmRkzNDRkn62r
Z/7qecOOg4MD+6zdjIwMO62kpMTMzc0l3NarV69MRUXFrf29vr42BQUF5uLign9UIhAAiEAgnQis
rKw0R0dH5ubmxvT19ZmOjo646QpDTTs+Pk4YgS0tLTbO5ufnbfy1trba1wpAxZ5DUTc1NWXXpZ+R
kREbfMm2VVtba1ZXV+P2d2Jiwq4fRCAAEIFAmhG4vr4ee/3z5097pc09XYGYbF3e6Xp9fn4eOjx+
++23pOtaWFgwdXV1cfPrauTW1hb/oEQgABCBQLoRqCtvbu6rd4mW80ag33a8r3W7t6enxzQ1NZmy
sjLfdUlhYaHZ29uzv29ubsZuSYMIBAAiEEgzAr3uKwL12cPS0lL7GcLl5WV7yzcoAvv7+01bW5v9
vbm52YyNjfGPSQQCABEI3EUEbm9vx16fnZ3Zz/XdRwRqve5bxYeHh4EReHp6ageSnJycmKysrLhB
KyACAYAIBNKIwJqaGhtbui38+fNn8+7du3uJQN3adUYD7+7umurq6sAIFF0BbGxstINGQAQCABEI
3FEEKszy8vLsSN2PHz/aq4H3EYFra2umqKjI3m7WbeHZ2dlQEaiBK5q2s7PDPyQRCABEIHBXEfjQ
6bODuooIIhAAiEDgmUSgblF3d3eb3t5e/hGJQAAgAoG7CoAXL1486P3WoJC3b98yIIQIBAAiECAA
wDkAAEQgQACAcwAAiECAAADnAAAQgQABAM4BACACQQCAcwAAQASCAADnAACACAQBwDE95GPR1+QU
FxfzfgEAEQgQAM/l3+f6+to+0zmdf0fOAQAgAkFkxFxdXZnm5mb7pcwlJSX2Ob1unz59MpmZmXZ6
TU2NOTo6ilvn+Pi4ycnJMdnZ2WZmZsYMDQ2Zly9f2ucDLy4uxs07OTlp59X62tvb474A+uDgwDQ0
NNjtaFnti55p7F5+Y2PDPt+4qqrq1jF9//7dLvfbb7+Z8vJys7q6Guk4JiYm7KPptLx3373C7Kvf
+vQUlA8fPtj3KT8/30xPTwcGmvb5x48fRCAAEIHA3QRAT0+PmZ2dtb8vLCyY0tLS2DQF3cjIiI0W
/YyOjtpgdK+zpaXFXqWan5+3UdPa2mpfK3oUP+55KysrbXxpXX19faajoyM2vaKiwkxNTcW2pe0q
+NzLKxw1Tc8S9h6TO7SWlpZMUVFRpONQ1Dlh6N13rzD76re+r1+/moGBAbvs6empefPmTWCgLS8v
px1yRCAAEIEgAmMUfYqRRMrKyuyVQod+15U89zq9V9TOz88TblO/u68y/vz50xQUFPjus66iJduW
d/2KMCdm0z2OVIIpyr7qSqZ7fzY3N0NvjwgEACIQuJMA8Lvi5Q6bRPN71+n3Wr97Y9O7bd3u1ZXJ
pqYmG27e5f2OSVf/nKuNvb29aR1HmGBKZ1+9x633hQgEACIQeDARmGiaX+wERaDf+vV5QV2V1GcM
detTt3yjhJUTZrqlXVdXZ7q6ulI+jqBgSndfg/aHCAQAIhC49wjUV44kux2sARbe26gvXrxIOQK3
t7djr8/OzuxnCB363X0r+fDwMOVQ03bc06IeR1Awpbuvr1+/jtuf3d1dIhAAiEDg10agbmnqVqqs
rKzcGhgyPDwcGwDx7du3uO+pixqBGuGqgRBa1+fPn+1Xnjg0ktYZYasoqq6ujhRW2m+NEBbvQIyo
xxEUTOnuqwaV9Pf3xwaG1NbWEoEAQAQCvzYC9TUt79+/t9Gkz7ZpkIKb89Uq+tGI2v39/ZQjUOGU
l5dnB3F8/PjRXg10rK2t2RG92g8FnQZ5RAkr3QrW/jtfyeIEYSrHERRM6e6rfPnyxQ5OycrKsqOV
iUAAIAKBXxqBz2X74N8AAIhAEAAECOcAAIAIBAHwK7gHYoAIBAAiECAAwDkAAEQgQACAcwAAiECA
AADnAAAQgQABAM4BACACAQIAnAMAQAQCvzoAdnZ2eGOJQAAgAoHHGADphIH3a1+ec2Q8hmMnAgGA
CASRci/rJALZRwAgAoFHEgDeZ95OTEyYwsLC2DN4FxcXky7n/nH+Njw87Lt8X1+ffV6unuHb2dnp
u896/q/WoXWVl5eb1dXV0Ou6urqyzwjOyMgwJSUlZn19PW668yxhTa+pqTFHR0eh34ebmxvz4cMH
8/LlS5Ofn2+mp6fj3seDgwPT0NBg161ltX09N9m9fj3rWM9QfvXqlamoqLh17NfX16agoMBcXFwQ
gQBABAL3H4GKFyeIFD6KmLDr1Ov6+vqky4+Ojtq4UkQpchRPg4ODSdfvjq+lpSVTVFQUel09PT1m
dnbW/r6wsGBKS0tj04aGhszIyIhdVj9al4Ix7Pvw9etXMzAwYJc9PT01b968iXsvFHVTU1Ox9Wtb
Cj73+tvb2+204+NjU1tbeytwdWytra2/5BwAABCBIALjrogFhUOiCPRbvrKy0oaPmzvsvBROTsh5
Ba1L0eed7igrK7NXCh36PScnJ/RxVFVVxS2/ubkZGFi6ophs/YrUurq6uPm1ja2tLSIQAIhA4NdE
YJRwCPOZQPffdDXNexvZHUdeuvqneRR8vb29cdOC1uV3BTPRNt3zhzkON8Wmdxnd7tXVyKamJhud
Qe+zbj3v7e3FolIR+KvOAQAAEQgi8F4j0C/4klFMOVfKurq6Qq/LLwITTYvyPgQtPzk5aa9Ejo+P
m+XlZXvLN2j9/f39pq2tzf6uW9NjY2NEIAAQgcDTiEAN7jg/P09p/7e3tyOtq7i4OOntYC3rvR3s
/rqboON4/fp13PK7u7tx0zVgxL1vh4eHge+zPluogSQnJyd2sMvl5SURCABEIPAwI1DRos+2OUEU
tLwGZDgDKvSj1xqZm4yupmmEsHgHZwStS7didTtZVlZWbg0M0ShmZ9lv377ZaAz7PmjQh67cOQND
NLDDPV23dp3RwArE6urqwPdZdAWwsbHRDhr5lecAAIAIBBEYKRw0GldX0JyraGGW7+7utlfKtIxG
4OpWaTK6FazP0zlf0+IEYZh16Ura+/fv7XJahz5n5+Z8RYx+FF/7+/uR3ocvX77YwSS6aqfRxe7p
a2trdpCKtq341OCWMBGor7HRtPt6EgsRCABEIIhAPECKWF1F5BwAACIQIACeCd1a1pVN7yhozgEA
IAIBAuAJ0+cr3759ey8DQjgHAIAIBBEIzgEAABEIAgCcAwAAIhAEADgHAABEIAgAcA4AABEIEADg
HAAAIhAgAMA5AABEIEAAcEy8XwBABAIEADgHAIAIBB5wAFxdXdln5+rLiktKSuzza92cZ+xqek1N
jTk6Oopb5/j4uH2GbnZ2tpmZmTFDQ0P2eb56bu7i4mLcvJOTk3Zera+9vT3ui5EPDg7s83+1HS2r
fZmbm4tbXs8Szs3NNVVVVbeOSc8V1nJ6znB5eblZXV2NdBwTExP2kW3Oc4rd+04EAgARCDy5AOjp
6TGzs7P294WFBVNaWhqbpqAbGRmxjzTTz+joqA1G9zpbWlrM9fW1mZ+ft/HX2tpqXyuiFFPueSsr
K218aV19fX2mo6MjNr2iosJMTU3FtqXtKvjcyyscNU3P2PUekzvclpaWTFFRUaTjUIA6YejddyIQ
AIhA4MkFgKJPYZRIWVmZvVLo0O+6kudep/eK2vn5ecJt6nf3VcafP3+agoIC333WVblk2/KuX8Ho
xGy6x/FUg4kIBAAiEERgjN8VL3eEJZrfu06/1/rdG5vebet2r65MNjU12XDzLu93TLr651xt7O3t
Tes4iEAAIAKBZx2Biab5hVlQBPqtX58X1FVJfcZweXnZ3vKNEoFOROqWdl1dnenq6kr5OIhAACAC
gScfAMXFxUlvB2uAhfc26osXL1KOwO3t7djrs7Mz+xlCh35330o+PDxMOdS0Hfe0qMdBBAIAEQg8
+QDQ7VfdSpWVlZVbA0OGh4djAyq+fftmozHVCNSo3NPTU7uuz58/m3fv3sWma2SuMxp4d3fXVFdX
R4pA7bdGCIt3YEfU4yACAYAIBJ58AOhrWt6/f2+jSZ/D29zcjJvufLWKfjSidn9/P+UIVOTl5eXZ
QRwfP360VwMda2trdkSv9kNBp0EeUSJQt4K1/85XvDhBmMpxEIEAQAQCBAABwjkAAEQgQAAQIJwD
AEAEAgRAaO6BGCACAYAIBAgAcA4AABEIEADgHAAAIhAgAMA5AABEIEAAgHMAAIhAgAAA5wAAEIEA
AQDOAQAgAgECAJwDAEAEggDglOYc4BwAACIQBAA4BwAARCAIAHAOAACIQBAA4BwAACIQIADAOQAA
RCBAAIBzAACIQIAIAP/2AEAEAsQA+DcHACIQeKhRwM/z+QEARPN/mxcH94jEBFoAAAAASUVORK5C
YII=
</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2017-07-12 04:46:29 -0400" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Risk of bias summary: review authors' judgements about each risk of bias item for each included trial.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAVMAAAIXCAIAAACuCCrEAAAa0ElEQVR42u3dv44lRxXH8ZGQEMEG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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2017-07-11 22:24:13 -0400" MODIFIED_BY="[Empty name]" NO="3" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included trials.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAjAAAAEACAMAAACavbxtAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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==
</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-04" MODIFIED="2017-07-12 16:07:48 -0400" MODIFIED_BY="[Empty name]" NO="4" REF_ID="CMP-001.01" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_MORE_DECIMALS:NO;SHOW_ROB_TABLE:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Use of initial sustained inflation vs standard inflations in newborns receiving resuscitation with no chest compressions, outcome: 1.1 Death.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAywAAAJgCAMAAABfvRcMAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-05" MODIFIED="2017-07-12 16:07:18 -0400" MODIFIED_BY="[Empty name]" NO="5" REF_ID="CMP-001.04" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_MORE_DECIMALS:NO;SHOW_ROB_TABLE:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Use of initial sustained inflation vs standard inflations in newborns receiving resuscitation with no chest compressions, outcome: 1.4 Endotracheal intubation.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA1kAAALACAMAAABWwUg+AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-06" MODIFIED="2017-07-12 16:07:59 -0400" MODIFIED_BY="[Empty name]" NO="6" REF_ID="CMP-001.05" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_MORE_DECIMALS:NO;SHOW_ROB_TABLE:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Use of initial sustained inflation vs standard inflations in newborns receiving resuscitation with no chest compressions, outcome: 1.5 Surfactant administration.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA4AAAAJgCAMAAADs2f1TAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK MODIFIED="2013-06-05 16:45:00 -0400" MODIFIED_BY="[Empty name]"/>
<APPENDICES MODIFIED="2017-07-12 04:57:01 -0400" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2017-07-12 04:49:20 -0400" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2017-07-12 04:49:20 -0400" MODIFIED_BY="[Empty name]">Standard search method</TITLE>
<APPENDIX_BODY MODIFIED="2017-02-17 11:36:01 -0500" MODIFIED_BY="[Empty name]">
<P>PubMed: ((infant, newborn[MeSH] OR newborn OR neonate OR neonatal OR premature OR low birth weight OR VLBW OR LBW or infan* or neonat*) AND (randomized controlled trial [pt] OR controlled clinical trial [pt] OR randomized [tiab] OR placebo [tiab] OR drug therapy [sh] OR randomly [tiab] OR trial [tiab] OR groups [tiab]) NOT (animals [mh] NOT humans [mh]))</P>
<P>Embase: (infant, newborn or newborn or neonate or neonatal or premature or very low birth weight or low birth weight or VLBW or LBW or Newborn or infan* or neonat*) AND (human not animal) AND (randomized controlled trial or controlled clinical trial or randomized or placebo or clinical trials as topic or randomly or trial or clinical trial)</P>
<P>CINAHL: (infant, newborn OR newborn OR neonate OR neonatal OR premature OR low birth weight OR VLBW OR LBW or Newborn or infan* or neonat*) AND (randomized controlled trial OR controlled clinical trial OR randomized OR placebo OR clinical trials as topic OR randomly OR trial OR PT clinical trial)</P>
<P>Cochrane Library: (infant or newborn or neonate or neonatal or premature or preterm or very low birth weight or low birth weight or VLBW or LBW)</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2017-07-12 04:57:01 -0400" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2017-02-17 12:17:54 -0500" MODIFIED_BY="[Empty name]">Risk of bias tool</TITLE>
<APPENDIX_BODY MODIFIED="2017-07-12 04:57:01 -0400" MODIFIED_BY="[Empty name]">
<P>We used the standard methods of Cochrane and Cochrane Neonatal to assess the methodological quality (to meet the validity criteria) of the trials. For each trial, we sought information regarding the method of randomisation, and the blinding and reporting of all outcomes of all infants enrolled in the trial. We assessed each criterion as low, high, or unclear risk. Two review authors separately assessed each study. We resolved any disagreement by discussion. We added this information to the table Characteristics of included studies. We evaluated the following issues and entered the findings into the risk of bias table.<BR/>
<BR/>1. Sequence generation (checking for possible selection bias). Was the allocation sequence adequately generated?<BR/>
<BR/>For each included study, we categorised the method used to generate the allocation sequence as:<BR/>
<BR/>a. low risk (any truly random process, e.g. random number table; computer random number generator);<BR/>b. high risk (any non-random process, e.g. odd or even date of birth; hospital or clinic record number); or<BR/>c. unclear risk.<BR/>
<BR/>2. Allocation concealment (checking for possible selection bias). Was allocation adequately concealed?<BR/>
<BR/>For each included study, we categorised the method used to conceal the allocation sequence as:<BR/>
<BR/>a. low risk (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes);<BR/>b. high risk (open random allocation; unsealed or non-opaque envelopes, alternation; date of birth); or<BR/>c. unclear risk.<BR/>
<BR/>3. Blinding of participants and personnel (checking for possible performance bias). Was knowledge of the allocated intervention adequately prevented during the study?<BR/>
<BR/>For each included study, we categorised the methods used to blind study participants and personnel from knowledge of which intervention a participant received. Blinding was assessed separately for different outcomes or classes of outcomes. We categorised the methods as:<BR/>
<BR/>a. low risk, high risk, or unclear risk for participants; and<BR/>b. low risk, high risk, or unclear risk for personnel.<BR/>
<BR/>4. Blinding of outcome assessment (checking for possible detection bias). Was knowledge of the allocated intervention adequately prevented at the time of outcome assessment?<BR/>
<BR/>For each included study, we categorised the methods used to blind outcome assessment. Blinding was assessed separately for different outcomes or classes of outcomes. We categorized the methods as:<BR/>
<BR/>a. low risk for outcome assessors;<BR/>b. high risk for outcome assessors; or<BR/>c. unclear risk for outcome assessors.<BR/>
<BR/>5. Incomplete outcome data (checking for possible attrition bias through withdrawals, dropouts, protocol deviations). Were incomplete outcome data adequately addressed?<BR/>
<BR/>For each included study and for each outcome, we described the completeness of data including attrition and exclusions from the analysis. We noted whether attrition and exclusions were reported, the numbers included in the analysis at each stage (compared with the total randomised participants), reasons for attrition or exclusion when reported, and whether missing data were balanced across groups or were related to outcomes. When sufficient information was reported or supplied by trial authors, we re-included missing data in the analyses. We categorised the methods as:<BR/>
<BR/>a. low risk (&lt; 20% missing data);<BR/>b. high risk (&#8805; 20% missing data); or<BR/>c. unclear risk.<BR/>
<BR/>6. Selective reporting bias. Are reports of the study free of suggestion of selective outcome reporting?<BR/>
<BR/>For each included study, we described how we investigated the possibility of selective outcome reporting bias and what we found. We assessed the methods as:<BR/>
<BR/>a. low risk (when it is clear that all of the study's prespecified outcomes and all expected outcomes of interest to the review have been reported);<BR/>b. high risk (when not all of the study's prespecified outcomes have been reported; one or more reported primary outcomes were not prespecified outcomes of interest and are reported incompletely and so cannot be used; study fails to include results of a key outcome that would have been expected to have been reported); or<BR/>c. unclear risk.<BR/>
<BR/>7. Other sources of bias. Was the study apparently free of other problems that could put it at high risk of bias?<BR/>
<BR/>For each included study, we described any important concerns we had about other possible sources of bias (e.g. whether a potential source of bias was related to the specific study design, whether the trial was stopped early owing to some data-dependent process). We assessed whether each study was free of other problems that could put it at risk of bias as:<BR/>
<BR/>a. low risk;<BR/>b. high risk; or<BR/>c. unclear risk.<BR/>
<BR/>If needed, we explored the impact of the level of bias by undertaking sensitivity analyses.</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS MODIFIED="2013-06-05 16:45:00 -0400" MODIFIED_BY="[Empty name]">
<EXTENSION ID="AFF_19748_1" NAME="PERSON" REVMAN_VERSION="5.1.0" TYPE="ADDRESS">
<ALIAS ALIAS_ID="19748">
<ADDRESS>
<DEPARTMENT>Unit of Clinical Epidemiology</DEPARTMENT>
<ORGANISATION>IRCCS Galeazzi Orthopaedic Institute</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>Milan</CITY>
<ZIP/>
<REGION/>
<COUNTRY CODE="IT">Italy</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
</ALIAS>
</EXTENSION>
<EXTENSION ID="AFF_74399549152662702367110526175045_1" NAME="PERSON" REVMAN_VERSION="5.1.0" TYPE="ADDRESS">
<ALIAS ALIAS_ID="74399549152662702367110526175045">
<ADDRESS>
<DEPARTMENT>Research &amp; Development, Section for HTA Analysis</DEPARTMENT>
<ORGANISATION>Skåne University Hospital</ORGANISATION>
<ADDRESS_1>Wigerthuset, Remissgatan 4, first floor</ADDRESS_1>
<ADDRESS_2>room 11-221</ADDRESS_2>
<CITY>Lund</CITY>
<ZIP>22185</ZIP>
<REGION/>
<COUNTRY CODE="SE">Sweden</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
</ALIAS>
</EXTENSION>
<EXTENSION ID="AFF_17716_1" NAME="PERSON" REVMAN_VERSION="5.1.0" TYPE="ADDRESS">
<ALIAS ALIAS_ID="17716">
<ADDRESS>
<DEPARTMENT/>
<ORGANISATION>Murdoch Childrens Research Institute</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>Melbourne</CITY>
<ZIP/>
<REGION/>
<COUNTRY CODE="AU">Australia</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
</ALIAS>
</EXTENSION>
<EXTENSION ID="AFF_17716_2" NAME="PERSON" REVMAN_VERSION="5.1.0" TYPE="ADDRESS">
<ALIAS ALIAS_ID="17716">
<ADDRESS>
<DEPARTMENT/>
<ORGANISATION>The Royal Women&#8217;s Hospital</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>Parkville</CITY>
<ZIP>3052</ZIP>
<REGION>VIC</REGION>
<COUNTRY CODE="AU">Australia</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
</ALIAS>
</EXTENSION>
<EXTENSION ID="FLOW_1" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="1">
<FLOWCHARTBOX TEXT="&lt;p&gt;TOTAL 8 studies included in quantitative synthesis (meta-analysis): 7 studies in the primary comparison and 1 in the secondary comparison&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;TOTAL 8 studies included in qualitative synthesis&lt;/p&gt;" WIDTH="125">
<FLOWCHARTBOX TEXT="&lt;p&gt;2 studies included in previous version of review&lt;/p&gt;"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;6 NEW studies included&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;6 full-text articles assessed for eligibility&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;86 records screened&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;86 records after duplicates removed&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;104 records identified through database searching (2015-2017)&lt;/p&gt;" WIDTH="120"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;5 additional records identified through other sources&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;80 record excluded&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
</EXTENSIONS>
</COCHRANE_REVIEW>